Back to GetFilings.com



Table of Contents

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

     
þ
  Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  For the fiscal year ended December 31, 2004 or
 
   
o
  Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  For the transition period from                      to                     

Commission File Number 001-31320

PROVINCE HEALTHCARE COMPANY

(Exact Name of Registrant Specified in Its Charter)
     
Delaware   62-1710772
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)
     
105 Westwood Place
Suite 400
Brentwood, Tennessee

(Address of Principal Executive Offices)
 

37027
(Zip Code)

(615) 370-1377
(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

     
Title of Each Class   Name of Each Exchange on Which Registered
     
Common Stock, $.01 par value per share   New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $.01 par value per share
(Title of Class)

     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. þ

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes þ No o

     The aggregate market value of the shares of Common Stock of the registrant held by nonaffiliates on June 30, 2004 (the last business day of the registrant’s second fiscal quarter) was $839,009,573 (based upon the closing price of $17.15 per share as reported on the New York Stock Exchange on such date).

     As of March 1, 2005, 50,285,014 shares of the registrant’s Common Stock were issued and outstanding.

 
 

 


Table of Contents

DOCUMENTS INCORPORATED BY REFERENCE

     None.

FORWARD-LOOKING STATEMENTS

Proposed Merger with LifePoint Hospitals, Inc.

     Our disclosure and analysis in this report contain some forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Such statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Our proposed merger with LifePoint Hospitals, Inc., projected to close by April 15, 2005, will affect a number of the forward-looking statements made in this report. Although we believe our management team and management of LifePoint share many of the same goals and operating strategies, some of the forward-looking statements contained in this report may become inapplicable once the operations of the two companies are combined upon completion of the merger. The discussions contained in this report apply only to Province Healthcare and do not give effect to the proposed merger, the operations of LifePoint, or the combined operations of our company and LifePoint following the merger.

     Any or all of our forward-looking statements in this report may turn out to be wrong. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many factors mentioned in our discussion in this report will be important in determining future results. Consequently, no forward-looking statement can be guaranteed. Actual future results may vary materially. Factors that may cause our plans, expectations, future financial condition and results to change include, but are not limited to:

  •   the highly competitive nature of the healthcare business;
 
  •   the efforts of insurers, healthcare providers and others to contain healthcare costs;
 
  •   the financial condition of managed care organizations that pay us for healthcare services;
 
  •   possible changes in the levels and terms of reimbursement for our charges by government programs, including Medicare and Medicaid or other third-party payors;
 
  •   changes in or failure to comply with federal, state or local laws and regulations affecting the healthcare industry;
 
  •   the possible enactment of federal or state healthcare reform;
 
  •   the departure of key members of our management;
 
  •   claims and legal actions relating to professional liability;
 
  •   our ability to implement successfully our acquisition and development strategy;
 
  •   our ability to recruit and retain qualified personnel and physicians;
 
  •   potential federal or state investigations;
 
  •   fluctuations in the market value of our common stock or notes;
 
  •   changes in accounting principles generally accepted in the United States or in our critical accounting policies;
 
  •   changes in demographic, general economic and business conditions, both nationally and in the regions in which we operate;

2


Table of Contents

  •   changes in the availability, cost and terms of insurance coverage for our hospitals and physicians who practice at our hospitals; and
 
  •   other risks described in this report.

     Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any additional disclosures we make in our Forms 10-K, 10-Q and 8-K reports to the Securities and Exchange Commission, as well as the discussion of risks and uncertainties described in Item 1 of this Report under the caption “Principal Risk Factors That May Affect Our Business and Results of Operations” and in the joint proxy statement/prospectus filed by our company and LifePoint Holdings, Inc. on February 18, 2005. These are factors that we think could cause our actual results to differ materially from expected results. Other factors besides those listed here also could affect us adversely. You are cautioned not to place undue reliance on such forward-looking statements when evaluating the information presented in this report. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

3


Table of Contents

PROVINCE HEALTHCARE COMPANY

FORM 10-K ANNUAL REPORT TO
THE SECURITIES AND EXCHANGE COMMISSION
FOR THE YEAR ENDED DECEMBER 31, 2004

TABLE OF CONTENTS

         
Item   Page
    5  
 
       
    5  
 
       
    26  
 
       
    26  
 
       
    27  
 
       
    28  
 
       
    28  
 
       
    28  
 
       
    29  
 
       
    44  
 
       
    44  
 
       
    44  
 
       
    44  
 
       
    45  
 
       
    46  
 
       
    46  
 
       
    52  
 
       
    56  
 
       
    58  
 
       
    58  
 
       
    59  
 
       
    59  
 
       
EXHIBIT INDEX
    59  
 
       
    65  
 EX-10.39 5TH AMENDMENT TO CREDIT AGREEMENT
 EX-21.1 LIST OF SUBSIDIARIES
 EX-23.1 CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO
 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO
 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO & CFO

4


Table of Contents

PART I

ITEM 1. BUSINESS

Overview

     We own and operate acute care hospitals located in non-urban markets. We currently own or lease 21 general acute care hospitals in 13 states with a total of 2,529 licensed beds. Our objective is to be the primary provider of quality healthcare services in the selected non-urban markets that we serve. We target hospitals for acquisition that are the sole or a primary provider of healthcare in the non-urban communities that they serve. After acquiring a hospital, we implement a number of strategies designed to improve financial performance. These strategies include improving hospital operations, expanding the breadth of services and recruiting and retaining physicians to increase market share.

Merger with LifePoint Hospitals, Inc.

     On August 16, 2004, our company and LifePoint Hospitals, Inc. announced that we had entered into a definitive merger agreement (the “Merger Agreement”) pursuant to which LifePoint will acquire our company. Pursuant to the terms of the Merger Agreement, our Company and LifePoint Hospitals, Inc. will each become wholly-owned subsidiaries of a newly formed holding company that will be publicly traded. Each of our shareholders will receive a per share consideration comprised of $11.375 of cash and a number of shares of common stock of the new company equal to an exchange ratio of between 0.3447 and 0.2917, which shares will have a value of $11.375 to the extent that LifePoint’s average share price is between $33.00 and $39.00. The exchange ratio will be 0.3447 if the volume weighted average daily share price of a share of LifePoint’s common stock for the twenty consecutive trading day period ending at close of business on the third trading day prior to the closing (the “LifePoint Average Share Price”) is $33.00 or less, and 0.2917 if LifePoint’s Average Share Price is $39.00 or more. If LifePoint’s Average Share Price is between $33.00 and $39.00, then the exchange ratio will be equal to $11.375 divided by the LifePoint Average Share Price.

     The proposed merger is projected to close by April 15, 2005, subject to approval by the stockholders of our company and LifePoint and the satisfaction of other customary closing conditions.

     Please see our statement regarding the effect of the proposed merger on the descriptions of our business contained in this report under the heading “Forward-Looking Statements” on the second page of this report.

What We Do

     Our general acute care hospitals typically provide a full range of services commonly available in acute care hospitals, such as internal medicine, general surgery, cardiology, oncology, orthopedics, obstetrics, rehabilitation, subacute care, as well as diagnostic and emergency services. Our hospitals also generally provide outpatient and ancillary healthcare services such as outpatient surgery, laboratory, radiology, respiratory therapy, home healthcare and physical therapy. In addition, certain of our general acute care hospitals have a limited number of licensed psychiatric beds. We provide capital resources and make available a variety of management services to our owned and leased hospitals.

The Non-Urban Healthcare Market

     According to 2000 U.S. Census Bureau statistics, over one-third of the people in the United States live in counties with a population of less than 150,000. In these non-urban areas, hospitals are typically the primary resource for healthcare services, and in many cases the local hospital is the only provider of acute hospital services. According to the American Hospital Association, as of November 2004, there were approximately 2,200 non-urban hospitals in the country. Of those, approximately 1,200 hospitals meet our acquisition criteria described below.

     We believe that non-urban areas are attractive markets in which to operate hospitals. Because non-urban service areas have smaller populations, only one or two hospitals generally are located in each market. We believe the size and demographic characteristics of non-urban markets and the relative strength of the local hospital also make non-urban markets less attractive to health maintenance organizations, other forms of managed care, and alternate site providers, such as full service outpatient surgery centers, rehabilitation or diagnostic imaging providers.

5


Table of Contents

     We believe that a significant opportunity for consolidation exists in the non-urban healthcare market. Despite the attractive characteristics of these markets for healthcare service providers, many not-for-profit and governmental operators of non-urban hospitals are under increasing pressure due to capital constraints, limited management resources and the challenges of managing in a complex healthcare regulatory environment. This combination of factors often causes these operators to limit the range of services offered through their non-urban hospitals. As a result, patients, by choice or physician direction, may obtain care outside of the community. This out-migration often leads to deteriorating operating performance at the hospital, further limiting its ability to address the issues that initially led to these pressures. As a result of these pressures, not-for-profit and governmental hospitals increasingly are selling or leasing these hospitals to companies, like us, that have greater financial and management resources, coupled with proven operating strategies, to help serve the community better.

Business Strategy

     The key elements of our business strategy are to:

     Acquire Hospitals in Attractive Non-Urban Markets. We seek to acquire hospitals that are the sole or a primary provider of healthcare services in their markets and that present the opportunity to increase profitability and local market share. We believe that approximately 1,200 non-urban hospitals in the United States meet our acquisition criteria; however, we remain selective in our acquisition decisions.

     Improve Hospital Operations. Following the acquisition of a hospital, we augment local management with appropriate operational and financial managers and, where appropriate, install our standardized information system. Using demonstrated best practices, the local management team implements expense controls, manages staffing levels according to patient volumes, reduces supply costs by requiring strict compliance with our supply arrangements and often renegotiates vendor contracts. By implementing this strategy, we seek to improve operating performance at each of the hospitals we acquire.

     Expand Breadth of Services to Increase Market Share and Reduce Patient Out-Migration. We seek to provide additional healthcare services and programs in response to community needs. These services may include specialty inpatient, outpatient and rehabilitation services. We also may make capital investments in technology and physical plant to improve both the quality of healthcare and the reputation of the hospital in the community. By providing a broader range of services in a more attractive setting, we encourage residents in our markets to seek care in our hospitals, thereby reducing patient out-migration and increasing hospital revenues.

     Recruit and Retain Physicians. We believe that recruiting physicians into local communities and retaining their services at our hospitals are key to increasing the quality of healthcare and breadth of available services. We work with the local hospital board, management and medical staff to determine the number and type of additional physicians needed in the community. Our Vice President of Medical Staff Development and his staff then assist the local management team and local hospital boards in identifying and recruiting specific physicians to the community to meet those needs. We added 148, 106 and 82 new physicians to our medical staffs during 2004, 2003 and 2002, respectively. Approximately 32% of the physicians recruited during the last three years were primary care physicians and approximately 68% were specialty-care physicians. We believe that expansion of services in our hospitals should assist in future physician recruiting efforts.

Acquisition Program

     We proactively identify acquisition targets and respond to requests for proposals from entities that are seeking to sell or lease hospitals. We identify attractive markets and hospitals and initiate meetings with hospital systems to discuss acquiring non-urban hospitals or operating them through a joint venture.

     We believe that it generally takes six to twelve months from a hospital owner’s decision to accept an offer until the consummation of a sale or lease of a hospital. After a potential acquisition has been identified, we undertake a systematic approach to evaluate and close the transaction. We begin the acquisition process with a thorough due diligence review of the acquisition target and its community. We use our dedicated teams of experienced personnel to conduct a formalized review of all aspects of the acquisition target’s operations, including Medicare reimbursement, purchasing, fraud and abuse compliance, litigation, capital requirements and employment and environmental issues. During the course of our due diligence review, we prepare an operating plan for the acquisition target, identify opportunities for operating efficiencies and physician recruiting needs, and assess productivity and management information systems. Throughout the process, we work closely with community leaders in order to enhance both the community’s understanding of our philosophy and abilities and our knowledge of the needs of the community.

6


Table of Contents

     From time to time, we enter into letters of intent with acquisition targets in connection with our evaluation of a potential acquisition. Such letters of intent generally are executed prior to the commencement of due diligence undertaken during the evaluation process. In addition to due diligence, proposed transactions to acquire hospitals for which we have signed a letter of intent are subject to numerous conditions and contingencies, including internal approvals of both our company and the acquisition target, receipt of regulatory approvals, receipt of attorney general approval, resolution of legal and equitable matters relating to continuation of labor agreements, review of supply and service agreements, receipt of satisfactory surveys, title insurance commitments and environmental and engineering surveys, and preparation and negotiation of documentation. In addition, our letters of intent generally provide that they may be terminated by either party without cause. Accordingly, we cannot assure you that any such proposed transaction for which we have signed a letter of intent will occur, or if it occurs, we cannot predict the values or condition of the assets that may be acquired, the purchase price of such assets or the terms of their acquisition.

     The acquisition of non-urban hospitals is competitive, and we believe that the acquiror will be selected for a variety of reasons, not exclusively on the basis of price. We believe that we are well-positioned to compete for acquisitions for several reasons. First, our management team has extensive experience in acquiring and operating previously under-performing non-urban hospitals. Second, we benefit from access to capital, strong financial and operating systems, a national purchasing organization and training programs focused on employee and patient satisfaction. Third, we believe our strategy of increasing access to, and quality of, healthcare in the communities served by our hospitals aligns our interests with those of the communities. Finally, we believe that the alignment of interests with the community, our reputation for providing market-specific, quality healthcare, and our focus on physician recruiting and retention enables us to compete successfully for acquisitions.

Hospital Operations

     Following the acquisition of a hospital, we implement our systematic policies and procedures to improve the hospital’s operating and financial performance. We implement an operating plan designed to reduce costs by improving operating efficiency and increasing revenue through the expansion of the breadth of services offered by the hospitals and the recruitment of physicians to the community. We believe that the long-term growth potential of a hospital is dependent on that hospital’s ability to add appropriate healthcare services and effectively recruit and retain physicians.

     Each hospital management team is comprised of a chief executive officer, chief financial officer, chief nursing officer and in certain instances a chief operating officer. We believe that the quality of the local management team at each hospital is critical to the hospital’s success because the management team is responsible for implementing the elements of our operating plan. The operating plan is developed by the local management team in conjunction with our senior management team and sets forth revenue enhancement strategies and specific expense benchmarks. We have implemented a performance-based compensation program for each local management team based upon the achievement of the goals set forth in the operating plan.

     The local management team is responsible for the day-to-day operations of the hospitals. Our corporate staff provides support services to each hospital, including physician recruiting, corporate compliance, reimbursement advice, standardized information systems, human resources, accounting, cash management and other finance activities, as well as tax and risk management support. Financial controls are maintained through utilization of standardized policies and procedures. We promote communication among our hospitals so that local expertise and improvements can be shared throughout our network.

     To achieve the operating efficiencies set forth in the operating plan, we do the following:

  •   evaluate existing hospital management;
 
  •   adjust staffing levels according to patient volumes using best demonstrated practices by department;
 
  •   where appropriate, install a standardized management information system;
 
  •   capitalize on purchasing efficiencies and renegotiate certain vendor contracts; and
 
  •   improve billing and collection policies and procedures.

     We also enforce strict protocols for compliance with our supply contracts. All of our owned or leased hospitals currently purchase supplies and certain equipment pursuant to an arrangement we have with HealthTrust Purchasing Group, Inc., an affiliate of HCA Inc. We also evaluate the vendor contracts, and based on cost comparisons, we may renegotiate or terminate such contracts. We prepare

7


Table of Contents

for the transition of management information systems to our standardized system prior to the completion of an acquisition, in order that the newly-acquired hospital may begin using our management information systems following completion of the acquisition.

Expansion of Services

     As part of our efforts to improve access to quality healthcare in the communities we serve, we add services at our hospitals on an as-needed basis. Added services and care programs may include specialty inpatient services, such as cardiology, rehabilitation and subacute care, and outpatient services such as same-day surgery. We believe the establishment of quality emergency room departments and obstetrics and gynecological services are particularly important because they are often the most visible and needed services in the community. We also make capital investments in technology and facilities to increase the quality and breadth of services available in the communities. By increasing the services provided at our hospitals and upgrading the technology used in providing such services, we believe that we improve each hospital’s quality of care and reputation in the community, which in turn may increase patient admissions and revenue.

Physician Recruitment

     We work with local hospital boards, management and medical staff to determine the number and specialty of additional physicians needed in the community. Our corporate staff then assists the local management team in identifying and recruiting specific physicians to the community to meet those needs. The majority of physicians who relocate their practices to the communities served by our hospitals are identified by our Vice President of Medical Staff Development and his physician recruiting staff, with assistance from independent recruiting firms at times. When recruiting a physician to a community, we generally guarantee the physician a minimum level of cash collections during a limited initial period and assist the physician with his or her transition to the community. We require the physician to repay some or all of the amounts expended for such assistance in the event the physician leaves the community prior to the end of the contract period. We prefer not to employ physicians; therefore, recruited physicians generally do not become our employees.

Physician Retention

     We have implemented a number of procedures to help retain physicians at our hospitals. We have designated a Vice President of Medical Staff Development to oversee all aspects of physician recruiting and retention and to work with our hospital chief executive officers in recognizing and addressing physician issues. Additionally, our company has instituted an “early alert system” in every hospital to address physician concerns and to identify physicians that are at risk of leaving.

Owned and Leased Hospitals

     We currently own or lease 21 general acute care hospitals in 13 states, with a total of 2,529 licensed beds. Of our 21 hospitals, 19 are the only providers of acute hospital services in their communities.

     On April 30, 2004, we sold Glades General Hospital in Belle Glade, Florida to the Health Care District of Palm Beach County. On June 1, 2004, we purchased the 286-bed Memorial Medical Center in Las Cruces, New Mexico from the City of Las Cruces, New Mexico and the County of Doña Ana, New Mexico. We have recently completed construction of a new 41-bed acute care hospital in Hardeeville, South Carolina, which opened November 29, 2004. We are currently constructing a new 60-bed acute care hospital in Fort Mohave, Arizona, which is expected to be completed in the third quarter of 2005 and a new 52-bed replacement acute care hospital in Eunice, Louisiana, which is expected to be completed in the second quarter of 2006.

     Our hospitals offer a wide range of inpatient medical services such as operating/recovery rooms, intensive care units, diagnostic services and emergency room services, as well as outpatient services such as same-day surgery, radiology, laboratory, pharmacy and physical therapy. Our hospitals frequently provide specialty services that include rehabilitation and home healthcare. Our hospitals currently do not provide highly specialized surgical services such as organ transplants and open heart surgery and are not engaged in extensive medical research or educational programs.

8


Table of Contents

The following table sets forth certain information with respect to each of our owned or leased hospitals as of March 1, 2005.

                         
    Licensed   Owned/     Date  
Hospital
  Beds   Leased     Acquired/Opened  
Ashland Regional Medical Center
    123 (1)   Owned   Aug. 2001
Ashland, Pennsylvania
                       
Bolivar Medical Center
    165 (2)   Leased   Apr. 2000
Cleveland, Mississippi
                       
Coastal Carolina Medical Center
    41     Owned   Nov. 2004
Hardeeville, South Carolina
                       
Colorado Plains Medical Center
    50     Leased(3)   Dec. 1996
Fort Morgan, Colorado
                       
Colorado River Medical Center
    49     Leased(4)   Aug. 1997
Needles, California
                       
Doctors’ Hospital of Opelousas
    171     Owned   Jun. 1999
Opelousas, Louisiana
                       
Ennis Regional Medical Center
    45     Leased(5)   Feb. 2000
Ennis, Texas
                       
Eunice Community Medical Center
    72     Leased(6)   Feb. 1999
Eunice, Louisiana
                       
Havasu Regional Medical Center
    138     Owned   May 1998
Lake Havasu City, Arizona
                       
Los Alamos Medical Center
    47     Owned   Jun. 2002
Los Alamos, New Mexico
                       
Medical Center of Southern Indiana
    96     Owned   Oct. 2001
Charlestown, Indiana
                       
Memorial Hospital of Martinsville and Henry County
    237     Owned   May 2002
Martinsville, Virginia
                       
Memorial Medical Center
    286     Leased(7)   June 2004
Las Cruces, New Mexico
                       
Minden Medical Center
    159     Owned   Oct. 1999
Minden, Louisiana
                       
Northeastern Nevada Regional Hospital (8)
    75     Owned   Jun. 1998
Elko, Nevada
                       
Palestine Regional Medical Center (9)
    249     Owned   July 1996
Palestine, Texas
                       
Palo Verde Hospital
    51     Leased(10)   Dec. 1996
Blythe, California
                       
Parkview Regional Hospital
    59     Leased(11)   Dec. 1996
Mexia, Texas
                       
Starke Memorial Hospital
    53     Leased(12)   Oct. 1996
Knox, Indiana
                       
Teche Regional Medical Center
    149     Leased(13)   Dec. 2001
Morgan City, Louisiana
                       
Vaughan Regional Medical Center (14)
    214     Owned   Oct. 2001
 
                     
Selma, Alabama
                       
Total licensed beds
    2,529                  


(1)   Includes 40 dually licensed skilled nursing and long-term care beds.
 
(2)   Includes 24 skilled nursing beds but excludes 35 long-term care beds. The lease expires in April 2040.
 
(3)   On March 15, 2005, the existing lease, which was set to expire April 2014, was amended and is now a prepaid lease which expires March 2035, and is subject to two five-year renewal terms. We have a right of first refusal to purchase the hospital.

9


Table of Contents

(4)   The lease expires in July 2012, and is subject to three five-year renewal terms. We have a right of first refusal to purchase the hospital.
 
(5)   The lease expires in February 2030, and is subject to three 10-year renewal terms at our option.
 
(6)   The lease expires in February 2009, and is subject to a five-year renewal at our option.
 
(7)   The lease expires in May 2044.
 
(8)   This 75-bed, 125,000 square foot hospital replaced the 50-bed Elko General Hospital in September 2001.
 
(9)   The hospital is owned by a partnership in which a subsidiary of ours is the sole general partner, with a 1.0% general partnership interest, and another subsidiary of ours has a limited partnership interest of 96.35%, subject to an option by the other non-affiliated limited partner (which currently owns a 2.65% interest) to acquire up to 10% of the total limited partnership interests.
 
(10)   The lease expires in December 2012. We have the option to purchase the hospital at any time prior to termination of the lease, subject to regulatory approval.
 
(11)   The lease expires in January 2011, and is subject to two five-year renewal terms. We have a right of first refusal to purchase the hospital.
 
(12)   The lease expires in September 2016, and is subject to two ten-year renewal terms at our option. We have a right of first refusal to purchase the hospital.
 
(13)   The lease expires in December 2041.
 
(14)   We acquired Selma Regional Medical Center, formerly known as Selma Baptist Medical Center, located in Selma, Alabama, in July 2001. In October 2001, we acquired Vaughan Regional Medical Center, which is also located in Selma, Alabama, approximately four miles from Selma Baptist. In April 2002, we consolidated the operations of Selma Regional Medical Center with Vaughan Regional Medical Center, and formed one regional hospital with two campuses. Upon completion of the consolidation, we changed the name of Selma Regional Medical Center to Vaughan Regional Medical Center — Parkway Campus, and we changed the name of Vaughan Regional Medical Center to Vaughan Regional Medical Center — Dallas Avenue Campus. The hospital is owned by a limited liability company in which a subsidiary of ours owns a 99% Class A membership interest and a non-affiliated entity owns a 1% Class B membership interest.

     Ashland Regional Medical Center is a general acute care facility with 123 beds located in Ashland, Pennsylvania, approximately 110 miles northwest of Philadelphia, Pennsylvania. Ashland, Pennsylvania has a service area population of approximately 65,000. The nearest competitor of Ashland Regional Medical Center is Regional Medical Center in Pottsville, Pennsylvania, located 20 miles from Ashland.

     Bolivar Medical Center is a general acute care facility with 141 acute care beds, 24 skilled nursing beds and 35 long-term care beds located in Cleveland, Mississippi. Established in 1962, the hospital is owned by Bolivar County, Mississippi. Cleveland is a manufacturing-based community with an estimated 16,000 residents and an estimated service area population of 55,000. The nearest competitor is South Sunflower County Hospital in Indianola, Mississippi, located 32 miles from Cleveland.

     Coastal Carolina Medical Center is a 41-bed acute care facility located in Hardeeville, South Carolina. Hardeeville is located in the low country of South Carolina, near Hilton Head, South Carolina and Savannah, Georgia. The hospital serves two of the fastest growing counties in the United States (Beaufort County and Jasper County). Its nearest competitor is Hilton Head Regional Medical Center on Hilton Head Island, South Carolina, which is approximately 22 miles from Hardeeville.

     Colorado Plains Medical Center is a 50-bed general acute care facility located in Fort Morgan, Colorado, approximately 70 miles from Denver. Fort Morgan is an agricultural-based community with an estimated 12,000 residents and an estimated service area population of 43,000. The original hospital was built in 1952. The hospital is the only rural-based Level III trauma center in Colorado, and one of only 10 such rural centers in the United States. The hospital’s major competition comes from the 276-bed Northern Colorado Medical Center located in Greeley, Colorado, which is approximately 45 miles west of Colorado Plains. East Morgan County Hospital, located nine miles away in Brush, Colorado, is the closest hospital to Colorado Plains and offers only limited services. Both of these competing hospitals are owned by the Lutheran Health System.

10


Table of Contents

     Colorado River Medical Center is a 49-bed general acute care facility located in Needles, California, approximately 100 miles southwest of Las Vegas, Nevada. The hospital, established in 1974, previously was owned by the City of Needles. Colorado River Medical Center is the only hospital serving a community base of approximately 20,000 people. The nearest competitor is Bullhead Community Hospital, located 22 miles away, which serves the Laughlin, Nevada and Bullhead City, Arizona areas.

     Doctors’ Hospital of Opelousas is a 171-bed general acute care facility, located in Opelousas, Louisiana, approximately 21 miles east of Eunice, Louisiana, where we operate Eunice Community Medical Center, a 72-bed healthcare facility and approximately 22 miles north of Lafayette, Louisiana. Opelousas is the parish seat with a population of approximately 21,000 in the city of Opelousas and approximately 100,000 residents of the St. Landry Parish. The primary competition for Doctors’ Hospital of Opelousas is the 134-bed Opelousas General Hospital, a county-owned not-for-profit facility located approximately five miles from Doctors’ Hospital of Opelousas. We completed a $3.0 million 32-bed addition to the hospital in April 2000.

     Ennis Regional Medical Center is a 45-bed general acute care facility located in Ennis, Texas, approximately 35 miles southeast of Dallas. Established in the mid-1950’s, the hospital is owned by the City of Ennis. The acute care facility is the only hospital serving the Ennis community, which has a total service area population of approximately 85,000 people. The nearest competitor is the 73-bed Baylor HealthCare System Waxahachie Hospital, located 17 miles from Ennis.

     Eunice Community Medical Center is a 72-bed general acute care facility located in Eunice, Louisiana. Eunice, Louisiana is a community of approximately 20,000 people, located approximately 50 miles northwest of Lafayette. The total service area consisting of St. Landry Parish has a population of approximately 100,000. The hospital is located 21 miles from Opelousas General Hospital, a 133-bed facility. We are currently constructing a 52-bed replacement hospital in Eunice, which is scheduled for completion in mid-2006. The replacement hospital is being constructed on property we will lease from the St. Landry Hospital Service District. The existing lease will terminate at the time the replacement facility commences operations. Eunice Community Medical Center competes with Savoy Medical Center located in Mamou, Louisiana, approximately 15 miles north of Eunice.

     Havasu Regional Medical Center is a 138-bed general acute care facility providing healthcare services for a population of over 41,000, primarily in the Lake Havasu City, Arizona area. Lake Havasu City is on the shore of Lake Havasu on the Colorado River border of California and Arizona. It is now the major population center of southern Mohave County, one of the fastest growing counties in the United States. Lake Havasu City has a service area population of 127,000 residents in the rapidly growing Colorado River basin. The nearest acute hospital competitor is Kingman Regional Medical Center in Kingman, Arizona, which is approximately 60 miles from Havasu Regional Medical Center.

     Los Alamos Medical Center is a 47-bed acute care facility located in Los Alamos, New Mexico. Los Alamos, New Mexico is located approximately 96 miles north of Albuquerque and 40 miles west of Santa Fe, New Mexico, and has a service area population of approximately 50,000. Los Alamos Medical Center is the only hospital in the community. The hospital’s nearest competitor is Espanola Hospital in Espanola, New Mexico, which is located approximately 35 miles from Los Alamos Medical Center.

     Medical Center of Southern Indiana is a 96-bed general acute care facility located in Charlestown, Indiana. Charlestown, Indiana is located approximately 16 miles northwest of Louisville, Kentucky, and has a service area population of approximately 48,000. Medical Center of Southern Indiana is the only hospital in the community. The hospital’s nearest competitor is Clark Memorial in Jeffersonville, Indiana, which is located approximately 20 miles from Medical Center of Southern Indiana.

     Memorial Hospital of Martinsville and Henry County is a 237-bed acute care facility located in Martinsville, Virginia. Martinsville, Virginia is located approximately 50 miles south of Roanoke, Virginia and has a service area population of approximately 100,000. Memorial Hospital is the only hospital in the county. Its nearest competitor is Danville Regional Medical Center in Danville, Virginia, which is located approximately 30 miles from Memorial Hospital of Martinsville and Henry County.

     Memorial Medical Center is a 286-bed acute care facility located in Las Cruces, New Mexico. Las Cruces is in the southeastern corner of New Mexico and has a primary service area population of approximately 150,000. The hospital’s nearest competitor is Mountain View Regional Medical Center in Las Cruces, which is located approximately four miles from Memorial Medical Center.

     Minden Medical Center is a 159-bed general acute care facility located in Minden, Louisiana. Minden, Louisiana is approximately 28 miles from Shreveport and has a service area population of approximately 64,000. The hospital’s nearest competitors are the Willis-Knight Medical Center and Bossier Medical Center, which are both located in Shreveport.

11


Table of Contents

     Northeastern Nevada Regional Hospital, which opened in September 2001 as a replacement to Elko General Hospital, is a 75-bed general acute care facility located in Elko, Nevada. Elko, Nevada is located 237 miles west of Salt Lake City, Utah, 295 miles northeast of Reno and 475 miles north of Las Vegas. Elko County’s population is approximately 55,000, with the primary population base residing in the City of Elko. The nearest acute care hospital competitors are in Salt Lake City, Utah.

     Palestine Regional Medical Center is a two-campus facility located in Palestine, Texas. Palestine, a community of approximately 19,000 residents, is located 50 miles south of Tyler, Texas and is roughly equidistant from Dallas and Houston. The total service area population for the hospital, which includes Anderson and eight surrounding counties, is estimated at 104,000 people. The facility is comprised of Palestine Regional Medical Center, the former Trinity Valley Medical Center, a 172-bed acute care facility that we acquired in October 1999 from Tenet Healthcare Corporation, and Palestine Regional Rehabilitation Hospital, the former Memorial Mother Frances Hospital, a 77-bed inpatient rehabilitation facility also located in Palestine, which we have owned since 1996. Palestine Regional Medical Center competes indirectly with two other hospitals, Trinity Mother Frances Hospital and East Texas Medical Center, both in Tyler, Texas.

     Palo Verde Hospital is a 51-bed general acute care facility located in Blythe, California, which is in southeast California on the Arizona border. The hospital is located in a community with a stable population of 20,000; however, the population increases significantly during the winter months due to a seasonal influx of retirees. The nearest competitor is Parker Hospital in Parker, California, which is approximately 45 miles from Palo Verde Hospital.

     Parkview Regional Hospital is a 59-bed general acute care facility located in Mexia, Texas, approximately 85 miles south of Dallas, Texas. Parkview’s primary service area includes Mexia and the surrounding Limestone County, as well as Freestone, Leon, and Hill counties. Mexia is the area’s largest city with a population of 7,000 people. The service area of the hospital includes approximately 50,000 residents. Parkview Regional Hospital is the only hospital in the community, but experiences competition from Waco hospitals, about 40 miles to the west.

     Starke Memorial Hospital is a 53-bed general acute care facility in Knox, Indiana, a community located approximately 50 miles from South Bend. The town of Knox has a population of approximately 8,000, and the population of Starke County is estimated to be 23,000. The hospital’s total service area, including the surrounding counties, is approximately 35,000. The nearest competing hospitals are the 36-bed St. Joe Marshall County Hospital, which is located 18 miles east in Plymouth, Indiana, and the 307-bed Porter Memorial Hospital, which is located 32 miles away in Valparaiso, Indiana.

     Teche Regional Medical Center is a general acute care facility with 149 beds located in Morgan City, Louisiana, approximately 67 miles south of Baton Rouge, Louisiana. The hospital has a service area of approximately 82,000 people. Teche Regional Medical Center is the only acute care hospital in the community it serves. The hospital’s nearest competitor is Thibodeaux Regional Medical Center, located approximately 30 miles away in Thibodeaux, Louisiana.

     Vaughan Regional Medical Center and Selma Regional Medical Center located in Selma, Alabama, were consolidated in April 2002 into a two-campus, 214-bed general acute care facility. Selma, Alabama, which has a service area population of approximately 90,000, is located approximately 50 miles west of Montgomery, Alabama and 97 miles south of Birmingham, Alabama. The Parkway Campus is comprised of the former Selma Regional Medical Center that we acquired from Baptist Health of Montgomery, Alabama in July 2001. The Dallas Avenue Campus is comprised of the former Vaughan Regional Medical Center that we acquired from Vaughan Regional Medical Center, Inc. in October 2001. The two campuses are located approximately four miles from each other. The hospital’s current nearest competitor is Baptist Medical Center, located approximately 48 miles away in Montgomery, Alabama.

Operating Statistics

     The following table sets forth certain operating statistics for our owned or leased hospitals classified as continuing operations for each of the periods presented.(1)

12


Table of Contents

                                         
    Year Ended December 31,  
    2004     2003     2002     2001     2000  
Number of hospitals owned at end of period
    21       19       19       18       13  
Licensed beds at end of period (2)
    2,533       2,189       2,207       2,063       1,253  
Beds in service at end of period
    2,157       1,933       1,933       1,839       1,168  
Inpatient admissions (3)
    76,107       72,630       69,107       52,053       44,194  
Adjusted admissions (4)
    141,671       131,557       120,990       86,198       76,358  
Net patient revenue per adjusted admission
  $ 6,157     $ 5,593     $ 5,372     $ 5,576     $ 5,496  
Patient days (5)
    323,949       307,195       299,138       227,596       204,550  
Adjusted patient days (6)
    602,962       556,331       523,307       376,539       352,999  
Average length of stay(days) (7)
    4.3       4.2       4.3       4.4       4.6  
Net patient revenue (in thousands)
  $ 872,275     $ 735,841     $ 649,954     $ 480,627     $ 419,657  
Gross revenue (in thousands) (8):
                                       
Inpatient
  $ 1,033,038     $ 903,740     $ 799,358     $ 588,203     $ 482,773  
Outpatient
    889,903       732,844       599,333       387,195       351,468  
 
                             
Total gross patient revenue
  $ 1,922,941     $ 1,636,584     $ 1,398,691     $ 975,398     $ 834,241  
 
                             


(1)   All statistics have been restated to exclude the ownership and operations of Glades General Hospital, which was sold on April 30, 2004. The statistics above have not been impacted by the disposal of Brim Healthcare, Inc. on June 30, 2004.
 
(2)   Beds for which a hospital has been granted approval to operate from the applicable state licensing agency.
 
(3)   Represents the total number of patients admitted (in a facility for a period in excess of 23 hours) and used by management and investors as a general measure of inpatient volume.
 
(4)   Used by management and investors as a general measure of combined inpatient and outpatient volume. Adjusted admissions are computed by multiplying admissions (inpatient volume) by the outpatient factor. The outpatient factor is the sum of gross inpatient revenue and gross outpatient revenue divided by gross inpatient revenue. The adjusted admissions computation equates outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.
 
(5)   Represents the total number of days the patients who are admitted stay in our hospitals.
 
(6)   Adjusted patient days are computed by multiplying patient days (inpatient volume) by the outpatient factor. The outpatient factor is the sum of gross inpatient revenue and gross outpatient revenue divided by gross inpatient revenue. The adjusted patient days computation equates outpatient revenue to the volume measure (patient days) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.
 
(7)   The average number of days admitted patients stay in our hospitals.
 
(8)   Represents revenues prior to reductions for discounts and contractual allowances.

Sources of Revenue

     We receive payments for patient care from private insurance carriers, federal Medicare programs for elderly and disabled patients, health maintenance organizations, preferred provider organizations, state Medicaid programs, TriCare, and from employers and patients directly. See Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” The approximate percentages of net patient revenue of our facilities (excluding Glades General Hospital) from these sources during the periods specified below were as follows:

                         
    Year Ended December 31,  
    Source   2004     2003     2002  
Medicare
    37.7 %     38.5 %     45.4 %
Medicaid
    10.1       10.3       11.3  
Other
    52.2       51.2       43.3  
 
                 
Total
    100.0 %     100.0 %     100.0 %
 
                 

13


Table of Contents

Management Information Systems

     Following the acquisition of a hospital, we implement our systematic procedures to improve the hospital’s operating and financial performance. In many cases, where appropriate, one of our first steps is to convert the newly-acquired hospital to our broad-based management information system. Our hospital management information system contains the primary software required to run an entire hospital, bundled into one software package. This software generally includes features such as a general ledger, patient accounting, billing, accounts receivable, payroll, accounts payable and pharmacy.

Quality Assurance

     Our hospitals implement quality assurance procedures to monitor the level of care. Each hospital also has a medical executive committee, which reviews the professional credentials of physicians applying for medical staff privileges at the hospital. Each facility monitors outcomes along with procedures performed and the quality of the logistical, medical and technological support provided to the physician. We survey our patients either during their stay at the hospital or subsequently by mail to identify potential areas of improvement. All of our hospitals are accredited by the Joint Commission on Accreditation of Healthcare Organizations, except Coastal Carolina Medical Center, which is in process for its initial survey.

Regulatory Compliance Program

     We currently operate a voluntary Corporate Compliance Program designed to help reduce the risk and prevent the potential exposure for misconduct. It is an aid to the development of effective internal controls that promote adherence to applicable Federal and state law, and the program requirements of Federal, state and private health plans. The adoption and implementation of this program significantly advances the prevention of fraud, abuse and waste in our health care efforts while at the same time furthering the fundamental mission of our hospitals, which is to provide quality care to patients. In practice our compliance program effectively articulates and demonstrates our commitment to the compliance process. Our compliance program focuses on all areas of regulatory compliance, including physician recruitment, reimbursement, cost reporting practices and laboratory and home healthcare operations. Each of our hospitals designates a compliance officer and undergoes an periodic (18 to 24 months) risk assessment to determine potential risk issues and develop plans to correct problems should they arise. In addition, all of our employees are given a thorough introduction to our ethical and compliance guidelines, as well as a guide to the proper resources to address any concerns that may arise. We also conduct periodic training to re-emphasize our established guidelines every 18 to 24 months. We regularly monitor our corporate compliance programs to respond to developments in healthcare regulation and the industry. We also maintain a toll-free hotline to permit employees to report compliance concerns on an anonymous basis. In addition, the staff is available to answer questions of compliance encountered during the day-to-day operation of a facility.

Management and Professional Services

     On June 30, 2004, we sold the stock of Brim Healthcare, Inc., our wholly-owned subsidiary that provided management services to primarily non-urban hospitals, to an unaffiliated investor group for approximately $13.2 million in cash.

Competition

     The primary bases of competition among hospitals in non-urban markets are the quality and scope of medical services, strength of referral network, location, and, to a lesser extent, price. With respect to the delivery of general acute hospital services, most of our hospitals face less competition in their immediate patient service areas than would be expected in larger communities. While our hospitals are generally the primary provider of healthcare services in their respective communities, our hospitals face competition from larger tertiary care centers and, in some cases, other non-urban hospitals and full service outpatient surgery centers. Some of the hospitals that compete with us are owned by governmental agencies or not-for-profit entities supported by endowments and charitable contributions, and can finance capital expenditures on a tax-exempt basis.

     One of the most significant factors in the competitive position of a hospital is the number and quality of physicians affiliated with the hospital. Although physicians may at any time terminate their affiliation with a hospital that we operate, our hospitals seek to retain physicians of varied specialties on the hospitals’ medical staffs and to recruit other qualified physicians through our in-house recruiting department overseen by our Vice President of Medical Staff Development and his staff. We believe the key reasons physicians refer patients to a hospital are the quality of services it renders to patients and physicians, the quality of other physicians on the medical staff, the location of the hospital and the quality of the hospital’s facilities, equipment and employees. Accordingly, we

14


Table of Contents

strive to maintain high ethical and professional standards and quality facilities, equipment, employees and services for physicians and their patients.

     Another factor in the competitive position of a hospital is management’s ability to negotiate service contracts with purchasers of group healthcare services. Health maintenance organizations and preferred provider organizations attempt to direct and control the use of hospital services through managed care programs and to obtain discounts from hospitals’ established charges. In addition, employers and traditional health insurers increasingly are interested in containing costs through negotiations with hospitals for managed care programs and discounts from established charges. Generally, hospitals compete on the basis of market reputation, geographic location, quality and range of services, quality of the medical staff, convenience and price for service contracts with group healthcare service purchasers. The importance of obtaining contracts with managed care organizations varies from market to market, depending on the market strength of such organizations. Managed care contracts generally are less important in the non-urban markets served by us than they are in urban and suburban markets where there is typically a higher level of managed care penetration.

     State certificate of need laws, which place limitations on a hospital’s ability to expand hospital services and add new equipment, also may have the effect of restricting competition. Five states in which we operate, Alabama, South Carolina, Mississippi, Nevada and Virginia, currently have certificate of need laws. The application process for approval of covered services, facilities, changes in operations and capital expenditures is, therefore, highly competitive. In those states that have no certificate of need laws or that set relatively high thresholds before expenditures become reviewable by state authorities, competition in the form of new services, facilities and capital spending may be more prevalent. We have not experienced, and do not expect to experience, any material adverse effects from state certificate of need requirements or from the imposition, elimination or relaxation of such requirements. See “Item 1. Business - Healthcare Regulation and Licensing.”

     We, and the healthcare industry as a whole, face the challenge of continuing to provide quality patient care while dealing with rising costs, strong competition for patients and a slow growth in reimbursement rates by both private and government payors. As both private and government payors reduce the scope of what may be reimbursed and reduce reimbursement levels for what is covered, federal and state efforts to reform the healthcare system may further impact reimbursement rates. Changes in medical technology, existing and future legislation, regulations and interpretations and competitive contracting for provider services by private and government payors may require changes in our facilities, equipment, personnel, rates and/or services in the future.

     The hospital industry and some of our hospitals continue to have significant unused capacity. Inpatient utilization, average lengths of stay and average inpatient occupancy rates continue to be affected by payor-required pre-admission authorization, utilization review, and payment mechanisms to maximize outpatient and alternative healthcare delivery services for less acutely ill patients. Admissions constraints, payor pressures and increased competition are expected to continue. We will endeavor to meet these challenges by expanding our facilities’ outpatient services, offering appropriate discounts to private payor groups, upgrading facilities and equipment, and offering new programs and services.

     We also face competition for acquisitions primarily from for-profit hospital management companies as well as not-for-profit entities. Some of our competitors have greater financial and other resources than us. Increased competition for the acquisition of non-urban acute care hospitals could have an adverse impact on our ability to acquire such hospitals on favorable terms.

Properties

     In addition to real estate associated with our owned and leased hospitals, we lease approximately 43,508 square feet of office space for our corporate headquarters in Brentwood, Tennessee under a ten-year lease that expires on December 31, 2013 and contains customary terms and conditions. See “Item 1. Business - Owned and Leased Hospitals.”

Employees and Medical Staff

     As of March 1, 2005, we had approximately 8,400 employees. We consider relations with our employees to be good. Approximately 3.8% of our employees are represented by unions.

     We typically do not employ physicians; however, as of March 1, 2005, we employed 34 practicing physicians. Certain of our hospital services, including emergency room coverage, radiology, pathology and anesthesiology services, are provided through independent contractor arrangements with physicians.

15


Table of Contents

Environmental Matters

     We are subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Our healthcare operations generate medical waste, such as pharmaceuticals, biological materials and disposable medical instruments, that must be disposed of in compliance with federal, state and local environmental laws, rules and regulations. Our operations, as well as our purchases and sales of facilities, also are subject to various other environmental laws, rules and regulations. We do not expect that we will be required to expend any material amounts in order to comply with these laws and regulations or that compliance will materially affect our capital expenditures, earnings or competitive position. Environmental regulations also may apply when we renovate or refurbish hospitals, particularly older facilities. While these requirements may impose some additional costs for such improvements, we do not expect these amounts to be material.

Government Reimbursement

Medicare/Medicaid Reimbursement

     For the year ended December 31, 2004, approximately 37.7% and 10.1% of our net patient revenue from continuing operations resulted from Medicare and Medicaid payments, respectively. The Medicare program pays hospitals on a prospective payment system for acute inpatient services. Under this prospective payment system, a hospital receives a fixed amount for inpatient hospital services based on the patient’s final diagnosis. These payments do not take into consideration a specific hospital’s actual costs, but instead are based upon set national rates adjusted for area wage differentials and case-mix index. Certain sub-acute inpatient services, which historically were reimbursed on a hospital’s actual costs, are currently being converted by Medicare to a prospective payment system. Rehabilitation sub-acute services were converted to a prospective payment system for cost report periods beginning on or after January 1, 2002. This system is similar to the acute inpatient system because it pays a rate based on the type of discharge. Skilled nursing sub-acute services are paid based on a prospective per diem, which is also tied to the patient’s needs and condition. Psychiatric sub-acute services are also transitioning to a prospective payment system. With respect to implementation of the prospective payment system for psychiatric services, the Centers for Medicare and Medicaid Services began implementing a three-year transition period starting with the cost reporting periods beginning on or after January 2005. For these three years, CMS is proposing a blended payment. The payment for the first year of the transition period (cost reporting periods beginning after January 1, 2005 but on or before June 30, 2006) would consist of 75% based on the current cost-based reimbursement system and 25% on the proposed federal prospective payment rate. In the second year, the split will be 50% each and in the third year the split will be 25% based on the current cost-based system and 75% prospective payment system. For cost reporting periods beginning on or after July 1, 2008, the prospective payment federal rate percentage will be 100%. The first update to rates under this methodology is anticipated to occur in July 2006, with annual updates anticipated thereafter.

     For several years, the percentage increases to the prospective payment rates have been lower than the percentage increases in the cost of goods and services purchased by general hospitals. The index used to adjust payment rates is based on a price proxy, known as the hospital market basket index, reduced by Congressionally-mandated reduction factors. For fiscal year 2003, the hospital market basket index was rebased and revised based on 1997 data. Acute care hospitals received Medicare payment rate increases for inpatient services based upon the full market basket increase in federal fiscal year 2004. On December 8, 2003, President Bush signed into law the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the “Medicare Modernization Act”). The Medicare Modernization Act provides for changes in Medicare reimbursement for hospitals. For example, the Medicare Modernization Act requires all acute care hospitals to participate in CMS’s quality-of-care National Voluntary Hospital Reporting Initiative in order to receive the full market basket increase in fiscal year 2005 through 2007. Those acute care hospitals that fail to participate in CMS’s quality-of-care National Voluntary Reporting Initiative will receive a lesser increase in Medicare reimbursement equal to the market basket update minus 0.4 percent.

     Many of our hospitals receive an add-on to the Medicare DRG payment for providing care to indigent patients. This add-on is referred to as the disproportionate share adjustment. Section 402 of the Medicare Modernization Act increased the cap on the disproportionate share adjustment from 5.25% to 12% for rural hospitals. This increase in the cap was effective April 1, 2004. We currently have seven hospitals that benefited from this change.

     Approximately 71% (labor share) of the Medicare DRG payment is adjusted by the hospital’s wage index. The wage index compares the cost of labor in the hospital’s market compared to the national average. For those hospitals with wage indices over 1.00, the labor share is increased and, for those hospitals with wage indices under 1.00, the labor share is reduced. Section 403 of the Medicare Modernization Act reduces the labor share to 62% of the DRG payment for those hospitals with wage indices below 1.00. We currently have 11 hospitals that benefited from this change.

16


Table of Contents

     Most outpatient services provided by general hospitals are reimbursed by Medicare under the outpatient prospective payment system. The Balanced Budget Act of 1997 mandated the implementation of the prospective payment system for Medicare outpatient services. This outpatient prospective payment system is based on a system of Ambulatory Payment Classifications. Each Ambulatory Payment Classification represents a bundle of outpatient services, and each Ambulatory Payment Classification has been assigned a fully prospective reimbursement rate. On November 15, 2004, the Centers for Medicare and Medicaid Services published the final rule establishing the calendar year 2005 conversion factor and revisions to Ambulatory Payment Classifications for hospital outpatient services. The 2005 conversion factor was increased by 3.3%, the full market basket for fiscal year 2005.

     The Medicare Modernization Act extends for two years (through December 31, 2005) special payments to small rural hospitals with 100 or fewer beds to ensure that they are paid at least as much under the outpatient prospective payment system as they had been paid under the prior cost-based system. These special payments were first authorized by the Balanced Budget Refinement Act of 1999, and were scheduled to end for services on or after January 1, 2004. Besides extending the special payments for an additional two-year period, the Medicare Modernization Act also makes “Sole Community Hospitals” (regardless of the number of beds) eligible for the special payments. A Sole Community Hospital is generally the only hospital in at least a 35-mile radius or a 45-minute driving time radius. Bolivar Medical Center, Colorado Plains Medical Center, Colorado River Medical Center, Northeastern Nevada Regional Hospital, Havasu Regional Medical Center, Teche Regional Medical Center, Palo Verde Hospital, Parkview Regional Hospital, Palestine Regional Medical Center and Los Alamos Medical Center qualify as Sole Community Hospitals under Medicare regulations.

     Medicare has other special payment provisions for Sole Community Hospitals. Special payment provisions related to Sole Community Hospitals include the payment of a hospital’s specific rate which may be higher than the Federal DRG payment rate.

     Each state has its own Medicaid program that is funded jointly by such state and the federal government. Federal law governs how each state manages its Medicaid program, but there is wide latitude for states to customize Medicaid programs to fit local needs and resources. As a result, each state Medicaid plan has its own payment formula and recipient eligibility criteria.

Program Adjustments

     The Medicare, Medicaid and TRICARE programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review and new governmental funding restrictions, all of which may materially increase or decrease program payments as well as affect the cost of providing services and the timing of payments to facilities. The final determination of amounts earned under the programs often takes many years because of audits by the program representatives, providers’ rights of appeal and the application of numerous technical reimbursement provisions. Differences between original estimates and subsequent revisions (including final settlements) are included in consolidated statements of income in the period in which the revisions are made. Management believes that adequate provision has been made for such adjustments. Until final adjustment, however, significant issues remain unresolved and previously determined allowances could become either inadequate or more than ultimately required.

Healthcare Regulation and Licensing

Background Information

     Healthcare, as one of the largest industries in the United States, continues to attract much legislative interest and public attention. Medicare, Medicaid, and other public and private hospital cost-containment programs, proposals to limit healthcare spending, and proposals to limit prices and industry competitive factors are among the many factors that are highly significant to the healthcare industry. In addition, the healthcare industry is governed by a framework of federal and state laws, rules and regulations that are extremely complex and for which the industry has the benefit of only limited regulatory or judicial interpretation.

     There continue to be federal and state proposals that would, and actions that do, impose more limitations on government and private payments to providers such as us. In addition, there are proposals to increase co-payments and deductibles from program and private patients. Our facilities also are affected by controls imposed by government and private payors designed to reduce admissions and lengths of stay. Such controls, including what is commonly referred to as “utilization review,” have resulted in a decrease in certain treatments and procedures being performed.

     Many states have enacted, or are considering enacting, measures that are designed to reduce their Medicaid expenditures and to make changes to private healthcare insurance. Various states have applied, or are considering applying, for a federal waiver from current Medicaid regulations to allow them to serve some of their Medicaid participants through managed care providers. These

17


Table of Contents

proposals also may attempt to include coverage for some people who presently are uninsured, and generally could have the effect of reducing payments to hospitals, physicians and other providers for the same level of service provided under Medicaid.

Certificate of Need Requirements

     Some states require approval for purchase, construction and expansion of healthcare facilities, including findings of need for additional or expanded healthcare facilities or services. Certificates of need, which are issued by governmental agencies with jurisdiction over healthcare facilities, are at times required for capital expenditures exceeding a prescribed amount, changes in bed capacity or services and certain other matters. Five states in which we currently own hospitals, Alabama, South Carolina, Mississippi, Nevada and Virginia, have certificate of need laws. We are unable to predict whether our hospitals will be able to obtain any certificates of need that may be necessary to accomplish their business objectives in any jurisdiction where such certificates of need are required.

Anti-Kickback and Self-Referral Regulations

     Sections of the Anti-Fraud and Abuse Amendments to the Social Security Act, commonly known as the “anti-kickback” statute, prohibit certain business practices and relationships that might influence the provision and cost of healthcare services reimbursable under Medicaid or Medicare or other federal healthcare programs, including the payment or receipt of remuneration for the referral of patients whose care will be paid for by Medicare or other government programs. Sanctions for violating the anti-kickback statute include criminal penalties and civil sanctions, including fines and possible exclusion from government programs, such as the Medicare and Medicaid programs. Pursuant to the Medicare and Medicaid Patient and Program Protection Act of 1987, the U.S. Department of Health and Human Services issued regulations that create safe harbors under the anti-kickback statute. A given business arrangement that does not fall within an enumerated safe harbor is not per se illegal; however, business arrangements that fail to satisfy the applicable safe harbor criteria risk increased scrutiny by enforcement authorities. The Health Insurance Portability and Accountability Act of 1996 or “HIPAA”, which became effective January 1, 1997, added several new fraud and abuse laws. These new laws cover all health insurance programs – private as well as governmental. In addition, HIPAA broadened the scope of certain fraud and abuse laws, such as the anti-kickback statute, to include not just Medicare and Medicaid services, but all healthcare services reimbursed under a federal or state healthcare program.

     There is increasing scrutiny by law enforcement authorities, the Office of Inspector General of the Department of Health and Human Services, the courts and Congress of arrangements between healthcare providers and potential referral sources to ensure that the arrangements are not designed as a mechanism to exchange remuneration for patient care referrals and opportunities. Investigators also have demonstrated a willingness to look behind the formalities of a business transaction to determine the underlying purpose of payments between healthcare providers and potential referral sources. Enforcement actions have increased, as evidenced by recent highly publicized enforcement investigations of certain hospital activities.

     In addition, provisions of the Social Security Act prohibit physicians from referring Medicare and Medicaid patients to providers of a broad range of designated health services with which the physicians or their immediate family members have ownership or certain other financial arrangements. Certain exceptions are available for employment agreements, leases, physician recruitment and certain other physician arrangements. These provisions are known as the Stark law and are named for the legislative sponsor, Rep. Fortney “Pete” Stark (R-CA). A person making a referral, or seeking payment for services referred, in violation of the Stark law would be subject to the following sanctions:

  •   civil money penalties of up to $15,000 for each service;
 
  •   restitution of any amounts received for illegally billed claims; and/or
 
  •   exclusion from participation in the Medicare program, which can subject the person or entity to exclusion from participation in state healthcare programs.

     Further, if any physician or entity enters into an arrangement or scheme that the physician or entity knows or should know has the principal purpose of assuring referrals by the physician to a particular entity, and the physician directly makes referrals to such entity, then such physician or entity could be subject to a civil money penalty of up to $100,000. Many states have adopted or are considering similar legislative proposals, some of which extend beyond the Medicaid program, to prohibit the payment or receipt of remuneration for the referral of patients and physician self-referrals regardless of the source of the payment for the care.

18


Table of Contents

Federal False Claims Act

     The government has shown an increasing willingness in recent years to bring lawsuits against healthcare providers alleging violations of a variety of healthcare and non-healthcare laws, including, among others, the federal false claims act (the “False Claims Act”) and mail fraud and wire fraud. The False Claims Act, in particular, has been used with increasing frequency and creativity. The False Claims Act has “qui tam” or “whistleblower” provisions that allow private individuals to bring actions on behalf of the government alleging that the defendant has defrauded the government. If the action is successful, the private individual may recover up to one-third of the government’s recovery. The False Claims Act provides for a penalty of up to three times the amount of the false claim, plus up to $11,000 for each claim falsely submitted to the government.

Healthcare Facility Licensing Requirements

     Our healthcare facilities are subject to extensive federal, state and local legislation and regulation. In order to maintain their operating licenses, healthcare facilities must comply with strict standards concerning medical care, fire and safety, equipment and hygiene. Various licenses and permits also are required in order to dispense narcotics, operate pharmacies, handle radioactive materials and operate certain equipment. Our healthcare facilities hold all required material governmental approvals, licenses and permits. All licenses, provider numbers and other permits or approvals required to perform our business operations are held by our subsidiaries. All of our hospitals are fully accredited by the Joint Commission on Accreditation of Healthcare Organizations, except Coastal Carolina Medical Center, which is in process for its initial survey.

Utilization Review Compliance and Hospital Governance

     Our healthcare facilities are subject to and comply with various forms of utilization review. In addition, under the Medicare prospective payment system, each state has a Quality Improvement Organization to carry out federally mandated systems of review of Medicare patient admissions, treatments and discharges in hospitals. Medical and surgical services and practices also are supervised extensively by committees of staff doctors at each healthcare facility, are overseen by each healthcare facility’s local governing board, the primary voting members of which are physicians and community members, and are reviewed by our quality assurance personnel. The local governing boards also:

  •   help maintain standards for quality care;
 
  •   develop long-range plans;
 
  •   establish, review and enforce practices and procedures; and
 
  •   approve the credentials and disciplining of medical staff members.

Governmental Developments Regarding Sales of Not-For-Profit Hospitals

     In recent years, the legislatures and attorneys general of several states have shown a heightened level of interest in transactions involving the sale of non-profit hospitals. Although the level of interest varies from state to state, the trend is to provide for increased governmental review, and in some cases approval and ongoing oversight, of transactions in which not-for-profit corporations sell a healthcare facility. Attorneys general in certain states, including California, have been especially active in evaluating these transactions.

Medical Records Privacy Laws

     There are currently numerous laws at the state and federal levels addressing patient privacy concerns. Federal regulations issued pursuant to HIPAA contain, among other measures, provisions that require many organizations, including us, to implement very significant and potentially expensive new computer systems, employee training programs and business procedures. The federal regulations are intended to encourage electronic commerce in the healthcare industry.

     On August 17, 2000 (with modifications in February 2003), the Department of Health and Human Services finalized regulations requiring all healthcare providers, including our facilities, and payors to use standard data formats and code sets established by the rule when electronically transmitting information in connection with several types of transactions, including health claims and equivalent encounter

19


Table of Contents

information, health care payment and remittance advice and health claim status. We have implemented or upgraded computer systems, as appropriate, at our facilities and at our corporate headquarters to comply with the new transaction and code set regulations.

     HIPAA requires the Department of Health and Human Services to issue regulations establishing standard unique health identifiers for individuals, employers, health plans and health care providers to be used in connection with the standard electronic transactions. All healthcare providers, including our facilities, will be required to obtain a new National Provider Identifier (“NPI”) to be used in standard transactions instead of other numerical identifiers beginning no later than May 23, 2007; healthcare providers may begin applying for NPIs on May 23, 2005. We cannot predict whether our facilities may experience payment delays during the transition to the new identifier. Additionally, the Department of Health and Human Services issued a final rule that calls for using the Employer Identification Number (the taxpayer identifying number for employers that is assigned by the Internal Revenue Service) as the identifying number for employers that will be used by all health plans, with compliance required by July 30, 2004. The Department of Health and Human Services has not yet issued proposed rules that establish the standard for unique health identifiers for health plans or individuals. Once these regulations are issued in final form, we expect to have approximately two years to become fully compliant, but cannot predict the impact of such changes at this time.

     On February 20, 2003, the Department of Health and Human Services finalized a rule that establishes, in part, standards to protect the confidentiality, availability and integrity of health information by health plans, health care clearinghouses and health care providers that receive, store, maintain or transmit health and related financial information in electronic form, regardless of format. These security standards require us to establish and maintain reasonable and appropriate administrative, technical and physical safeguards to ensure the integrity, confidentiality and the availability of electronic health and related financial information. The security standards were designed to protect electronic information against reasonably anticipated threats or hazards to the security or integrity of the information and to protect the information against unauthorized use or disclosure. Although the security standards do not reference or advocate a specific technology, and covered health care providers, plans and clearinghouses have the flexibility to choose their own technical solutions, we expect that the security standards will require us to implement significant new systems, business procedures and training programs. We must comply with these security regulations by April 21, 2005.

     The Department of Health and Human Services has established standards for the privacy of individually identifiable health information. These privacy standards apply to all health plans, all health care clearinghouses and health care providers that transmit health information in an electronic form in connection with the standard transactions. Our facilities are covered entities under the final rule. The privacy standards apply to individually identifiable information held or disclosed by a covered entity in any form, whether communicated electronically, on paper or orally. These standards impose extensive new administrative requirements on us. They require our compliance with rules governing the use and disclosure of this health information. They create new rights for patients in their health information, such as the right to amend their health information, and they require us to impose these rules, by contract, on any business associate to whom we disclose such information in order to perform functions on our behalf. In addition, our facilities will continue to remain subject to any state laws that are more restrictive than the privacy regulations issued under HIPAA. These state laws vary by state and could impose additional penalties.

     A violation of the HIPAA regulations could result in civil money penalties of $100 per incident, up to a maximum of $25,000 per person per year per standard. HIPAA also provides for criminal penalties of up to $50,000 and one year in prison for knowingly and improperly obtaining or disclosing protected health information, up to $100,000 and five years in prison for obtaining protected health information under false pretenses, and up to $250,000 and ten years in prison for obtaining or disclosing protected health information with the intent to sell, transfer or use such information for commercial advantage, personal gain or malicious harm. Because there is no history of enforcement efforts by the federal government at this time, it is not possible to ascertain the likelihood of enforcement efforts in connection with the HIPAA regulations or the potential for fines and penalties which may result from the violation of the regulations.

     We expect that compliance with these standards will require significant commitment and action by us and our facilities. We have appointed members of our management team to direct our compliance with these standards. Implementation will require us to engage in extensive preparation and make significant expenditures. At this time we have appointed a privacy officer at each facility, prepared privacy policies, trained our workforce on these policies and entered into business associate agreements with the appropriate vendors. Because some of the regulations are proposed regulations, we cannot predict the total financial impact of the regulations on our operations.

20


Table of Contents

Emergency Medical Treatment and Active Labor Act

     All of our facilities are subject to the Emergency Medical Treatment and Active Labor Act (“EMTALA”). This federal law requires any hospital that participates in the Medicare program to conduct an appropriate medical screening examination of every person who enters the hospital’s emergency department for treatment and, if the patient is suffering from an emergency medical condition, to either stabilize that condition or make an appropriate transfer of the patient to a facility that can handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of a patient’s ability to pay for treatment. There are severe penalties under EMTALA if a hospital fails to screen or appropriately stabilize or transfer a patient or if the hospital delays appropriate treatment in order to first inquire about the patient’s ability to pay. Penalties for violations of EMTALA include civil monetary penalties and exclusion from participation in the Medicare program. In addition, an injured patient, the patient’s family or a medical facility that suffers a financial loss as a direct result of another hospital’s violation of the law can bring a civil suit against the hospital.

     In September of 2003, CMS released final regulations to clarify hospitals’ obligations under EMTALA. The final regulations included a new definition of “dedicated emergency department,” and clarified that EMTALA does not apply to inpatients. The final regulations also clarified a hospital’s EMTALA obligations with respect to hospital owned ambulances, outpatient departments, off-campus provider-based entities, and other locations within the hospital other than the dedicated emergency department. The final rule also addressed a hospital’s physician on-call responsibilities. Under the final rule, each hospital must maintain an on-call list that best meets the needs of its patients, but only in accordance with the resources available to the hospital. There is no set formula for on-call obligations in the final rules, and the final rules recognize that not all hospitals will be able to have every specialist on call at all times. Hospitals must maintain written procedures to be followed when a specialist is not on call or a physician is not available due to circumstances beyond the physician’s control. The hospital’s written procedures may also provide for situations in which the on-call physician is performing elective surgery or on call simultaneously with other facilities. We believe that our facilities comply with EMTALA.

California Seismic Standards

     California’s Alfred E. Alquist Hospital Facilities Seismic Safety Act (the “Alquist Act”) requires that the California Building Standards Commission adopt earthquake performance categories, seismic evaluation procedures, standards and timeframes for upgrading certain facilities, and seismic retrofit building standards. These regulations require hospitals to meet seismic performance standards to ensure that they are capable of providing medical services to the public after an earthquake or other disaster. The Building Standards Commission completed its adoption of evaluation criteria and retrofit standards in 1998.

     The Alquist Act requires that within three years after the Building Standards Commission has adopted evaluation criteria and retrofit standards:

  •   certain hospitals must conduct seismic evaluations and submit these evaluations to the Office of Statewide Health Planning and Development, Facilities Development Division for its review and approval;
 
  •   hospitals must identify the most critical nonstructural systems that represent the greatest risk of failure during an earthquake and submit timetables for upgrading these systems to the Office of Statewide Health Planning and Development, Facilities Development Division for its review and approval; and
 
  •   regulated hospitals must prepare a plan and compliance schedule for each regulated building demonstrating the steps a hospital will take to bring the hospital buildings into substantial compliance with the regulations and standards.

     We are required to conduct engineering studies of our two California facilities (Palo Verde Hospital and Colorado River Medical Center) to determine whether and to what extent modifications to our facilities will be required. To date, we have conducted engineering studies and implemented compliance plans for our California facilities which satisfy all current requirements and, through December 31, 2004, have cost us approximately $450,000. In addition we are continuing to develop plans for compliance with 2008 California requirements. Any facilities not currently in compliance with the applicable seismic regulations and standards must be brought into compliance by 2008, or 2013 if the facility obtains an extension. We may be required to make significant capital expenditures to comply with the seismic standards, which could impact our earnings.

21


Table of Contents

Professional Liability

     As part of our business, we are subject to claims of liability for events occurring in the ordinary course of hospital operations. To cover these claims, we maintain professional malpractice liability insurance and general liability insurance coverage of approximately $50,000,000, although some claims may exceed the scope of the coverage in effect. We have purchased a tail policy that provides an unlimited claim reporting period for our professional liability for claims incurred in 2000 and prior years. We also maintain a claims-made policy and have provided an actuarial-based accrual for incurred but not reported claims. Recently, the cost of malpractice and other liability insurance has risen significantly. Therefore, adequate levels of insurance may not continue to be available at a reasonable price.

Available Information

     We make available free of charge through our Internet website (http://www.provincehealthcare.com) our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and, if applicable, amendments to those reports filed or furnished pursuant to Section 13(a) of the Exchange Act of 1934 as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission. However, the information found on our website is not part of this or any other report.

Principal Risk Factors That May Affect Our Business and Results of Operations

If government programs reduce the payments we receive as reimbursement for our services, our revenues may decline.

     The Medicare and Medicaid programs are highly regulated and subject to frequent and substantial changes. The Federal Balanced Budget Act of 1997, which established a plan to balance the federal budget by fiscal year 2002, included significant reductions in spending levels for the Medicare and Medicaid programs, including:

  •   payment reductions for inpatient and outpatient hospital services;
 
  •   establishment of a prospective payment system for hospital outpatient services, skilled nursing facilities and home health agencies under Medicare; and
 
  •   repeal of the federal payment standard often referred to as the “Boren Amendment” for hospitals and nursing facilities, which could result in lower Medicaid reimbursement rates.

     The financial impact of the Federal Balanced Budget Act of 1997, however, has been lessened somewhat by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000, and further lessened by the Medicare Modernization Act, which provided certain relief specifically affecting rural hospitals. Significant revisions in how hospitals are paid for some services are still proceeding. We cannot predict the impact of future legislative and regulatory actions which might be taken to reduce Medicare and Medicaid payment levels.

     The Medicare Modernization Act provides a broad range of provider payment benefits. Federal government spending in excess of federal budgetary provisions contained in passage of the Medicare Modernization Act could result in future deficit spending for the Medicare system, which could cause future payments under the Medicare system to grow at a slower rate or decline.

     In the future, Congress and state legislatures could introduce proposals to make major changes in the healthcare system. If these proposals are enacted, we may see a decline in the Medicare and Medicaid reimbursements we receive for our services; however, at this time, we do not know what healthcare reform legislation will be enacted or whether any changes in healthcare programs will occur.

The healthcare cost containment initiatives and the financial condition of purchasers of healthcare services may limit our revenue and profitability.

     During the past several years, major purchasers of healthcare, such as federal and state governments, insurance companies and employers, have undertaken initiatives to revise payment methodologies and monitor healthcare costs. As part of their efforts to contain healthcare costs, purchasers increasingly are demanding discounted fee structures or the assumption by healthcare providers of

22


Table of Contents

all or a portion of the financial risk through prepaid capitation arrangements. We expect efforts to impose reduced allowances, greater discounts and more stringent cost controls by government and other payors to continue. In addition, we anticipate that organizations offering prepaid and discounted medical services packages may represent an increasing portion of our patient admissions. An increasing number of managed care organizations have experienced financial difficulties in recent years, in some cases resulting in bankruptcy or insolvency. In some instances, organizations with provider agreements with certain of our hospitals have become insolvent, and the hospitals have been unable to collect the full amounts due from such organizations. Other managed care organizations with whom we do business may encounter similar difficulties in paying claims in the future. We believe that reductions in the payments we receive for our services, coupled with the increased percentage of patient admissions from organizations offering prepaid and discounted medical services and difficulty in collecting receivables from managed care organizations, could reduce our overall revenue and profitability.

If we fail to comply with regulations regarding licenses, ownership and operation, we could impair our ability to operate or expand our operations in any state.

     All of the states in which we operate require hospitals and most healthcare facilities to maintain a license. In addition, some states require prior approval for the purchase, construction and expansion of healthcare facilities, based upon a state’s determination of need for additional or expanded healthcare facilities or services. Such determinations, embodied in certificates of need issued by governmental agencies with jurisdiction over healthcare facilities, may be required for capital expenditures exceeding a prescribed amount, changes in bed capacity or services and other matters. Five states in which we currently own hospitals, Alabama, South Carolina, Mississippi, Nevada and Virginia, have certificate of need laws. The failure to obtain any required certificate of need or the failure to maintain a required license could impair our ability to operate or expand operations in any state.

We are subject to extensive governmental regulation regarding conduct of our operations and our relationships with physicians. If we fail to comply with these regulations, we could suffer penalties or be required to make significant changes to our operations.

     The healthcare industry must comply with many laws and regulations at federal, state and local governmental levels. These laws and regulations are extremely complex and, in many instances, the industry does not have the benefit of significant regulatory or judicial interpretation. In particular, Medicare and Medicaid anti-fraud and abuse provisions, known as the “anti-kickback statute,” prohibit some business practices and relationships related to items or services reimbursable under Medicare, Medicaid and other federal healthcare programs. For instance, the anti-kickback statute prohibits healthcare service providers from paying or receiving remuneration to induce or arrange for the referral of patients or items or services covered by a federal or state healthcare program. If regulatory authorities determine that any of our hospitals’ arrangements violate the anti-kickback statute, we could be subject to liabilities under the Social Security Act, including:

  •   criminal penalties;
 
  •   civil monetary penalties; and/or
 
  •   exclusion from participation in Medicare, Medicaid or other federal healthcare programs,

any of which could impair our ability to operate one or more of our hospitals or to operate profitably.

     There are currently numerous legislative and regulatory initiatives at the federal and state levels addressing patient privacy and security concerns. In particular, federal regulations issued under the Health Insurance Portability and Accountability Act of 1996 contain provisions that have required, and in the future may require us to implement costly new computer systems and to adopt business procedures designed to protect the privacy and security of each of our patients’ individually identifiable health and related financial information. In August 2000 (with modifications in February 2003), the Department of Health and Human Services issued regulations requiring most health care organizations, including us, to use standard data formats and code sets when electronically transmitting information in connection with several types of transactions, including health claims, health care payment and remittance advice and health claim status transactions. As required by HIPAA, the Department of Health and Human Services has established standards for the privacy of individually identifiable health information, which apply to all health care providers, health plans and health care clearinghouses that transmit health information in an electronic form in connection with the standard transactions. Compliance with the privacy regulations has been required since April 2003 for most health care organizations, including us, and continue to have a financial impact on the health care industry because they impose extensive administrative requirements, restrictions on the use and disclosure of individually identifiable patient health and related financial information, provide patients with rights with respect to their health information and require us to enter into contracts extending many of the privacy regulation requirements to third parties who perform functions on our behalf involving health information. On February 20, 2003, the Department of Health and

23


Table of Contents

Human Services issued final security regulations , which required us to implement administrative, physical and technical safeguards to protect the integrity, confidentiality and availability of electronically received, maintained or transmitted patient individually identifiable health and related financial information. Compliance with these security regulations is required by April 21, 2005 for most health care organizations, including us. We cannot predict the total financial or other impact of these regulations on our business over time. Compliance with these regulations requires substantial expenditures, which could negatively impact our financial results. In addition, our management has spent, and may spend in the future, substantial time and effort on compliance measures.

     Violations of the privacy, security and transaction regulations could subject us to civil penalties of up to $25,000 per person per calendar year for each provision contained in the privacy, security and transaction regulations that is violated and criminal penalties of up to $250,000 per violation for certain other violations. Because there is no significant history of enforcement efforts by the federal government at this time, it is not possible to ascertain the likelihood of enforcement efforts in connection with these regulations or the potential for fines and penalties which may result from the violation of the regulations.

     In addition, the portion of the Social Security Act commonly known as the “Stark law” prohibits physicians from referring Medicare or Medicaid patients to particular providers of designated health services if the physician or a member of the physician’s immediate family has an ownership interest or compensation arrangement with that provider. Sanctions for violating the Stark law include civil money penalties and possible exclusion from the Medicare program. Many states have adopted or are considering similar anti-kickback and physician self-referral legislation. Some of the state physician self-referral laws are more restrictive than the Stark law, in that they apply to services reimbursed by all payors, not just by Medicaid or other government payors.

     Moreover, the federal government has shown an increasing willingness to prosecute providers under a variety of fraud laws, including laws that have not traditionally been used for healthcare fraud, such as the federal civil false claims law and the federal mail and wire fraud laws.

     There are heightened coordinated civil and criminal enforcement efforts by federal and state government agencies relating to the healthcare industry. We may become the subject of an investigation in the future.

     In recent years, the media and public attention have focused on the hospital industry due to ongoing investigations related to:

  •   referral, cost reporting and billing practices;
 
  •   laboratory and home healthcare services; and
 
  •   physician ownership and joint ventures involving hospitals.

     Both federal and state government agencies have announced heightened and coordinated civil and criminal enforcement efforts. In addition, the Office of the Inspector General of the U.S. Department of Health and Human Services and the Department of Justice have established enforcement initiatives that focus on specific billing practices or other suspected areas of abuse. Recent initiatives include a focus on hospital billing for outpatient charges associated with inpatient services, as well as hospital laboratory billing practices.

     We cannot predict with accuracy whether we or other hospital operators will be the subject of future investigations or inquiries. In the event that we become the subject of an investigation, we will be required to devote management and financial resources to defending our company in the investigation. In addition, any negative publicity surrounding the investigation could affect adversely the trading price of our securities. If we incur significant fines or penalties or are forced to reimburse amounts as a result of the investigation, our profitability may decline.

We have a concentration of revenue in New Mexico, Louisiana and Texas, which makes us particularly sensitive to regulatory and economic changes in those states.

     Memorial Medical Center and Los Alamos Medical Center, each located in New Mexico, collectively accounted for 15.2% of our net patient revenue for the year ended December 31, 2004. This concentration makes us particularly sensitive to economic, competitive and regulatory conditions in New Mexico. Any adverse change in these conditions could reduce significantly our revenues and profitability.

24


Table of Contents

     Doctors’ Hospital of Opelousas, Eunice Community Medical, Minden Medical Center and Teche Regional Medical Center in Louisiana collectively accounted for approximately 15.0% of our net patient revenue from continuing operations for the year ended December 31, 2004. Similarly, this concentration of revenue in Louisiana makes us particularly sensitive to economic, competitive and regulatory conditions in Louisiana. Any adverse change in these conditions could reduce significantly our revenues and profitability.

     Palestine Regional Medical Center, Ennis Regional Medical Center and Parkview Regional Hospital, each located in Texas, collectively accounted for 15.0% of our net patient revenue for the year ended December 31, 2004. Similarly, this concentration makes us particularly sensitive to economic, competitive and regulatory conditions in Texas. Any adverse change in these conditions could reduce significantly our revenues and profitability.

Our California hospitals must comply with California seismic standards which may require us to make significant capital expenditures.

     California has a statute and regulations that require hospitals to meet seismic performance standards. Regulated hospitals that do not meet the standards may be required to retrofit facilities. California law requires that owners of regulated hospitals evaluate their facilities and develop a plan and schedule for complying with the standards. We are required to conduct engineering studies of our two California facilities (Palo Verde Hospital and Colorado River Medical Center) to determine whether and to what extent modifications to our facilities will be required. To date, we have conducted engineering studies and implemented compliance plans for our two California facilities, which satisfy all current requirements and, through December 31, 2004, have cost us approximately $450,000. In addition, we are continuing to develop plans for compliance with 2008 California requirements. Any facilities not in compliance with the seismic regulations and standards must be brought into compliance by 2008, or 2013 if the facility obtains an extension. In the event that our two California facilities are found not to be in compliance with the seismic standards, we may be required to make significant capital expenditures to bring the California facilities into compliance, which could adversely impact our earnings and liquidity.

Our performance depends on our ability to recruit and retain quality physicians, nurses and other healthcare professionals at our hospitals.

     The success of our owned or leased hospitals depends on:

  •   the number and quality of the physicians on the medical staff of our hospitals; and
 
  •   the maintenance of good relations between our company and such physicians.

     Our success has been dependent, in part, upon recruiting quality physicians and maintaining good relations with and retaining our physicians because physicians direct admissions to our hospitals and determine the services to be provided to patients at our hospitals. We generally do not employ physicians, and many of our staff physicians have admitting privileges at other hospitals. Only a portion of physicians are interested in practicing in the non-urban communities in which our hospitals are located. The departure of physicians from these communities, such as we experienced in 2002, or our inability to recruit physicians to these communities, could make it more difficult to attract patients to our hospitals and could affect our profitability. Also, if we are unable to maintain good relationships with physicians, our hospitals’ admissions may decrease and our operating performance may decline. In addition, hospitals nationwide are experiencing a shortage of nursing professionals, a trend which many industry observers expect to continue over the next decade. If the supply of qualified nurses or other healthcare professionals declines in the markets in which our hospitals operate, it may result in increased labor expenses and lower operating margins at those hospitals.

We depend heavily on key personnel, and loss of the services of one or more of our key executives or a significant portion of our local management personnel could weaken our management team and our ability to deliver healthcare services efficiently.

     Our success largely depends on the skills, experience and efforts of our senior management team and on the efforts, ability and experience of key members of our local management staff. The loss of services of one or more members of our senior management or of a significant portion of any of our local management staff could weaken significantly our management expertise and our ability to deliver healthcare services efficiently. We do not maintain key man life insurance policies on any of our officers.

Other hospitals and freestanding outpatient facilities provide services similar to those offered by our hospitals, which may raise the level of competition faced by our hospitals.

     In all geographic areas in which we operate, there are other healthcare providers, including hospitals, outpatient surgery centers and other outpatient facilities, that provide comparable services to those offered by our hospitals. Some of the hospitals with which we

25


Table of Contents

compete are owned by governmental agencies and are supported by tax revenues, and others are owned by not-for-profit corporations and may be supported to a large extent by endowments and charitable contributions. Some of these competitors are larger, may be more established and may have more capital and other resources than we do. Many of our hospitals attempt to attract patients from surrounding counties and communities, including communities in which a competing facility exists. If our competitors are able to finance capital improvements and expand services at their facilities, we may be unable to attract patients away from these facilities.

If we fail to improve the operations of acquired hospitals, we may be unable to achieve our growth objectives.

     Some of the hospitals we have acquired or will acquire had or may have operating losses prior to the time we acquired them. We may be unable to operate profitably any hospital or other facility we acquire, effectively integrate the operations of any acquisitions, or otherwise achieve the intended benefit of the acquisition.

We may be subject to liabilities because of claims brought against our owned and leased hospitals. In addition, if we acquire hospitals with unknown or contingent liabilities, we could become liable for material obligations.

     In recent years, plaintiffs have brought actions against hospitals and other healthcare providers, alleging malpractice, product liability or other legal theories. Many of these actions involved large claims and significant defense costs. We maintain professional malpractice liability and general liability insurance coverage of approximately $50,000,000 to cover claims arising out of the operations of our owned and leased hospitals. Some of the claims, however, could exceed the scope of the coverage in effect or coverage of particular claims could be denied. While our professional and other liability insurance has been adequate in the past to provide for liability claims, such insurance may not be available for us to maintain adequate levels of insurance. Moreover, healthcare providers in our industry have experienced significant increase in the premiums for malpractice insurance, and it is anticipated that such costs may continue to rise. Malpractice insurance coverage may not continue to be available at a cost allowing us to maintain adequate levels of insurance with acceptable deductible amounts.

     In addition, hospitals that we acquire may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations. Although we obtain contractual indemnification from sellers covering these matters, such indemnification may be insufficient to cover material claims or liabilities for past activities of acquired hospitals.

     Failure to complete the merger with LifePoint could negatively impact the share price and the future business and financial results of our company.

     If the merger is not completed, the ongoing business of our company may be adversely affected and we will be subject to several risks, including the following:

  •   we may be required, under certain circumstances, to pay LifePoint a termination fee of $50,000,000 under the merger agreement;
 
  •   we may be required to pay certain costs relating to the merger, such as legal, accounting, financial advisor and printing fees; and
 
  •   our management may be focused on the merger instead of pursuing other opportunities that could be beneficial to our company.

     If the merger is not completed, we cannot ensure that these risks will not materialize and will not materially affect the business or financial results of our company or the trading price of our shares.

ITEM 2. PROPERTIES

     Information with respect to our hospital facilities and other properties can be found in Item 1 of this report under the captions, “Business – Owned and Leased Hospitals,” and “Business – Properties.”

ITEM 3. LEGAL PROCEEDINGS

     Our company is from time to time, subject to claims and suits arising in the ordinary course of business, including claims for damages for personal injuries, breach of management contracts or for wrongful restriction of or interference with physicians staff privileges. In certain of these actions, plaintiff’s request punitive and other damages that may not be covered by insurance. We currently are not a party to any proceeding which, in our opinion, would have a material adverse effect on our business, financial condition or results of operations.

26


Table of Contents

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     Our company’s Board of Directors and the Board of Directors of LifePoint Hospitals, Inc. have unanimously approved an agreement and plan of merger, dated as of August 15, 2004 (subsequently amended on January 25, 2005 and March 15, 2005), by and among our company, LifePoint, Lakers Holding Corp., Lakers Acquisition Corp. and Pacers Acquisition Corp., pursuant to which LifePoint will combine with our company. On October 25, 2004, Lakers Holding Corp. filed a registration statement on Form S-4 (subsequently amended on January 4, 2005, January 26, 2005 and February 18, 2005), which included a joint proxy statement of LifePoint and our company. The special meeting of shareholders of our company relating to the merger will be held on March 28, 2005.

27


Table of Contents

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

     Since June 5, 2002, our common stock has been listed on the New York Stock Exchange under the symbol “PRV.” The following table sets forth the high and low sale prices for our common stock as reported by the New York Stock Exchange for the periods indicated.

                 
    High     Low  
2004
               
First Quarter
  $ 18.75     $ 15.20  
Second Quarter
    17.50       14.86  
Third Quarter
    21.15       13.25  
Fourth Quarter
    22.74       20.41  
2003
               
First Quarter
  $ 10.00     $ 5.29  
Second Quarter
    11.16       7.30  
Third Quarter
    14.82       10.60  
Fourth Quarter
    16.14       10.39  

     As of March 1, 2005, there were approximately 50,285,014 shares of our common stock outstanding, held by 719 record holders.

     We historically have retained and currently intend to retain all earnings to finance the development and expansion of our operations and, therefore, do not anticipate paying cash dividends or making any other distributions on our shares of common stock in the foreseeable future. Furthermore, our senior credit facility and the indenture for our 7 1/2% Senior Subordinated Notes contain restrictions on our ability to pay dividends. Our future dividend policy will be determined by our Board of Directors on the basis of various factors, including our results of operations, financial condition, business opportunities, capital requirements, restrictive covenants in our financing documents and such other factors as the Board of Directors may deem relevant.

ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA

     The selected consolidated financial data is qualified by, and should be read in conjunction with, “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes, appearing elsewhere in this report.

                                         
    Year Ended December 31,  
    2004     2003     2002     2001     2000  
            (In thousands, except per share data)          
Income Statement Data(1):
                                       
Revenue from continuing operations
  $ 882,906     $ 746,208     $ 658,262     $ 486,880     $ 425,405  
Income from continuing operations, net of tax(2)
    50,056       41,720       34,838       32,655       21,028  
Discontinued operations, net of tax
    4,443       (10,101 )     1,274       253       (1,090 )
Net income (2)
    54,499       31,619       36,112       32,908       19,938  
Per Common Share Data (1):
                                       
Basic earnings per share:
                                       
Income from continuing operations, net of tax
  $ 1.01     $ 0.85     $ 0.72     $ 0.69     $ 0.49  
Discontinued operations, net of tax
    0.09       (0.20 )     0.03       0.01       (0.03 )
 
                             
Net income
  $ 1.10     $ 0.65     $ 0.75     $ 0.70     $ 0.46  
Diluted earnings per share:
                                       
Income from continuing operations, net of tax
  $ 0.96     $ 0.84     $ 0.70     $ 0.67     $ 0.47  
Discontinued operations, net of tax
    0.08       (0.17 )     0.03             (0.02 )
 
                             
Net income
  $ 1.04     $ 0.67     $ 0.73     $ 0.67     $ 0.45  
Balance Sheet Data (at end of period)(1):
                                       
Total assets
  $ 1,183,067     $ 1,010,393     $ 974,187     $ 760,081     $ 530,852  
Long-term debt, less current portion
    428,383       447,956       460,370       328,898       159,526  
Stockholders’ equity
    515,799       446,873       413,202       362,005       314,714  

28


Table of Contents


(1)   On April 30, 2004, we completed the sale of Glades General Hospital to the Palm Beach Healthcare District. On June 30, 2004, we completed the sale of Brim Healthcare, Inc., our hospital management subsidiary. As required by Statement of Financial Accounting Standards No. 144 (“SFAS No. 144”), Accounting for the Impairment or Disposal of Long-Lived Assets, we have restated our historical consolidated financial statements to present the results of operations of Glades General Hospital and Brim Healthcare, Inc. separately as discontinued operations.
 
(2)   The Company adopted Statement of Financial Accounting Standards No. 142 (“SFAS No. 142”), Goodwill and Other Intangible Assets, effective January 1, 2002. Under SFAS No. 142, goodwill is no longer amortized, but is subject to annual impairment tests, or more frequently if certain indicators arise. Had we been accounting for our goodwill under SFAS No. 142 for all periods presented, our pro forma income from continuing operations would have been $36,991 and $26,051 for the years ended December 31, 2001 and 2000, respectively, and pro forma net income would have been $37,106 and $24,285 for the years ended December 31, 2001 and 2000, respectively.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

     The following discussion should be read in conjunction with our consolidated financial statements and related notes, appearing elsewhere in this report.

Overview

     We are a healthcare services company focused on acquiring and operating hospitals in attractive non-urban communities throughout the United States. As of December 31, 2004, we owned or leased 21 general acute care hospitals in 13 states with a total of 2,533 licensed beds.

     On April 30, 2004, we completed the sale of Glades General Hospital in Belle Glade, Florida to a wholly-owned subsidiary of the Health Care District of Palm Beach County. The District reacquired the operating assets of the hospital for a purchase price of approximately $1.5 million in cash at closing, net of assumed and contractual obligations. Under the purchase agreement, we retained the hospital’s accounts receivable, income tax receivable and deferred income taxes. We also retained certain payroll-related liabilities and other accrued expenses. On June 30, 2004, we completed the sale of the stock of Brim Healthcare, Inc., our hospital management subsidiary, to Brim Holding Company, Inc., an independent investor-owned entity for approximately $13.2 million in cash. As required by Statement of Financial Accounting Standards No. 144 (“SFAS No. 144”), Accounting for the Impairment or Disposal of Long-Lived Assets, the operations and non-cash impairment of assets charge related to Glades General Hospital and Brim Healthcare, Inc. are reported as “discontinued operations” and the consolidated financial statements, statistics and all references to such information contained in this Report have been adjusted to reflect this presentation for all periods. Our remaining 21 hospitals continue to be reported as “continuing operations.”

     Effective June 1, 2004, we completed the acquisition, through a long-term lease, of the 286-bed Memorial Medical Center in Las Cruces, New Mexico (“Memorial Medical Center”) for approximately $152.2 million, including direct and incremental costs of the acquisition.

     On August 16, 2004, our company and LifePoint Hospitals, Inc. (“LifePoint”) announced that we had entered into a definitive merger agreement (the “Merger Agreement”) pursuant to which LifePoint will acquire us. Pursuant to the terms of the Merger Agreement, our company and LifePoint will each become wholly-owned subsidiaries of a newly formed holding company that will be publicly traded. Each of our shareholders will receive a per share consideration comprised of $11.375 of cash and a number of shares of common stock of the new company equal to an exchange ratio of between 0.3447 and 0.2917, which shares will have a value of $11.375 to the extent that LifePoint’s average share price is between $33.00 and $39.00. The exchange ratio will be 0.3447 if the volume weighted average daily share price of a share of LifePoint’s common stock for the twenty consecutive trading day period ending at close of business on the third trading day prior to the closing (the “LifePoint average share price”) is $33.00 or less, and 0.2917 if LifePoint’s average share price is $39.00 or more. If LifePoint’s average share price is between $33.00 and $39.00, then the exchange ratio will be equal to $11.375 divided by the LifePoint average share price.

29


Table of Contents

     The proposed merger is subject to approval by the stockholders of our company and LifePoint. The proposed merger is projected to close by April 15, 2005, subject to the satisfaction of customary closing conditions.

     During the fourth quarter of 2004, we completed the construction of the 41-bed Coastal Carolina Medical Center in Hardeeville, South Carolina and opened the hospital on November 29, 2004.

     Revenues from continuing operations for the year ended December 31, 2004 increased 18.3% to $882.9 million, compared with $746.2 million for the year ended December 31, 2003, primarily as a result of the acquisition of Memorial Medical Center and increases in same-store net patient revenue per adjusted admission of 6.2% and outpatient revenue of 11.2%, as well as the recording of cost report settlements. For the year ended December 31, 2004, income from continuing operations was $50.1 million compared with $41.7 million for the year ended December 31, 2003. The increase in income from continuing operations was primarily due to the acquisition of Memorial Medical Center and improved operations at our same store hospitals. Cash flow from operations for the year ended December 31, 2004 increased 21.0% to $126.3 million, compared with $104.3 million for the year ended December 31, 2003. The increase was due primarily to an increase of $8.3 million in our income from continuing operations, a $9.3 million increase in depreciation and amortization expense (of which $5.0 million is attributable to the Memorial Medical Center acquisition), and an increase of $15.2 million in our deferred income tax provision resulting from the Memorial Medical Center acquisition and divestitures of Glades General Hospital and Brim Healthcare, Inc. The increase in cash flow from operations is partially offset by an increase in net accounts receivable of continuing operations of $12.6 million. The increase in net accounts receivable principally relates to a $6.2 million loan to a third party for the construction of a medical office building on one of our facility’s campuses and approximately $5.9 million from the lessor of Memorial Medical Center for their obligations required under the facility lease agreement.

     For the year ended December 31, 2004, 19 of our 21 owned or leased hospitals are considered same-store hospitals. Memorial Medical Center and Coastal Carolina Medical Center are excluded from same-store results. On a same-store basis, net patient revenue for the year ended December 31, 2004 increased 5.9%, net patient revenue per adjusted admission increased 6.2% and surgeries increased 3.1% as compared to the year ended December 31, 2003. We continue to see the results of the successful recruitment of primary care physicians and specialists in 2003 and 2004, strong outpatient growth and an increase in acuity. Same-store outpatient revenue for the year ended December 31, 2004 increased 11.2% and same-store acuity increased 2.2%.

     In the fourth quarter of 2003, we announced plans to construct a new 60-bed acute care hospital in Ft. Mohave, Arizona, near our existing hospital in Needles, California. Construction of the Ft. Mohave facility is anticipated to be completed in the third quarter of 2005. In the first quarter of 2005, we announced plans to construct a 52-bed replacement facility for our existing 72-bed facility in Eunice, Louisiana. Construction of the Eunice replacement facility is anticipated to be completed in the second quarter of 2006.

Revenues

     The table below reflects the approximate percentages of net patient revenue received from Medicare, Medicaid, managed care and other payors and self-pay for the periods presented:

                         
    Year Ended December 31,  
    2004     2003     2002  
Medicare
    37.7 %     38.5 %     45.4 %
Medicaid
    10.1       10.3       11.3  
Managed care and other payors
    41.2       44.2       38.2  
Self-pay
    11.0       7.0       5.1  
 
                 
Total
    100.0 %     100.0 %     100.0 %
 
                 

     Net patient revenue is reported net of contractual adjustments and policy discounts. Net patient revenue includes amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems and provisions of cost-reimbursement and other payment methods. In addition, we are reimbursed by non-governmental payors using a variety of payment methodologies. Amounts we receive from treatment of patients covered by these programs are generally less than the standard billing rates. We account for the differences between the estimated program reimbursement rates and the standard billing rates as contractual adjustments, which we deduct from gross revenues to arrive at net patient revenue. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. We account for adjustments to previous reimbursement estimates as contractual adjustments and report them in the periods that such adjustments become known. Cost report settlements and the filing of cost reports increased net patient revenue by $9.9 million, of which $2.9 million related to facilities that

30


Table of Contents

had not previously qualified for disproportionate share payments in prior years, and $5.5 million for the years ended December 31, 2004 and 2003, respectively, and decreased net patient revenue by $0.9 million for the year ended December 31, 2002.

     The payment rates under the Medicare program for inpatients are based on a prospective payment system, depending upon the diagnosis of a patient’s condition. While these rates are indexed for inflation annually, the increases have historically been less than actual inflation. Reductions in the rate of increase in Medicare reimbursement may have an adverse impact on our net patient revenue growth. Effective April 1, 2002, the Centers for Medicare and Medicaid Services implemented changes to the Medicare outpatient prospective system. Although these changes have resulted in reductions to Medicare outpatient payments, these reductions, as well as changes to the Medicare system caused by the Benefit Improvement and Protection Act of 2000, should not materially affect our net patient revenue growth. While the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (“MMA”) provides a broad range of provider payment benefits, federal government spending in excess of federal budgetary provisions contained in passage of MMA could result in future deficit spending for the Medicare system, which could cause future payments under the Medicare system to grow at a slower rate or decline.

     We continually monitor the cost/benefit relationship of services provided at our hospitals, and make decisions about adding new services or discontinuing existing services.

Revenue/Volume Trends

     The key metrics we use to internally evaluate our revenues are adjusted admissions, which we equate to volume, and revenues per adjusted admission, which we relate to pricing and acuity. We anticipate our patient volumes and related revenues will continue to be impacted by the following factors:

•   Physician Recruitment and Retention. Recruiting and retaining both primary care physicians and specialists for our non-urban communities is a key to increasing revenues and patient volumes. Adding specialists and new services typically results in an increase in volumes at a hospital. We recruited 148 physicians during the year ended December 31, 2004, of which approximately two-thirds of these physicians are specialists.
 
•   Medicare Rate Increases. MMA provides a prescription drug benefit for Medicare beneficiaries and also contains numerous provisions that provide incremental funding to hospitals. Hospitals qualify for Medicare disproportionate share hospital (“DSH”) payments when their percentage of low-income patients exceeds 15%. A majority of our hospitals qualify to receive DSH payments. Effective April 1, 2004, MMA raised the cap on the DSH payment adjustment percentage from 5.25% to 12.0% for rural and small urban hospitals and specified that payments to all hospitals are based on the same conversion factor, regardless of geographic location. A majority of our hospitals are benefiting from these provisions.
 
•   Growth in Outpatient Services. Many procedures once performed only on an inpatient basis are now performed as outpatient procedures. This shift is the result of continuing advances in medical and pharmaceutical technologies, and of efforts by payors to control costs. Reimbursement for inpatient services is typically higher than that for the same procedures performed on an outpatient basis. We anticipate that the long-term growth trend toward outpatient services will continue. The following table reflects gross outpatient, inpatient and other revenues as a percentage of our total gross revenues:

                         
    Year Ended December 31,  
    2004     2003     2002  
Outpatient
    46.0 %     44.5 %     42.6 %
Inpatient
    53.4       54.9       56.8  
Other
    0.6       0.6       0.6  
 
                 
Total
    100.0 %     100.0 %     100.0 %
 
                 

Other Trends

Increase in Provision for Doubtful Accounts. Like many of the other companies in our industry, we are experiencing an increase in our provision for doubtful accounts relating to “self-pay” accounts receivable. “Self-pay” revenue refers to payment for healthcare services received directly from individual patients, either in the form of a deductible or co-payment under a health insurance plan or as full or partial payment of the amount charged by the provider or not covered by insurance. The current soft economic environment, higher unemployment rates and increasing numbers of uninsured patients, combined with higher co-payments and deductibles, are placing a greater portion of the financial responsibility for healthcare services on the patient rather than insurers. Additionally, many of these patients are being admitted through the emergency room department and often require more costly care, resulting in higher

31


Table of Contents

billings. Many of these accounts remain uncollected for extended periods of time, requiring providers to increase the amounts reserved as “doubtful accounts” and ultimately written off as uncollectible.

     We experienced an increase in our provision for doubtful accounts during each of the years in the three-year period ending December 31, 2004. Although the economies of a majority of the communities in which we operate hospitals have stabilized, some of our hospitals are experiencing a reduction in state Medicaid coverage, primarily in Texas. In addition, we realized an increase in our provision for doubtful accounts during the year ended December 31, 2004 as a result of our acquisition of Memorial Medical Center. Our provision for doubtful accounts relates primarily to self-pay revenues. Self-pay revenues as a percentage of total net patient revenue were 11.0%, 7.0% and 5.1% for the years ended December 31, 2004, 2003 and 2002, respectively.

     Our gross revenues are reduced for patient accounts identified as charity and indigent care. Our hospitals write-off a patient’s account upon the determination that the patient qualifies, or when it is not paid and deemed uncollectible, under a hospital’s charity and indigent care policy. Charity care (based on gross charges) was approximately $17.5 million, $23.5 million and $19.3 million for the years ended December 31, 2004, 2003 and 2002, respectively. Charity care and provision for doubtful accounts was approximately $112.5 million, $96.1 million and $72.5 million for the years ended December 31, 2004, 2003 and 2002, respectively.

Results of Operations

     The following tables present, for the periods indicated, the results of operations of our company and its subsidiaries. Such information has been derived from our audited consolidated statements of income for the years ended December 31, 2004, 2003 and 2002. The results of operations for the periods presented include hospitals from their respective dates of acquisition.

                                         
    Year Ended December 31,        
    2004     2003        
    (Dollars in Thousands, Except Per Share Data)        
            % of             % of     % Change  
    Amount     Revenues     Amount     Revenues     From Prior Year  
Revenues:
                                       
Net patient revenue
  $ 872,275             $ 735,841                  
Other
    10,631               10,367                  
 
                                   
 
    882,906       100.0 %     746,208       100.0 %     18.3 %
Expenses:
                                       
Salaries, wages and benefits
    323,565       36.6       282,794       37.9          
Purchased services
    85,698       9.7       68,872       9.2          
Supplies
    114,186       12.9       95,579       12.8          
Provision for doubtful accounts
    95,015       10.8       72,583       9.7          
Other operating expenses
    96,934       11.0       88,137       11.8          
Rentals and leases
    11,250       1.3       9,007       1.2          
Transaction costs
    851       0.1                      
Depreciation and amortization
    46,881       5.3       37,617       5.1          
Interest expense
    29,652       3.3       26,262       3.5          
Minority interests
    687       0.1       260                
Loss on sale of assets
    30             75                
Loss on early extinguishment of debt
                486       0.1          
 
                               
Total expenses
    804,749       91.1       681,672       91.3       18.1 %
Income from continuing operations before provision for income taxes
    78,157       8.9       64,536       8.7       21.1 %
Income taxes
    28,101       3.2       22,816       3.1          
 
                               
Income from continuing operations
    50,056       5.7       41,720       5.6       20.0 %

32


Table of Contents

                                         
    Year Ended December 31,        
    2004     2003        
    (Dollars in Thousands, Except Per Share Data)      
            % of             % of     % Change  
    Amount     Revenues     Amount     Revenues     From Prior Year  
Discontinued operations, net of tax:
                                       
Loss from operations
    (2,220 )             (1,149 )                
Net gain (loss) on divestitures
    6,663               (8,952 )                
 
                                   
Net income
  $   54,499                         $   31,619                           72.4 %
 
                                   
Diluted earnings per common share:
                                       
Continuing operations
  $ 0.96             $ 0.84                  
Discontinued operations, net of tax:                     
                                       
Loss from operations
    (0.03 )             (0.02 )                
Net gain (loss) on divestitures
    0.11               (0.15 )                
 
                                   
Net income
  $ 1.04             $ 0.67                  
 
                                   
                                         
    Year Ended December 31,        
    2003     2002        
    (Dollars in Thousands, Except Per Share Data)        
            % of             % of     % Change  
    Amount     Revenues     Amount     Revenues     From Prior year  
Revenues:
                                       
Net patient revenue
  $ 735,841             $ 649,954                  
Other
    10,367               8,308                  
 
                                   
 
    746,208       100.0 %     658,262       100.0 %     13.4 %
Expenses:
                                       
Salaries, wages and benefits
    282,794       37.9       261,499       39.7          
Purchased services
    68,872       9.2       69,934       10.6          
Supplies
    95,579       12.8       84,408       12.8          
Provision for doubtful accounts
    72,583       9.7       53,201       8.1          
Other operating expenses
    88,137       11.8       69,447       10.6          
Rentals and leases
    9,007       1.2       8,284       1.3          
Depreciation and amortization
    37,617       5.1       32,169       4.9          
Interest expense
    26,262       3.5       21,285       3.2          
Minority interests
    260             34                
Loss (gain) on sale of assets
    75             (77 )              
Loss on early extinguishment of debt
    486       0.1                      
 
                               
Total expenses
    681,672       91.3       600,184       91.2       13.6 %
Income from continuing operations before provision for income taxes
    64,536       8.7       58,078       8.8       11.1 %
Income taxes
    22,816       3.1       23,240       3.5          
 
                               
Income from continuing operations
    41,720       5.6       34,838       5.3       19.8 %
Discontinued operations, net of tax:
                                       
(Loss) earnings from operations
    (1,149 )             1,274                  
Net loss on divestitures
    (8,952 )                              
 
                                   
Net income
  $ 31,619             $ 36,112               (12.4 )%
 
                                   
Diluted earnings (loss) per common share:
                                       
Continuing operations
  $ 0.84             $ 0.70                  
Discontinued operations, net of tax:
                                       
(Loss) earnings from operations
    (0.02 )             0.03                  
Net loss on divestitures
    (0.15 )                              
 
                                   
Net income
  $ 0.67             $ 0.73                  
 
                                   

33


Table of Contents

     The following tables present key operating statistics for our owned and leased hospitals (excluding discontinued operations) for the periods presented. (1)

                         
    Year Ended December 31,  
    2004     2003     % Change  
CONSOLIDATED HOSPITALS (CONTINUING OPERATIONS):
                       
Number of hospitals at end of period
    21       19       10.5 %
Licensed beds at end of period (2)
    2,533       2,189       15.7  
Beds in service at end of period
    2,157       1,933       11.6  
Inpatient admissions (3)
    76,107       72,630       4.8  
Adjusted admissions (4)
    141,671       131,557       7.7  
Net patient revenue per adjusted admission
  $ 6,157     $ 5,593       10.1  
Patient days (5)
    323,949       307,195       5.5  
Adjusted patient days (6)
    602,962       556,331       8.4  
Average length of stay (days) (7)
    4.3       4.2       2.4  
Net patient revenue (in thousands)
  $ 872,275     $ 735,841       18.5  
Gross patient revenue (in thousands) (8):
                       
Inpatient
  $ 1,033,038     $ 903,740       14.3 %
Outpatient
    889,903       732,844       21.4  
                   
Total gross patient revenue
  $ 1,922,941     $ 1,636,584       17.5 %
                   
 
                       
SAME HOSPITALS (CONTINUING OPERATIONS)(9):
                       
Number of hospitals at end of period
    19       19       %
Licensed beds at end of period (2)
    2,206       2,189       0.8  
Beds in service at end of period
    1,920       1,933       (0.7 )
Inpatient admissions (3)
    70,071       72,630       (3.5 )
Adjusted admissions (4)
    131,277       131,557       (0.2 )
Net patient revenue per adjusted admission
  $ 5,937     $ 5,592       6.2  
Patient days (5)
    297,083       307,195       (3.3 )
Adjusted patient days (6)
    556,459       556,331        
Average length of stay (days) (7)
    4.2       4.2        
Net patient revenue (in thousands)
  $ 779,419     $ 735,727       5.9  
Gross patient revenue (in thousands) (8):
                       
Inpatient
  $ 933,552     $ 903,740       3.3 %
Outpatient
    814,808       732,844       11.2  
                   
Total gross patient revenue
  $ 1,748,360     $ 1,636,584       6.8 %
                   


(1)   All statistics have been restated to exclude the ownership and operations of Glades General Hospital, which was sold on April 30, 2004. The statistics above have not been impacted by the disposal of Brim Healthcare, Inc. on June 30, 2004.
 
(2)   Beds for which a hospital has been granted approval to operate from the applicable state licensing agency.
 
(3)   Represents the total number of patients admitted (in a facility for a period in excess of 23 hours) and used by management and investors as a general measure of inpatient volume.
 
(4)   Used by management and investors as a general measure of combined inpatient and outpatient volume. Adjusted admissions are computed by multiplying admissions (inpatient volume) by the outpatient factor. The outpatient factor is the sum of gross inpatient revenue and gross outpatient revenue divided by gross inpatient revenue. The adjusted admissions computation equates outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.
 
(5)   Represents the total number of days the patients who are admitted stay in our hospitals.
 
(6)   Adjusted patient days are computed by multiplying patient days (inpatient volume) by the outpatient factor. The outpatient factor is the sum of gross inpatient revenue and gross outpatient revenue divided by gross inpatient revenue. The adjusted patient days computation equates outpatient revenue to the volume measure (patient days) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.

34


Table of Contents

(7)   The average number of days admitted patients stay in our hospitals.
 
(8)   Represents revenues prior to reductions for discounts and contractual allowances.
 
(9)   Same hospital information includes the operations of only those hospitals which were owned or leased during both entire periods presented and excludes the ownership and operations of Glades General Hospital, which was sold on April 30, 2004.
                         
    Year Ended December 31,  
    2003     2002     % Change  
CONSOLIDATED HOSPITALS (CONTINUING OPERATIONS):
                       
Number of hospitals at end of period
    19       19       %
Licensed beds at end of period (2)
    2,189       2,207       (0.8 )
Beds in service at end of period
    1,933       1,933        
Inpatient admissions (3)
    72,630       69,107       5.1  
Adjusted admissions (4)
    131,557       120,990       8.7  
Net patient revenue per adjusted admission
  $ 5,593     $ 5,372       4.1  
Patient days (5)
    307,195       299,138       2.7  
Adjusted patient days (6)
    556,331       523,307       6.3  
Average length of stay (days) (7)
    4.2       4.3       (2.3 )
Net patient revenue (in thousands)
  $ 735,841     $ 649,954       13.2  
Gross patient revenue (in thousands) (8):
                       
Inpatient
  $ 903,740     $ 799,358       13.1 %
Outpatient
    732,844       599,333       22.3  
 
                 
Total gross patient revenue
  $ 1,636,584     $ 1,398,691       17.0 %
 
                 
 
                       
SAME HOSPITALS (CONTINUING OPERATIONS)(9):
                       
Number of hospitals at end of period
    19       19       %
Licensed beds at end of period (2)
    2,189       2,207       (0.8 )
Beds in service at end of period
    1,933       1,933        
Inpatient admissions (3)
    68,205       67,694       0.8  
Adjusted admissions (4)
    121,707       118,035       3.1  
Net patient revenue per adjusted admission
  $ 5,521     $ 5,363       2.9  
Patient days (5)
    287,880       293,248       (1.8 )
Adjusted patient days (6)
    513,539       510,906       0.5  
Average length of stay (days) (7)
    4.2       4.3       (2.3 )
Net patient revenue (in thousands)
  $ 671,910     $ 633,005       6.1  
Gross patient revenue (in thousands) (8):
                       
Inpatient
  $ 857,340     $ 787,050       8.9 %
Outpatient
    672,018       584,687       14.9  
 
                 
Total gross patient revenue
  $ 1,529,358     $ 1,371,737       11.5 %
 
                 

See notes following preceding table.

     Hospital revenues are received primarily from Medicare, Medicaid and commercial insurance. The revenues received from the Medicare program are expected to increase with the general aging of the population. The payment rates under the Medicare program for inpatients are based on a prospective payment system, based upon the diagnosis of a patient. While these rates are indexed for inflation annually, the increases historically have been less than actual inflation. In addition, states, insurance companies and employers are actively negotiating the amounts paid to hospitals as opposed to paying standard hospital rates. The trend toward managed care, including health maintenance organizations, preferred provider organizations and various other forms of managed care, may affect our hospitals’ ability to maintain their current rate of net operating revenue growth.

     We continually monitor the cost/benefit relationship of services provided at our hospitals, and make decisions related to adding new services or discontinuing existing services.

     Net patient revenue is reported net of contractual adjustments and policy discounts. The adjustments principally result from differences between our hospitals’ customary charges and payment rates under the Medicare, Medicaid and other third-party payor programs. Customary charges generally have increased at a faster rate than the rate of increase for Medicare and Medicaid payments.

35


Table of Contents

We provide care without charge to patients who are financially unable to pay for the healthcare services they receive. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net patient revenue. Operating expenses of our hospitals primarily consist of salaries, wages and benefits, purchased services, supplies, provision for doubtful accounts, rentals and leases, and other operating expenses, principally consisting of utilities, insurance, property taxes, travel, physician recruiting, telephone, advertising, repairs and maintenance.

Year Ended December 31, 2004 Compared to Year Ended December 31, 2003

     Revenues increased 18.3% to $882.9 million in 2004 compared to $746.2 million in 2003. This increase was primarily attributable to the acquisition of Memorial Medical Center in Las Cruces, New Mexico (“Memorial Medical Center”) effective June 1, 2004 and an increase in same hospital revenues. Same hospital net patient revenues increased 5.9% in 2004 from 2003 primarily due to increases in net patient revenue per adjusted admission of 6.2% and outpatient revenue of 11.2%. The increase in same-store net patient revenue per adjusted admission was due, in part, by acuity as our same-store Medicare case mix index increased approximately 2.2% to 1.23 for the year ended December 31, 2004 from 1.20 for the year ended December 31, 2003. Cost report settlements and the filing of cost reports also increased revenues in 2004 by $9.9 million, of which $2.9 million related to facilities that had not previously qualified for disproportionate share payments in prior years, and $5.5 million in 2003, respectively. Under our agreement with the seller of Memorial Medical Center, we are to receive payments from the seller through June 1, 2007 as reimbursement for providing certain levels of charity services. For the period from June 1, 2004 (date of acquisition) through the end of 2004, we recorded $4.2 million in reimbursement for these services provided.

     The table below reflects the sources of our net patient revenue for the years ended December 31, 2004 and 2003, expressed as a percentage of total net patient revenue:

                 
    Year Ended December 31,  
    2004     2003  
Medicare
    37.7 %     38.5 %
Medicaid
    10.1       10.3  
Other (including self-pay)
    52.2       51.2  
 
           
 
    100.0 %     100.0 %
 
           

     Salaries, wages and benefits as a percentage of revenues, decreased to 36.6% from 37.9% in 2003. The decrease is primarily due to improvements resulting from continued implementation of our flexible staffing standards throughout our hospitals, which effectively matches labor with hospital volume trends and continued cost containment of employee benefit expenses.

     Purchased services, as a percentage of revenues, increased to 9.7% in 2004 from 9.2% in 2003. The increase is primarily due to an increase in legal fees of $1.6 million and a $4.0 million increase in contract labor (primarily contract services for nursing, emergency room and physical therapy at Memorial Medical Center and four of our same-store hospitals) for the year ended December 31, 2004 compared to the year ended December 31, 2003. The increase in legal fees is related to medical staff bylaws and physician contract matters.

     The provision for doubtful accounts, as a percentage of revenues, increased to 10.8% in 2004 from 9.7% in 2003 due primarily to the increase in bad debts resulting from the increase in self-pay revenue and due to the purchase of Memorial Medical Center. During the year ended December 31, 2004, self-pay revenue as a percentage of gross revenues increased to 5.9% from 4.6% for 2003. The increase in self-pay revenue is due to the current economic environment and slow employment recovery, coupled with changes in benefit plan design toward increased co-pays and deductibles as employers pass a greater percentage of healthcare costs to individual employees. Although the economies of a majority of the communities in which we operate hospitals have stabilized, some of our hospitals are experiencing a reduction in state Medicaid coverage, particularly in Texas. Net patient revenue associated with self-pay patients are generally recorded at gross charges, which are higher than what government programs and managed care plans pay. As a result, failure to receive payment from self-pay and uninsured patients results in a higher provision for doubtful accounts as a percentage of total net patient revenue.

     Other operating expenses decreased as a percentage of revenues to 11.0% in 2004 from 11.8% in 2003 primarily due to a reduction of $1.2 million in insurance cost as we continued to realize favorable experience in both professional and general liability and workers’ compensation insurance, as determined by our independent third party actuary.

36


Table of Contents

     Depreciation and amortization expense increased $9.3 million to $46.9 million in 2004 from $37.6 million in 2003. Approximately $5.0 million of this increase is the result of the additional expense associated with the acquisition of Memorial Medical Center, with the remainder of the increase resulting from our capital expenditure program focusing on revenue generating projects.

     Interest expense increased to $29.7 million in 2004 from $26.3 million in 2003. The increase is primarily driven by the additional debt associated with the acquisition of Memorial Medical Center and the issuance in May 2003 of $200.0 million aggregate principal amount of 7 1/2% Senior Subordinated Notes due 2013, offset by repayments of outstanding borrowings on our senior bank credit facility and repurchases of a portion of our 4 1/2% Convertible Subordinated Notes due 2005. The interest related to the $200.0 million 7 1/2% Senior Subordinated Notes due 2013 was reduced by a $100.0 million fixed to floating interest rate swap agreement entered into in the third quarter of 2003, which has rates currently lower than the underlying debt.

     The provision for income taxes totaled $28.1 million, or a 36.0% effective tax rate, in 2004 compared to $22.8 million, or a 35.4% effective tax rate, in 2003. The reduction in the effective tax rate for both 2004 and 2003 from the statutory rate was primarily attributable to a reduction in our tax liabilities due to the final and favorable resolution of examinations by taxing authorities in 2004. In addition, the reduction in the federal tax rate for 2004 was attributable to the realization of Empowerment Zone and Renewal Community Tax credits related to two of our facilities and the impact of the disposition of Glades General Hospital and Brim Healthcare, Inc.

     In 2004, our company’s discontinued operations incurred an after-tax gain on divestitures of $6.7 million and a loss from operations totaling $2.2 million. In 2003, our company’s discontinued operations incurred an after-tax impairment of assets charge of $9.0 million and a loss from discontinued operations totaling $1.1 million. The gain on divestitures recorded in 2004 was principally due to the gain on sale of Brim Healthcare, Inc., which resulted in an after-tax gain of $7.0 million. The impairment of assets charge in 2003 was related to the write-off of goodwill and physician recruiting costs and the write down of other assets of Glades General Hospital to their net realizable value, less cost to sell. The decline in loss from operations resulted primarily from the recording of an additional provision for doubtful accounts for Glades General Hospital patient accounts receivable that we retained in the sale of that entity.

Year Ended December 31, 2003 Compared to Year Ended December 31, 2002

     Revenues increased 13.4% to $746.2 million in 2003 compared to $658.3 million in 2002. This increase was primarily attributable to the hospitals acquired in 2002 and an increase in same hospital revenues. During the second quarter of 2002, our company acquired Los Alamos Medical Center in New Mexico and Memorial Hospital of Martinsville and Henry County in Virginia. Same hospital net patient revenue increased 6.1% in 2003 from 2002 primarily due to increases in adjusted admissions of 3.1% and net patient revenue per adjusted admission of 2.9%. The increase in adjusted admissions was attributable, in part, to the addition of 106 new doctors, of which 17 were hospital-based, in our communities in 2003. Cost report settlements and the filing of cost reports also increased revenue in 2003 by $5.5 million compared to a reduction in revenue in 2002 of $0.9 million.

     The table below reflects the sources of our net patient revenue for the years ended December 31, 2003 and 2002, expressed as a percentage of total net patient revenue:

                 
    Year Ended December 31,  
    2003     2002  
Medicare
    38.5 %     45.4 %
Medicaid
    10.3       11.3  
Other (including self-pay)
    51.2       43.3  
 
           
 
    100.0 %     100.0 %
 
           

     Salaries, wages and benefits as a percentage of revenues, decreased to 37.9% from 39.7% in 2002. The decrease is primarily due to improvements resulting from continued implementation of our flexible staffing standards throughout our hospitals, which effectively matches labor with hospital volume trends and continued cost containment of employee benefit expenses.

     Purchased services, as a percentage of revenues, decreased to 9.2% in 2003 from 10.6% in 2002. The decrease is primarily attributable to an 18.5% reduction in contract labor and reductions in collection agency fees as we were less reliant on outside collection consultants and staffing.

37


Table of Contents

     Provision for doubtful accounts, as a percentage of revenues, increased to 9.7% in 2003 from 8.1% in 2002 due primarily to the increase in bad debts resulting from increases in self-pay revenue. During 2003, self-pay revenue as a percentage of total gross revenues increased to 4.6% from 3.8% in 2002. The most significant increase occurred in the second quarter of 2003 when self-pay revenue as a percentage of gross revenues increased to 5.1% but then declined slightly in the third quarter to 4.8% and continued to decline in the fourth quarter to 4.5%. The increase in self-pay revenue is due to the current economic environment and slow employment recovery, coupled with changes in benefit plan design toward increased co-pays and deductibles as employers pass a greater percentage of healthcare costs to individual employees. Net patient revenue associated with self-pay patients are generally recorded at gross charges, which are higher than what government programs and managed care plans pay. As a result, failure to receive payment from self-pay and uninsured patients results in a higher provision for doubtful accounts as a percentage of total net patient revenue.

     Other operating expenses increased as a percentage of revenues to 11.8% in 2003 from 10.6% in 2002 primarily due to increased medical malpractice, workers’ compensation and directors and officers insurance cost of $7.2 million and increased physician recruitment expense of $3.1 million based upon the significant number of physicians we recruited to our communities in 2003.

     Depreciation and amortization expense increased $5.4 million to $37.6 million in 2003 from $32.2 million in 2002 primarily due to depreciation at the two hospitals acquired in 2002 and capital expenditures.

     Interest expense increased to $26.3 million in 2003 from $21.3 million in 2002 primarily due to the issuance in May 2003 of $200.0 million aggregate principal amount of 7 1/2% Senior Subordinated Notes due 2013, offset by repayments of outstanding borrowings on our senior bank credit facility, repurchases of a portion of our 4 1/2% Convertible Subordinated Notes due 2005 and entering into a $100.0 million fixed to floating interest rate swap agreement during the third quarter of 2003.

     The write-off of deferred loan costs and the gain resulting from repurchasing a portion of our 4 1/2% Convertible Subordinated Notes due 2005 at a discount resulted in a net pre-tax loss on extinguishment of debt of $0.5 million during 2003.

     The provision for income taxes totaled $22.8 million, or a 35.4% effective tax rate, in 2003 compared to $23.2 million, or a 40.0% effective tax rate, in 2002. The reduction in the effective tax rate during 2003 was primarily attributable to a $2.3 million reduction in our tax liabilities due to the final and favorable resolution of examinations by taxing authorities as we recently concluded audits that have been ongoing for over one year.

     In 2003, our company’s discontinued operations incurred an after-tax impairment of assets charge of $9.0 million and a loss from operations totaling $1.1 million. In 2002, the discontinued operations achieved earnings from operations of $1.3 million. The decline in operations resulted primarily from a shift in the demographic make-up of the service area surrounding Glades General Hospital and a significant increase in the proportion of indigent care provided by that facility.

Liquidity and Capital Resources

     At December 31, 2004, we had working capital from continuing operations of $15.7 million, including cash and cash equivalents of $9.8 million, compared to working capital from continuing operations of $130.6 million, including $46.1 million in cash and cash equivalents at December 31, 2003.

     Net cash provided by operating activities was $126.3 million for the year ended December 31, 2004, compared to $104.3 million for the year ended December 31, 2003. The $22.0 million increase in cash provided by operating activities is primarily due to an increase of $8.3 million in our income from continuing operations, a $9.3 million increase in depreciation and amortization expense (of which $5.0 million is attributable to the Memorial Medical Center acquisition), and an increase of $15.2 million in our deferred income tax provision resulting from the Memorial Medical Center acquisition and divestitures of Glades General Hospital and Brim Healthcare, Inc. The increase in cash flow from operations is partially offset by an increase in net accounts receivable of continuing operations of $12.6 million. The increase in net accounts receivable principally relates to a $6.2 million loan to a third party for the construction of a medical office building on one of our facility’s campuses and approximately $5.9 million from the lessor of Memorial Medical Center for their obligations required under the facility lease agreement.

     Net cash used in investing activities increased to $228.1 million in 2004 from $56.9 million in 2003. The $171.2 million increase is primarily due to the $152.2 million acquisition of Memorial Medical Center, and as a result of our capital expenditure program focusing on revenue generating projects. Significant capital expenditures for the year ended December 31, 2004 included $6.3 million for the purchase of land and building at Havasu Regional Medical Center, $25.4 million in construction costs and equipment

38


Table of Contents

purchases for the new hospital in Hardeeville, South Carolina, $3.9 million for our MRI project at Los Alamos Medical Center, $3.8 million for women’s services at Teche Regional Medical Center, $6.6 million in construction costs for the new hospital in Ft. Mohave, Arizona and $9.3 million for a company-wide information system upgrade. Net cash used in investing activities was partially offset by approximately $14.7 million in cash proceeds from the sale of Glades General Hospital and Brim Healthcare, Inc. in the second quarter of 2004.

     Net cash provided by financing activities totaled $66.4 million for 2004 primarily due to borrowings of $110.4 million under our senior bank credit facility for the acquisition of Memorial Medical Center, as primarily offset by $55.4 million in repayments of borrowings under our senior bank credit facility and $0.8 million in payments under capital lease obligations. Net cash used in financing activities of $16.3 million in 2003 resulted from $194.2 million in net proceeds from the issuance of our 7 1/2% Senior Subordinated Notes due 2013, which were used to more than offset the cash used to repay $114.3 million outstanding on the senior bank credit facility and to repurchase $74.0 million principal amount of our 4 1/2% Convertible Subordinated Notes due 2005.

     We maintain a senior bank credit facility with Wachovia Bank, National Association, as agent and issuing bank for a syndicate of lenders with aggregate commitments up to $250.0 million. At December 31, 2004, we had $186.7 million, net of outstanding revolver borrowings of $55.0 million and letters of credit of $8.3 million, available for borrowing under the senior bank credit facility. Loans under the senior bank credit facility bear interest, at our option, at the adjusted base rate or at the adjusted LIBOR rate. We pay a commitment fee, which varies from three-eighths to one-half of one percent of the unused portion, depending on our compliance with certain financial ratios. We may prepay any principal amount outstanding under the senior bank credit facility at any time before the maturity date of November 13, 2006.

     In May 2003, we completed a public offering of $200.0 million aggregate principal amount of 7 1/2% Senior Subordinated Notes due June 1, 2013. Net proceeds of the offering totaling $194.2 million were used to repay $114.3 million in existing borrowings under the senior bank credit facility and to repurchase $74.0 million of our 4 1/2% Convertible Subordinated Notes due 2005. The 7 1/2% Notes bear interest from May 27, 2003 at the rate of 7 1/2% per year, payable semi-annually on June 1 and December 1, beginning on December 1, 2003. We may redeem all or a portion of the 7 1/2% Notes on or after June 1, 2008, at the then current redemption prices, plus accrued and unpaid interest. In addition, at any time prior to June 1, 2006, we may redeem up to 35% of the aggregate principal amount of the 7 1/2% Notes within 60 days of one or more common stock offerings with the net proceeds of such offerings at a redemption price of 107.5% of the principal amount, plus accrued and unpaid interest. Note holders may require us to repurchase all of the holder’s notes at 101% of their principal amount plus accrued and unpaid interest in some circumstances involving a change of control. The 7 1/2% Notes are unsecured and subordinated to our existing and future senior indebtedness. The 7 1/2% Notes rank equal in right of payment to our 4 1/2% Convertible Subordinated Notes due 2005 and our 4 1/4% Convertible Subordinated Notes due 2008. The 7 1/2% Notes effectively rank junior to our subsidiary liabilities. The indenture contains limitations on our ability to incur additional indebtedness, sell material assets, retire, redeem or otherwise reacquire its capital stock, acquire the capital stock or assets of another business, and pay dividends.

     In October 2001, we sold $172.5 million of 4 1/4% Convertible Subordinated Notes due October 10, 2008. Net proceeds of approximately $166.4 million were used to reduce the outstanding balance on our senior bank credit facility and for acquisitions. The 4 1/4% Notes bear interest at the rate of 4 1/4% per year, payable semi-annually on each April 10 and October 10. The 4 1/4% Notes are convertible at the option of the holder at any time on or prior to maturity into shares of our common stock at a conversion price of $27.70 per share. The conversion price is subject to adjustment. We may redeem all or a portion of the 4 1/4% Notes on or after October 10, 2004, at the then current redemption prices, plus accrued and unpaid interest. Note holders may require us to repurchase all of the holder’s notes at 100% of their principal amount plus accrued and unpaid interest in some circumstances involving a change of control. The 4 1/4% Notes are unsecured and subordinated to our existing and future senior indebtedness. The 4 1/4% Notes rank equal in right of payment to our 4 1/2% Convertible Subordinated Notes due 2005 and our 7 1/2% Senior Subordinated Notes due 2013. The 4 1/4% Notes effectively rank junior to our subsidiary liabilities. The indenture does not contain any financial covenants. A total of 6,226,767 shares of our common stock have been reserved for issuance upon conversion of the 4 1/4% Notes.

     In November and December 2000, we sold $150.0 million aggregate principal amount of 4 1/2% Convertible Subordinated Notes due November 20, 2005. The 4 1/2% Notes bear interest at the rate of 4 1/2% per year, payable semi-annually on each May 20 and November 20. The 4 1/2% Notes are convertible at the option of the holder at any time on or prior to maturity into shares of our common stock at a conversion price of $26.45 per share. The conversion price is subject to adjustment. We may redeem all or a portion of the 4 1/2% Notes on or after November 20, 2003, at the then current redemption prices, plus accrued and unpaid interest. Note holders may require us to repurchase all of the holder’s notes at 100% of their principal amount plus accrued and unpaid interest in some circumstances involving a change of control. The 4 1/2% Notes are unsecured obligations and rank junior in right of payment to all of our existing and future senior indebtedness. The 4 1/2% Notes rank equal in right of payment to our 4 1/4% Convertible

39


Table of Contents

Subordinated Notes due 2008 and our 7 1/2% Senior Subordinated Notes due 2013. The 4 1/2% Notes effectively rank junior to our subsidiary liabilities. The indenture does not contain any financial covenants. At December 31, 2004, approximately $76.0 million principal amount of the 4 1/2% Notes remained outstanding, and a total of 2,872,760 shares of common stock have been reserved for issuance upon conversion of the remaining 4 1/2% Notes.

     Our Board of Directors has authorized the repurchase from time to time and subject to market conditions of our outstanding 4 1/2% Notes and 4 1/4% Notes in the open market or in privately negotiated transactions. During 2003, we repurchased $74.0 million principal amount of the 4 1/2% Notes. We recorded a $0.5 million pretax loss associated with the early extinguishment of debt related to the repurchase of the 4 1/2% Notes. We did not repurchase any of the 4 1/2% Notes during 2004 and have not repurchased any of the 4 1/4% Notes.

     On March 18, 2005, in connection with the pending acquisition by LifePoint, we commenced a cash tender offer and consent solicitation for any and all of our 7 1/2% Notes. In addition, Lakers Holding Corp., a subsidiary of LifePoint, commenced a cash tender offer on that date for any and all of our 4 1/4% Notes. The tender offer consideration for each $1,000 principal amount of 7 1/2% Notes validly tendered and accepted for purchase will be based on a fixed spread of 50 basis points over the yield on the price, as of April 12, 2005, of the 2.625% U.S. Treasury Note due May 15, 2008, plus accrued interest minus a consent payment equal to $20 per $1,000 principal amount tendered and accepted for purchase. The tender offer consideration for each $1,000 principal amount of 4 1/4% Notes validly tendered and accepted for purchase will be $1,060, plus accrued interest. The tender offer on the 7 1/2% Notes is scheduled to expire on April 15, 2005 and the tender offer on the 4 1/4% Notes is scheduled to expire on April 14, 2005, unless extended or terminated earlier.

     Our shelf registration statement, providing for the offer, from time to time, of common stock and/or debt securities up to an aggregate of $300.0 million remains effective with the Securities and Exchange Commission. Following the issuance of $200.0 million aggregate principal amount of our 7 1/2% Senior Subordinated Notes due 2013, the shelf registration statement remains available for the issuance of up to $100.0 million of additional securities, subject to market conditions and our capital needs.

     Capital expenditures for our owned and leased hospitals may vary from year to year depending on facility improvements and service enhancements undertaken by the hospitals. We expect to make total capital expenditures in 2005 of approximately $51.0 million, exclusive of new hospital construction projects. Planned capital expenditures for 2005 consist principally of capital improvements to owned and leased hospitals. In addition, we expect our new hospital construction projects in Ft. Mohave, Arizona and Eunice, Louisiana will total $40.9 million in 2005. We anticipate opening the Arizona hospital in the third quarter of 2005 and the Louisiana hospital in the second quarter of 2006. We expect to fund these expenditures through cash provided by operating activities and borrowings under our senior bank credit facility.

     Our management anticipates that cash flows from operations, amounts available under our senior bank credit facility, and our anticipated access to capital markets are sufficient to meet expected liquidity needs, planned capital expenditures and other expected operating needs for the next twelve months.

     The following tables reflect a summary of our obligations and commitments outstanding as of December 31, 2004.

                                         
    Payments Due By Period        
    Less than 1                          
    Year     1-2 Years     3-4 Years     Thereafter     Total  
    (In Thousands)  
Contractual Cash Obligations:
                                       
Long-term debt
  $ 75,970     $ 55,000     $ 172,500     $ 198,337     $ 501,807  
Capital lease obligations, with interest
    479       940       892       2,311       4,622  
Operating leases
    7,609       12,127       7,693       15,538       42,967  
 
                             
Subtotal
  $ 84,058     $ 68,067     $ 181,085     $ 216,186     $ 549,396  
                                         
    Amount of Commitment Expiration Per Period  
    Less than 1                          
    Year     1-2 Years     3-4 Years     Thereafter     Total  
    (In Thousands)  
Other Commitments:
                                       
Letters of credit
  $     $ 8,277     $     $     $ 8,277  
Construction and improvement commitments
    69,643       12,394                   82,037  
Physician commitments(1)
    15,982       5,607       1,306             22,895  
 
                             
Subtotal
  $ 85,625     $ 26,278     $ 1,306     $     $ 113,209  
 
                             
Total obligations and commitments
  $ 169,683     $ 94,345     $ 182,391     $ 216,186     $ 662,605  
 
                             


(1)   Represents the aggregate of our contractual obligations for advances to physicians as reflected in physician recruiting agreements. Amounts shown are calculated based on the full extent of the obligation set forth in the agreements, although the actual amount of such advances often depends on the financial performance of the physician’s practice during the first year after relocating to the

40


Table of Contents

community and whether the physician remains in the community. In most cases, the amounts advanced under the agreements are significantly less than the contractual commitment.

Critical Accounting Policies

     Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. In preparing our financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We evaluate our estimates and judgments on an ongoing basis. We base our estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our actual results may differ from these estimates, and different assumptions or conditions may yield different estimates. The following represent the estimates that we consider most critical to our operating performance and involve the most complex assumptions and assessments.

Allowance for Doubtful Accounts

     Substantially all of our accounts receivable are related to providing healthcare services to our hospitals’ patients. Our ability to collect outstanding receivables from third-party payors and others is critical to our operating performance and cash flows. The primary collection risk lies with uninsured patient accounts or patient accounts for which a balance remains after primary insurance has paid. Insurance coverage is verified prior to treatment for all procedures scheduled in advance and walk-in patients. Insurance coverage is not verified in advance of procedures for emergency room patients. Deductibles and co-payments are generally determined prior to the patient’s discharge with emphasis on collection efforts before discharge. Once these amounts are determined, any remaining patient balance is identified and collection activity is initiated before the patient is discharged. Our standard collection procedures are then followed until such time that management determines the account is uncollectible, at which point the account is written off. For hospitals that we have owned in excess of one year, our policy with respect to estimating our allowance for doubtful accounts is to reserve 50% of all self-pay accounts receivable aged between 121 and 150 days and 100% of all self-pay accounts that have aged greater than 150 days. For hospitals that the Company has owned less than one year, the Company estimates the allowance for doubtful accounts by applying a hospital-specific reserve percentage for each self-pay and non self-pay aging category, beginning with the 0-30 day aging category, with all self-pay and non-self pay accounts fully reserved at 150 days. Accordingly, substantially all of our bad debt expense is related to uninsured patient accounts and patient accounts for which a balance remains after primary insurance has paid. We continually monitor our accounts receivable balances and utilize cash collections data and other analytical tools to support the basis for our estimates of the provision for doubtful accounts. In addition, we perform hindsight procedures on historical collection and write-off experience to determine the reasonableness of our policy for estimating the allowance for doubtful accounts. Significant changes in payor mix or business office operations, or deterioration in aging accounts receivable could result in a significant increase in this allowance.

     In general, the standard collection cycle at our hospitals is as follows:

•   Upfront cash collection of deductibles, co-payments, and self-pay accounts.
 
•   From the time the account is billed until the period 120 days after the billing, internal business office collections and early out program collections are performed.
 
•   From the time the account is 121 days after billing until the period one year after billing, uncollected accounts are turned over to one of two primary collection agencies utilized by our company.
 
•   One year following the date of billing, any uncollected accounts are written off and the accounts are turned over to our secondary collection agency.

     The following table summarizes our days revenue outstanding on a same-store basis as of the dates indicated:

         
December 31, 2004
  December 31, 2003   December 31, 2002
         
54   54   62

     Our target for days revenue outstanding ranges from 53 to 58 days.

41


Table of Contents

     Uncollected accounts are manually written off: (a) if the balance is less than $10.00, (b) when turned over to an outside secondary collection agency at 365 days, or (c) earlier than 365 days if all collection efforts indicate an account is uncollectible. Once accounts have been written off, they are not included in our gross accounts receivable or allowance for doubtful accounts.

     The approximate percentage of total gross accounts receivable summarized by aging categories is as follows:

                         
    December 31, 2004     December 31, 2003     December 31, 2002  
0 to 60 days
    59.8 %     57.7 %     52.9 %
61 to 150 days
    18.7       17.2       17.3  
Over 150 days
    21.5       25.1       29.8  
 
                 
Total
    100.0 %     100.0 %     100.0 %
 
                 

     The approximate percentage of total gross accounts receivable summarized by payor is as follows:

                         
    December 31, 2004     December 31, 2003     December 31, 2002  
Medicare
    24.5 %     25.5 %     23.3 %
Medicaid
    11.1       11.6       12.5  
Managed Care and Other
    30.1       25.4       26.2  
Self-Pay
    34.3       37.5       38.0  
 
                 
Total
    100.0 %     100.0 %     100.0 %
 
                 

     We owned or leased three hospitals in Texas, which accounted for 16.1% and 16.6% of net accounts receivable in 2004 and 2003, respectively. We owned or leased four hospitals in Louisiana, which accounted for 9.5% and 13.2% of net accounts receivable in 2004 and 2003, respectively. We owned or leased two hospitals in New Mexico, one of which was acquired in 2004, which accounted for 16.2% and 3.6% of net accounts receivable in 2004 and 2003, respectively.

     Same-store upfront cash collections for the year ended December 31, 2004 were approximately $13.5 million compared to $11.5 million and $8.1 million for the years ended December 31, 2003 and 2002, respectively.

Allowance for Contractual Discounts

     We derive a significant portion of our revenues from Medicare, Medicaid and other payors that receive discounts from our standard charges. The Medicare and Medicaid regulations and various managed care contracts under which these discounts must be calculated are often complex and subject to interpretation and adjustment. In addition, the services authorized and provided and resulting reimbursement, are often subject to interpretation. These interpretations sometimes result in payments that differ from our estimates. Additionally, updated regulations and contract negotiations occur frequently, necessitating our continual review and assessment of the estimation process. Our hospitals’ computerized billing systems do not automatically calculate and record contractual allowances. Rather, we utilize an internally developed contractual model to estimate the allowance for contractual discounts on a payor — specific basis, given our interpretation of the applicable regulations or contract terms. Our contractual model for Medicare and Medicaid inpatient services utilizes the application of actual diagnosis related group (“DRG”) data to individual patient accounts to calculate contractual allowances. For all inpatient and outpatient non-Medicare and non-Medicaid services, our contractual model utilizes six month historical paid claims data by payor for such services to calculate the contractual allowances. Differences between the contractual allowances estimated by our contractual model and actual paid claims are adjusted when the individual claims are paid. Our contractual model is updated each quarter. In addition to the contractual allowances estimated and recorded by our contractual model, we also record an allowance equal to 100% of all Medicare, Medicaid, and other insurance payors accounts receivable that are aged greater than 365 days.

General and Professional Liability Reserves

     We purchased a professional liability claims-made reporting policy effective January 1, 2004. This coverage is subject to a $5.0 million self-insured retention per occurrence for general and professional liability and provides coverage up to $50.0 million for claims incurred during the annual policy term. This retention amount increases our exposure for claims occurring prior to December 31, 2002, and reported on or after January 1, 2004, due to the increased retention amount as compared to prior years. In 2002, our company had a claims-made reporting policy subject to a $750,000 deductible and a $2.0 million self-insured retention per

42


Table of Contents

occurrence, providing coverage up to $51.0 million for claims incurred during the annual policy term in 2002. In 2001, we maintained insurance for individual malpractice claims exceeding $50,000 per medical incident, subject to an annual maximum of $500,000 for claims occurring and reported in 2001. We purchased a tail policy that provides an unlimited claim reporting period for our professional liability for claims incurred in 2000 and prior years. We estimate our self-insured retention portion of the malpractice risks using an outside actuary which uses historical claims data, demographic factors, severity factors and other actuarial assumptions. The estimated accrual for malpractice claims could be significantly affected should current and future occurrences differ from historical claims trends. The estimation process is also complicated by the relatively short period of time in which we have owned some of our healthcare facilities, as occurrence data under previous ownership may not necessarily reflect occurrence data under our ownership. While management monitors current claims closely and considers outcomes when estimating our insurance accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in the estimates. We maintain a reserve to cover both reported claims and claims that have been incurred but not yet reported within our self-insured retention.

Workers’ Compensation Reserves

     Workers’ compensation claims are insured with a deductible with stop loss limits of $100,000 per accident and a $1.9 million and $2.2 million minimum cap on total losses for the 1999 and 2000 years, respectively, and $250,000 per accident and a $6.6 million and $3.0 million minimum cap on total losses for the 2002 and 2001 years, respectively. We increased our deductible loss amount to $500,000 per accident effective January 1, 2003. The minimum cap for total 2003 losses is $12.0 million. The minimum cap for total 2004 losses is $12.1 million. In 2002 and 2003 our arrangement with the insurance provider allows us to prepay the expected amounts of annual workers’ compensation claims, which is based upon claims experience. The claims processor tracks payments for the policy year. At the end of the policy year, the claims processor compares the total amount prepaid by us to the actual amount paid by the claims processor. This comparison ultimately will result in a receivable from or a payable to the claims processor. For 2004, we elected not to prepay our expected workers’ compensation losses. We estimate our deductible portion of the workers’ compensation risk using an outside actuary which uses historical claims data, demographic factors, severity factors and other actuarial assumptions. The estimated accrual for workers’ compensation claims could be significantly affected should current and future occurrences differ from historical claims trends. The estimation process also is complicated by the relatively short period of time in which we have owned some of our healthcare facilities, as occurrence data under previous ownership may not necessarily reflect occurrence data under our ownership. While management monitors current claims closely and considers outcomes when estimating our insurance accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in the estimates. We maintain a reserve to cover both reported claims and claims that have been incurred but not yet reported within our deductible levels.

     We are fully insured in the commercial marketplace for workers’ compensation claims prior to January 1, 1999. We utilize loss run reports provided by the claims administrator to determine the appropriate range of loss reserves for the 1999 and subsequent years. Our accruals are calculated to cover the risk from both reported claims and claims that have been incurred but not yet reported.

Goodwill and Long-Lived Assets, Including Impairment

     Our consolidated financial statements primarily include the following types of long-lived assets: property and equipment, goodwill and other intangible assets. Property and equipment purchased in the normal course of business are recorded at the cost of the purchase and a useful life is assigned based upon the nature of the asset in comparison to our policy. We also, in connection with our acquisition of businesses, acquire property and equipment, goodwill and other intangible assets. We use outside firms to perform a valuation of these acquired assets for the purpose of allocating the purchase price of the acquisition. As a result of the adoption of Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets (“SFAS No. 142”), we have obtained valuation reports to identify property and equipment, as well as any intangible assets purchased in our acquisitions. Based on the valuation reports completed to date, the only identifiable intangible assets valued have been non-compete agreements and licenses and accreditations, which have had minimal associated value; the remainder was goodwill. In accordance with SFAS No. 142, goodwill resulting from acquisitions after June 30, 2001 has not been amortized.

     Impairment of goodwill is governed by SFAS No. 142. In accordance with the adoption of SFAS No. 142, we completed our annual impairment test as of October 1, 2004. The results of our 2004 review indicated no impairment of our long-lived assets. Our annual impairment test is based upon a combination of market capitalization and a projected run-rate for income from continuing operations before provision for income taxes, depreciation and amortization, interest, minority interests, loss on sale of assets and loss on extinguishment of debt (adjusted for a multiple of earnings) for the consolidated company.

43


Table of Contents

     Impairment of long-lived assets other than goodwill is governed by Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. We adopted this statement effective January 1, 2002. In accordance with the standard, in connection with the sale of Glades General Hospital, which was effective April 30, 2004, the Company recorded an after tax impairment charge of $9.0 million related to the write-off of goodwill associated with the hospital, the write-off of the net book value of physician recruiting costs and the write down of other assets of the hospital to their net realizable value, less costs to sell.

Inflation

     The healthcare industry is labor intensive. Wages and other expenses increase, especially during periods of inflation and labor shortages. In addition, suppliers pass along to us rising costs in the form of higher prices. We generally have been able to offset increases in operating costs by increasing charges for services, expanding services, and implementing cost control measures to curb increases in operating costs and expenses. In light of cost containment measures imposed by government agencies and private insurance companies, we do not know whether we will be able to offset or control future cost increases, or be able to pass on the increased costs associated with providing healthcare services to patients with government or managed care payors, unless such payors correspondingly increase reimbursement rates.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     Our policy is not to hold or issue derivatives for trading purposes and to avoid derivatives with leverage features. Our primary market risk involves interest rate risk. Our interest expense is sensitive to changes in the general level of interest rates. To mitigate the impact of fluctuations in interest rates, we generally maintain 50% - 80% of our debt at a fixed rate, either by borrowing on a long-term basis or entering into an interest rate swap. At December 31, 2004, approximately 70% of our outstanding debt was effectively at a fixed rate. We entered into an interest rate swap agreement which effectively converted, for a ten-year period, $100.0 million of the $200.0 million fixed-rate borrowings under our 7 1/2% Senior Subordinated Notes due 2013 to floating rate borrowings. Floating rate borrowings are based on LIBOR plus 2.79% over the term of the agreement. Our interest rate swap is a fair value hedge. We are exposed to credit losses in the event of nonperformance by the counterparty to the financial instrument. We anticipate that the counterparty will fully satisfy its obligations under the contract.

     The carrying value of our 4 1/2% Notes, 4 1/4% Notes and 7 1/2% Notes was $75,970,000, $172,500,000 and $200,000,000, respectively, at December 31, 2004. The fair value of our 4 1/2% Notes, 4 1/4% Notes, and 7 1/2% Notes was $76,540,000, $174,656,000 and $209,962,000, respectively, at December 31, 2004, based on the quoted market prices at December 31, 2004. At the December 31, 2004 borrowing level, a hypothetical 1% increase in interest rates, considering the effect of the interest rate hedge agreement and the Senior Credit Facility, would have a $1,550,000 impact on our net income and cash flows. A hypothetical 1% increase in interest rates on fixed-rate debt would result in an approximate 1.5% decrease in the fair values at December 31, 2004.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

     The financial statements can be found beginning at page F-1 following this report.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

     None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

     Our company carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and

44


Table of Contents

procedures (as defined in Exchange Act Rule 13a-14(c)) as of the end of the period covered by this report. Based on their evaluation of such controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by our company in the reports we file under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Management’s Report on Internal Control Over Financial Reporting

     Management’s Report on Internal Control Over Financial Reporting appears on page F-1 of this report.

Changes in Internal Control Over Financial Reporting

     We continue to evaluate our internal controls and procedures and implement additional procedures to ensure accurate and consistent reporting of financial results from period to period. There have been no significant changes in our internal controls over financial reporting that occurred during the fourth quarter of 2004 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

     None.

45


Table of Contents

PART III

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

Directors and Executive Officers

     The following table sets forth certain information concerning our directors and executive officers as of March 1, 2005.

             
Name   Age   Position
Martin S. Rash
    50     Chief Executive Officer and Chairman of the Board
Joseph P. Nolan (2)(3)(4)
    40     Director
Winfield C. Dunn (1)(2)(3)(4)
    77     Director
Paul J. Feldstein Ph.D. (1)(3)(4)
    71     Director
David R. Klock Ph.D. (1)(2)(3)
    60     Director
Michael P. Haley (1)(2)(3)
    54     Director
Daniel S. Slipkovich
    47     President and Chief Operating Officer
Christopher T. Hannon
    42     Senior Vice President and Chief Financial Officer
James Thomas Anderson
    51     Senior Vice President of Acquisitions and Development
Howard T. Wall, III
    46     Senior Vice President, General Counsel and Secretary
Samuel H. Moody
    56     Senior Vice President of Operations
Mark T. Brenzel
    50     Regional Vice President, Western Division
Thomas A. Pemberton
    51     Regional Vice President, Eastern Division
Carl Wayne Gower
    57     Regional Vice President, Central Division
Steven R. Brumfield
    41     Vice President and Controller


(1)   Member of the Audit Committee
 
(2)   Member of the Compensation Committee
 
(3)   Member of the Nominating and Governance Committee
 
(4)   Member of the Compliance Committee

     Mr. Rash has been a director of our company since February 1996. He has served as Chief Executive Officer of our company since December 1996 and Chairman of the Board since May 1998. He served as President of our company from December 1996 until May 2001. He was Chief Executive Officer and director of our predecessor, Principal Hospital Company, from February 1996 to December 1996. From February 1994 to February 1996, he was the Chief Operating Officer of Community Health Systems, Inc., a provider of general hospital care services in non-urban areas. Mr. Rash has served as a director of Odyssey Healthcare, Inc., a provider of hospice care, since July 2000.

     Mr. Nolan has been a director of our company since February 1996. He has been a Senior Principal of GTCR Golder Rauner, LLC and has been a Principal of Golder, Thoma, Cressey, Rauner, Inc. (“GTCR, Inc.”), which is a general partner of Golder, Thoma, Cressey, Rauner Fund IV, L.P. (“GTCR”), since July 1996. Mr. Nolan joined GTCR, Inc. in February 1994.

     Dr. Dunn has been a director of our company since February 2000. Dr. Dunn is a former Governor of the State of Tennessee. Dr. Dunn served as Vice Chairman of the Board of Directors of Total eMed, Inc., a provider of web-based electronic medical transcription services, from June 1998 through September 2000. From 1993 to 1998, he served as Chairman of the Board of MedShares Management Group, Incorporated, an owner and manager of home health care agencies. Dr. Dunn served as a director of Aveta Health, Inc. (formerly known as PhyCor, Inc.), from 1988 until July 2002. He earned his D.D.S. from the University of Tennessee Dental School.

     Professor Feldstein has been a director of our company since May 2001. Professor Feldstein has held the Robert Gumbiner Chair at the Graduate School of Management, University of California, Irvine, since 1987. He has written six books and over 60 articles on healthcare. His book Health Care Economics, 6th edition, 2004, is one of the most widely used texts on health economics. During several leaves from the University, Professor Feldstein has worked at the U.S. Office of Management and Budget, Social Security Administration and the World Health Organization. Prior to joining the University of California, he was professor in both the Department of Economics and the School of Public Health at the University of Michigan. Professor Feldstein earned his Ph.D. in

46


Table of Contents

Economics from the University of Chicago. Professor Feldstein has served as a director of Odyssey Healthcare, Inc., a provider of hospice care, since May 2002.

     Dr. Klock has been a director of our company since February 2002. He currently is Chairman of the Board of CompBenefits Corporation, a prepaid dental and vision plan service. Dr. Klock has served on the Board of Directors of CompBenefits since 1984 and was President of that company from 1991 to 1993 and Chief Executive Officer from 1993 to 2004. Dr. Klock is co-author of four books on finance and insurance. He also has held several academic appointments, including Chairman of the Finance Department at the University of Central Florida. He earned his Ph.D. in Finance from the University of Illinois.

     Mr. Haley has been a director of our company since February 2004. He currently is Chairman of MW Manufacturers Inc., a manufacturer of windows and doors, and Senior Vice President Sales and Marketing of MW’s parent company, Ply Gem Industries, Inc. Prior to his present position, Mr. Haley served as MW’s President and CEO from 2001 to 2004. From 1994 to 2001 and from 1980 to 1988, Mr. Haley served in various capacities with American of Martinsville (“AOM”), a furniture manufacturer and a part of the La-Z-Boy company. Mr. Haley’s last position with AOM was as Divisional President of AOM Contract and La-Z-Boy Group. From 1988 to 1994, Mr. Haley served as President of Lowenstein Furniture Group. Mr. Haley is a member of the Boards of Directors of American National Bank & Trust Company (Nasdaq: AMNB), Stanley Furniture Company (Nasdaq NM: STLY) and Aero Products in Wauconda, Illinois. Mr. Haley earned his Bachelor’s Degree in Business Administration from Roanoke College.

     Mr. Slipkovich has served as President and Chief Operating Officer of our company since February 1, 2004. Prior to joining our company, Mr. Slipkovich served as a Division President of LifePoint Hospitals, Inc., a provider of hospital care services in non-urban areas, from May 1999 until September 2003. From October 1998 until May 1999, Mr. Slipkovich served as a Division President of the America Group of HCA Inc., a company that owns and operates hospitals. From July 1996 through September 1998, Mr. Slipkovich served as Vice President and Chief Financial Officer of the Florida Group of HCA Inc. Prior to October 1996, Mr. Slipkovich served in various financial positions with HCA Inc. and its predecessor.

     Mr. Hannon has served as Chief Financial Officer of our company since October 2002. Mr. Hannon joined our company in 1996 as Vice President and Assistant Treasurer and served as interim Chief Financial Officer of our company in 2001. Mr. Hannon has served as a director of Ventas, Inc., a publicly-traded healthcare real estate investment trust, since September 2004.

     Mr. Anderson has served as Senior Vice President of Acquisitions and Development of our company since January 1998. From January 1994 to January 1998, Mr. Anderson served as a Vice President and Regional Director of Community Health Systems, Inc., an operator of general acute care hospitals.

     Mr. Wall has served as Senior Vice President and General Counsel of our company since September 1997 and has served as Secretary since March 1998 and as Corporate Governance Officer since May 2004. From 1983 to September 1997, Mr. Wall was an attorney in private practice with Waller Lansden Dortch & Davis, PLLC, in Nashville, Tennessee, where he chaired the firm’s healthcare working group.

     Mr. Moody has served as Senior Vice President of Operations of our company since June 1999 and oversees financial operations of our company-owned hospitals. Prior to joining the company in 1999, he held a variety of positions with HCA Inc., a company that owns and operates hospitals, beginning as a reimbursement consultant and culminating as a Group Chief Financial Officer.

     Mr. Brenzel has served as Regional Vice President of our company’s Western Division since July 2004. Prior to joining the company, Mr. Brenzel served as Western Regional Vice President of Vanguard Health Services, an owner and operator of hospitals and other healthcare facilities, primarily in urban areas, from 1999 to 2002, and as a healthcare consultant focused on merging physician groups in the Phoenix, Arizona area from 2002 to 2004.

     Mr. Pemberton has served as Regional Vice President of our company’s Eastern Division since March 2003. Prior to joining the company, Mr. Pemberton served as President of the Medical/Surgical Group at Ardent Health Services, a provider of inpatient and outpatient mental health services, from May 2001 to March 2003. From October 1999 to October 2001, Mr. Pemberton served as Vice President and Chief Operating Officer of NetCare Health Systems, Inc., an operator of acute-care community hospitals in non-urban markets. Mr. Pemberton also served as President and Chief Executive Officer of Tallahasee Community Hospital in Tallahasee, Florida from October 1997 to September 1999.

     Mr. Gower has served as Regional Vice President of our company’s Central Division since October 2002. Prior to joining our company, Mr. Gower was a founder of Iasis Healthcare, an operator of general acute care hospitals, where he served as Chief

47


Table of Contents

Executive Officer from October 1998 through May 2001. From March 1994 to October 1998, Mr. Gower was a Division President of HCA Inc.

     Mr. Brumfield has served as Vice President and Controller of our company since May 1, 2004, and served as Assistant Vice President and Assistant Controller from December 8, 2003 until that time. Prior to joining our company, Mr. Brumfield served as Director, Financial Audit of LifePoint Hospitals, Inc., a provider of hospital care services in non-urban areas from January 2002 until December 2003. From October 1996 until December 2001, Mr. Brumfield served as Vice President and Controller of NetCare Health Systems, Inc., an operator of acute-care community hospitals in non-urban markets.

CORPORATE GOVERNANCE

     Our company’s business and affairs are managed under the direction of our Board of Directors, in accordance with our Certificate of Incorporation and Bylaws, the Delaware General Corporation Law, the listing standards of the New York Stock Exchange and the rules and regulations of the Securities and Exchange Commission. From our company’s inception, our Board and management have sought to create an environment in which the company’s affairs are managed in accordance with the highest ethical standards, while remaining true to our mission of delivering quality health care to the communities we serve. As a healthcare company, many aspects of our business, including payment for the services our hospitals provide, are heavily regulated by both the federal and state governments. Our Board has established internal policies and systems of reporting designed to ensure compliance with legal and regulatory requirements and to detect and deal with issues effectively and efficiently.

     The following is a description of our Board structure and the key policies and procedures by which we manage and conduct our business.

Board of Directors

     Our Bylaws provide that the business and affairs of our company shall be managed by or under the direction of the Board of Directors. The Board has the authority to establish the size of the Board from time to time by resolution, and has currently set the size of the Board at six members. The names of our directors and their backgrounds and qualifications are listed above.

Corporate Governance Principles

          The Board of Directors has adopted a set of Corporate Governance Principles, which addresses the practices of the Board and specifies the qualifications for members of the Board of Directors, criteria for determining directors’ independence, the responsibilities of the Board and its committees and the Board’s role in evaluating the performance of our company’s Chief Executive Officer and planning for his/her succession. A copy of the Corporate Governance Principles is posted on the Company’s website at www.provincehealthcare.com.

Director Nomination Process

     Identifying and Evaluating Nominees for Directors

          The Nominating and Governance Committee of the Board of Directors utilizes a variety of methods for identifying and evaluating nominees for director. The Nominating and Governance Committee regularly assesses the appropriate size of the Board, and whether any vacancies on the Board are expected due to retirement or otherwise. In the event that vacancies are anticipated, or otherwise arise, the Nominating and Governance Committee considers potential candidates for director. Candidates may come to the attention of the Nominating and Governance Committee through current Board members, professional search firms, shareholders or other persons. These candidates are evaluated at regular or special meetings of the Nominating and Governance Committee, and may be considered at any point during the year. The Nominating and Governance Committee reviews all materials provided by professional search firms or other parties in connection with any nominee. In evaluating each nominee, the Nominating and Governance Committee seeks to achieve a balance of knowledge, experience and ability on the Board. In addition, the Nominating and Governance Committee considers the membership criteria set forth under “Director Qualifications” below.

Although, to date, no Province shareholder has submitted a director nomination to the Nominating and Governance Committee, the Nominating and Governance Committee would consider properly submitted shareholder nominations as described below. Following verification of the shareholder status of persons proposing candidates, recommendations would be aggregated and considered by the

48


Table of Contents

Nominating and Governance Committee at one of its regularly scheduled meetings prior to the issuance of the proxy statement for our annual meeting. If any materials are provided by a shareholder in connection with the nomination of a director candidate, such materials would be forwarded to the Nominating and Governance Committee.

     Shareholder Nominees

          The policy of the Nominating and Governance Committee as contained in the committee’s charter is to consider properly submitted shareholder nominations of candidates for election to the Board as described above. In evaluating such nominations, the Nominating and Governance Committee seeks to achieve a balance of knowledge, experience and ability on the Board and to address the membership criteria set forth under “Director Qualifications.”

          Any shareholder nominations proposed for consideration by the Nominating and Governance Committee should include the nominee’s name and qualifications for Board membership and should be addressed to:

Corporate Secretary
Province Healthcare Company
105 Westwood Place, Suite 400
Brentwood, TN 37027

Our Bylaws also permit shareholders to propose their own nominees for election to the Board of Directors at an annual meeting of shareholders.

Director Qualifications

Our Corporate Governance Principles contain Board membership criteria that apply to Nominating and Governance Committee-recommended nominees for a position on our Board. Under these criteria, members of the Board should have the highest professional and personal ethics and values, consistent with our company’s existing values and standards. They should have broad experience at the policy-making level in business, government, education, healthcare or public interest. They should be committed to enhancing shareholder value and should have sufficient time to carry out their duties and to provide insight and practical wisdom based on experience. Their service on other boards of public companies should be limited to a number that permits them, given their individual circumstances, to perform responsibly all director duties. Each director must represent the interests of all shareholders.

Director Independence

          Five of the six members of our Board of Directors qualify as “independent” directors pursuant to the rules adopted by the Securities and Exchange Commission and the corporate governance standards for companies listed on the New York Stock Exchange. Mr. Rash, as an executive officer of the company, is not considered “independent” of management. Our Board committee structure includes Audit, Compensation, Nominating and Governance and Compliance Committees consisting entirely of independent directors.

          In determining independence, each year our Board of Directors affirmatively determines whether directors have any “material relationships” with our company. Material relationships can include current and past employment, consulting, legal, accounting, charitable, commercial, banking and familial relationships. When assessing the “materiality” of a director’s relationship with our company, our Board considers all relevant facts and circumstances, not merely from the director’s standpoint, but from that of the persons or organizations with which the director has an affiliation. In addition, under the listing standards of the New York Stock Exchange, no director can be considered “independent” who (1) is a present or former employee of our company or has an immediate family member who is a current or former executive officer of our company; (2) personally receives or has an immediate family member who receives more than $100,000 per year in direct compensation from us other than director and committee fees and pension or other forms of deferred compensation; (3) is employed, or has an immediate family member employed as an executive officer of another company where any of our current executive officers serves on that company’s compensation committee; (4) is currently employed by or affiliated with or has been employed by or affiliated with a present or former internal or external auditor of our company within the three previous years and personally worked on our company’s audit within that time; (5) has an immediate family member who is (i) currently a partner of our company’s present internal or external auditor or (ii) an employee of such firm and who participates in the firm’s audit, assurance or tax compliance practice; or (6) is an executive officer or employee, or has an immediate family member who is an executive officer of a company that makes payments to, or receives payments from us for property or services in an amount that exceeds the greater of $1 million, or 2% of such other company’s consolidated gross revenues.

49


Table of Contents

          Based on the Board’s analysis and consideration of our Corporate Governance Principles and the New York Stock Exchange director independence standards, our Board of Directors has determined that each of Messrs. Nolan, Dunn, Feldstein, Klock and Haley is independent of our company and its management.

Committees of the Board of Directors

          The Board of Directors has established the four standing committees described below.

          Audit Committee

          The primary purpose of the Audit Committee is to assist the Board of Directors in fulfilling its oversight responsibilities with respect to:

  •   the integrity of the financial reports and other financial information provided by our company to any governmental body or the public;
 
  •   our overall compliance with legal and regulatory requirements;
 
  •   the independent auditors’ qualifications and independence;
 
  •   the performance of our company’s systems of internal controls regarding finance, accounting and legal compliance of our independent auditors; and
 
  •   the performance of our company’s auditing, accounting and financial reporting processes generally.

          The Audit Committee operates under a written charter adopted by our Board of Directors, the full text of which is available on our website at www.provincehealthcare.com.

     In carrying out these responsibilities, the Audit Committee, among other things:

  •   serves as an independent and objective party to monitor our company’s financial reporting process;
 
  •   supervises the relationship between our company and its independent auditors, including: (i) having direct responsibility for their appointment, compensation and retention; (ii) reviewing the scope of their audit services; (iii) approving significant non-audit services; and (iv) continuing the independence of the independent auditors;
 
  •   oversees management’s implementation and maintenance of effective systems of internal and disclosure controls; and
 
  •   performs such other duties and responsibilities as may be delegated by the Board of Directors from time to time.

          The Audit Committee is currently comprised of Messrs. Klock, Haley, Dunn and Feldstein, each of whom the Board of Directors has determined to be “independent” as required by the listing standards of the New York Stock Exchange and the rules and regulations of the Securities and Exchange Commission. Each member of the Audit Committee is financially literate and possesses a general understanding of basic finance and accounting practices. The Board of Directors also has determined that Dr. Klock qualifies as an “audit committee financial expert” as that term is defined in Item 401(h) of Regulation S-K under the Securities Exchange Act of 1934.

          Compensation Committee

          The Board of Directors has appointed a Compensation Committee to evaluate the performance of our company’s executive officers, review and approve executive officers’ compensation and bonuses and administer awards under our company’s stock plans.

50


Table of Contents

The Compensation Committee is also responsible for setting the compensation of the Chief Executive Officer and annually reviews his performance. The Compensation Committee is comprised of Messrs. Dunn, Haley, Nolan and Klock. The Compensation Committee operates under a written charter adopted by our Board of Directors, the full text of which is available on our website at www.provincehealthcare.com.

          Nominating and Governance Committee

          The Board of Directors has appointed a Nominating and Governance Committee to recommend persons to act as directors, prepare for and recommend replacements for any vacancies in director positions during the year, and to review policy issues regarding the size and composition of the Board of Directors. The Nominating and Governance Committee also reviews and makes recommendations to the Board of Directors with respect to candidates for directors proposed by shareholders. In addition, the Nominating and Governance Committee is responsible for establishing and maintaining a set of Corporate Governance Principles for the company meeting New York Stock Exchange requirements. The Committee is responsible for establishing a code of ethics and conduct for the directors, management and employees of the company, reviewing such programs and codes on a periodic basis and recommending any proposed changes to the Board of Directors. The Nominating and Governance Committee operates pursuant to a written charter adopted by our Board of Directors, a copy of which is available on our website at www.provincehealthcare.com. The Nominating and Governance Committee is comprised of Messrs. Haley, Nolan, Dunn, Feldstein and Klock, each of whom the Board of Directors has determined to be “independent” as required by the listing standards of the New York Stock Exchange.

          Compliance Committee

          Our Board of Directors has appointed a Compliance Committee to oversee our corporate compliance program, which focuses primarily on healthcare, legal and regulatory compliance, including physician recruitment, reimbursement, cost reporting practices and laboratory and home health care operations. The Compliance Committee operates pursuant to a written charter adopted by our Board of Directors, a copy of which is available on our website at www.provincehealthcare.com. The Compliance Committee is comprised of Messrs. Feldstein, Dunn and Nolan.

Executive Sessions

          In order to promote open discussion among the non-management directors, we have scheduled regular executive sessions in which those directors meet without management participation. Joseph P. Nolan, as chair of the Nominating and Governance Committee, serves as the presiding director at all executive sessions of the Board.

Communications with Board of Directors

          The Board of Directors has implemented a process by which shareholders may send communications to the Board of Directors. Shareholders and other parties interested in communicating directly with the Board of Directors or with the non-management directors as a group may do so by writing to Howard T. Wall, III, Senior Vice President and General Counsel, or by calling Province’s Compliance Hotline at (800) 625-5578. Concerns relating to accounting, internal controls or auditing matters are immediately brought to the attention of our company’s internal audit department and handled in accordance with the procedures established by the Audit Committee with respect to such matters.

Code of Ethics

          Our Board of Directors has adopted a Code of Ethics meeting the requirements of Item 406 of Regulation S-K, which is applicable to our Chief Executive Officer, Chief Financial Officer and Controller. A copy of the Code of Ethics is available on our company’s website at www.provincehealthcare.com. We intend to post amendments to, or waivers from, our Code of Ethics on our website.

          The Board of Directors has also adopted revisions to our Integrity Compliance Program to meet the standards established by the New York Stock Exchange. The Integrity Compliance Program is a set of written guidelines applicable to all employees and directors of our company and its subsidiaries, which addresses our company’s standards for ethical conduct and compliance with company policies and procedures and with applicable legal requirements, including healthcare laws and regulations. A copy of the Integrity Compliance Program is available on our website at www.provincehealthcare.com. We intend to post amendments to, or waivers from, the Integrity Compliance Program (to the extent applicable to our Chief Executive Officer, Chief Financial Officer or Controller) on our website.

51


Table of Contents

Section 16(a) Beneficial Ownership Reporting Compliance

     Section 16(a) of the Securities Exchange Act of 1934, as amended, requires that our directors, executive officers and persons who own more than 10% of our common stock file with the Securities and Exchange Commission initial reports of ownership and reports of changes in beneficial ownership of our common stock. The Securities and Exchange Commission rules also require these officers, directors and shareholders to furnish us with copies of all Section 16(a) reports they file. In the event that these reports are not filed timely, we are required to report the failure to file the reports during 2004.

     Based solely upon a review of the reports furnished to us and written representations that no other reports were required, we believe that all persons required to file Section 16 reports with respect to our company complied with their reporting requirements during 2004.

ITEM 11. EXECUTIVE COMPENSATION

Executive Compensation

     The following table summarizes the compensation paid by our company for each of the years ended December 31, 2004, 2003 and 2002 to our Chief Executive Officer and our four other most highly compensated executive officers.

Summary Compensation Table

                                         
                            Long-Term  
            Annual Compensation(1)     Compensation  
                            Securities     All Other  
Name and Principal Position   Year     Salary     Annual Bonus     Underlying Options     Compensation  
Martin S. Rash (2)
    2004     $ 647,833     $ 643,500       218,500     $ 29,622  
Chairman of the Board and
    2003       624,000       624,000       236,000       31,047  
Chief Executive Officer
    2002       622,000       0       278,023       29,603  
 
                                       
John M. Rutledge (3)
    2004     $ 520,000     $ 0       0     $ 25,325  
Former President,
    2003       520,000       520,000       101,000       21,908  
Chief Operating Officer
    2002       518,333       0       443,062       21,712  
and Director
                                       
 
                                       
Daniel S. Slipkovich (4)
    2004     $ 366,667     $ 366,667       330,000     $ 225  
President and
                                       
Chief Operating Officer
                                       
 
                                       
James T. Anderson (5)
    2004     $ 328,831     $ 246,623       50,000     $ 17,082  
Senior Vice President
    2003       317,200       237,900       51,000       15,944  
of Acquisitions and
    2002       316,183       0       90,039       16,031  
Development
                                       
 
                                       
Howard T. Wall, III (6)
    2004     $ 305,651     $ 229,238       40,000     $ 15,867  
Senior Vice President,
    2003       294,840       221,130       41,000       14,934  
General Counsel and
    2002       293,895       0       99,593       14,673  
Secretary
                                       
 
                                       
Christopher T. Hannon (7)
    2004     $ 300,875     $ 225,656       50,000     $ 15,514  
Senior Vice President and
    2003       290,000       217,500       51,000       14,650  
Chief Financial Officer
    2002       168,253       0       124,290       8,328  


(1)   The perquisites and personal benefits paid to each of the named executive officers were less than $50,000 or 10% of the total salary and bonus reported for the named executive officers, and, therefore, the amount of such other annual compensation is not reportable under Securities Exchange Commission rules.
 
(2)   All other compensation for 2004 included contributions by our company of: $5,760 under a 401(k) plan; $19,435 under a supplemental deferred compensation plan; $3,977 for disability insurance; and $450 for group life insurance in excess of $50,000. All other compensation for 2003 included contributions by our company of: $8,050 under a 401(k) plan; $18,720 under a supplemental deferred compensation plan; $3,827 for

52


Table of Contents

    disability insurance; and $450 for group life insurance in excess of $50,000. All other compensation for 2002 included contributions by our company of: $6,000 under a 401(k) plan; $19,176 under a supplemental deferred compensation plan; $3,977 for disability insurance; and $450 for group life insurance in excess of $50,000.
 
(3)   All other compensation for 2004 included contributions by our company of: $9,275 under a 401(k) plan; $15,600 under a supplemental deferred compensation plan; and $450 for group life insurance in excess of $50,000. All other compensation for 2003 included contributions by our company of $5,858 under a 401(k) plan; $15,600 under a supplemental deferred compensation plan; and $450 for group life insurance in excess of $50,000. All other compensation for 2002 included contributions by our company of: $5,475 under a 401(k) plan; $15,787 under a supplemental deferred compensation plan; and $450 for group life insurance in excess of $50,000. Mr. Rutledge resigned as President and Chief Operating Officer of our company effective February 1, 2004. Pursuant to SEC rules, Mr. Rutledge is required to be included in the Summary Compensation Table even though he was not serving as an executive officer of our company at December 31, 2004.
 
(4)   All other compensation for 2004 included contributions by our company of: $225 for group life insurance in excess of $50,000. Mr. Slipkovich was appointed President and Chief Operating Officer of our company in February 2004.
 
(5)   All other compensation for 2004 included contributions by our company of: $6,528 under a 401(k) plan; $9,865 under a supplemental deferred compensation plan; and $690 for group life insurance in excess of $50,000. All other compensation for 2003 included contributions by our company of: $5,738 under a 401(k) plan; $9,516 under a supplemental deferred compensation plan; and $690 for group life insurance in excess of $50,000. All other compensation for 2002 included contributions by our company of: $5,978 under a 401(k) plan; $9,603 under a supplemental deferred compensation plan; and $450 for group life insurance in excess of $50,000.
 
(6)   All other compensation for 2004 included contributions by our company of: $6,248 under a 401(k) plan; $9,169 under a supplemental deferred compensation plan; and $450 for group life insurance in excess of $50,000. All other compensation for 2003 included contributions by our company of: $5,639 under a 401(k) plan; $8,845 under a supplemental deferred compensation plan; and $450 for group life insurance in excess of $50,000. All other compensation for 2002 included contributions by our company of: $5,557 under a 401(k) plan; $8,817 under a supplemental deferred compensation plan; and $300 for group life insurance in excess of $50,000.
 
(7)   All other compensation for 2004 included contributions by our company of: $6,188 under a 401(k) plan; $9,026 under a supplemental deferred compensation plan; and $300 for group life insurance in excess of $50,000. All other compensation for 2003 included contributions by our company of $5,650 under a 401(k) plan; $8,700 under a supplemental deferred compensation plan; and $300 for group life insurance in excess of $50,000. All other compensation for 2002 included contributions by our company of: $4,709 under a 401(k) plan; $3,365 under a supplemental deferred compensation plan; and $254 for group life insurance in excess of $50,000.

Stock Option Grants in Last Fiscal Year

     The following table sets forth certain information regarding grants of stock options under our 1997 Long-Term Equity Incentive Plan made to the executive officers listed in the summary compensation table during the year ended December 31, 2004. The 1997 Long-Term Equity Incentive Plan does not provide for the grant of stock appreciation rights.

                                                 
    Number of     Percent of                     Potential Realizable Value at  
    Securities     Total Options                     Assumed Annual Rates of  
    Underlying     Granted to     Exercise             Stock Price Appreciation for  
    Options     Employees in     Price Per             Option Term (2)  
           Name   Granted     Fiscal Year     Share(1)     Expiration Date     5%     10%  
Martin S. Rash
    218,500       13.16 %   $ 15.75       3/10/14     $ 2,164,262     $ 5,484,665  
 
                                               
John M. Rutledge
                                   
 
                                               
Daniel S. Slipkovich
    250,000       15.06       17.62       2/2/14       2,770,281       7,020,436  
 
    80,000       4.80       15.75       3/10/14       792,407       2,008,116  
 
                                               
James T. Anderson
    50,000       3.01       15.75       3/10/14       495,255       1,255,072  
 
                                               
Howard T. Wall, III
    40,000       2.41       15.75       3/10/14       396,204       1,004,058  
 
                                               
Christopher T. Hannon
    50,000       3.01       15.75       3/10/14       495,255       1,255,072  


(1)   Based upon the fair market value of our common stock on the date of grant of options, as determined by our Board of Directors.
 
(2)   The 5% and 10% assumed annual rates of compounded stock price appreciation are mandated by rules of the Securities and Exchange Commission. There can be no assurance provided to any of the executive officers set forth above or any other holder of our company’s securities that the actual stock price appreciation over the term will be at the assumed 5% and 10% levels or at any other defined level. Unless the market

53


Table of Contents

    price of the common stock appreciates over the option term, no value will be realized from the option grants made to the above executive officers.

Option Exercises and Year-End Values

     The following table provides certain information with respect to our executive officers named in the Summary Compensation Table on page 52 concerning the exercise of options during 2004 and with respect to unexercised options at December 31, 2004.

Aggregated Option Exercises in Last Fiscal Year
And Fiscal Year-End Option Values

                                                 
                    Number of Securities        
                    Underlying Unexercised     Value of Unexercised  
    Shares             Options at     In-the-Money Options at  
    Acquired             December 31, 2004     December 31, 2004(1)  
           Name   on Exercise     Value Realized     Exercisable     Unexercisable     Exercisable     Unexercisable  
Martin S. Rash
                650,039       533,869     $ 5,474,814     $ 4,880,331  
John M. Rutledge
    217,909     $ 1,738,351       631,610       162,404       2,743,643       1,638,734  
Daniel S. Slipkovich
                0       330,000       0       1,710,500  
James T. Anderson
    38,168       302,749       216,605       157,870       934,159       1,283,384  
Howard T. Wall, III
    28,451       291,362       240,865       119,029       1,557,634       1,029,133  
Christopher T. Hannon
                104,907       159,531       935,970       1,678,885  


(1)   Based upon the closing price of our common stock of $22.35 per share as reported on the New York Stock Exchange on December 31, 2004, less the exercise price of the options.

Director Compensation

     Directors who are also employees of our company or its subsidiaries are not entitled to receive any fees for serving on our Board of Directors. Non-employee directors of our company receive an annual retainer of $35,000. In addition, each director receives a fee of $2,000 per meeting for each special Board meeting held in addition to the four regular quarterly meetings. Directors receive the fees shown in the table below for service on committees of the Board. We also reimburse them for their out-of-pocket expenses incurred in their performance of services as directors. Non-employee directors of our company also are eligible to participate in our 1997 Long-Term Equity Incentive Plan. Non-employee directors, however, are not eligible to participate in our Employee Stock Purchase Plan.

                 
Committee   Chair     Member  
Audit
  $ 6,250     $ 5,000  
Compensation
  $ 5,000     $ 4,000  
Nominating and Governance
  $ 3,750     $ 3,000  
Compliance
  $ 3,750     $ 3,000  

Employment Agreements

     Our company entered into a Senior Management Agreement with Mr. Rash effective as of December 17, 1996, as amended on July 14, 1997 and October 15, 1997. Mr. Rash is our company’s Chief Executive Officer and currently receives an annual base salary determined by our Board of Directors, which is subject to adjustment by the Compensation Committee. Mr. Rash’s annual base salary may not be less than $250,000. He will be eligible to receive a bonus each year of up to fifty percent (50%) of his annual base salary for such year, based on the achievement of certain operational and financial objectives. His employment period continues until his resignation, disability, or death, or until our Board of Directors determines that termination of his employment is in our company’s interests. In the event that our company terminates Mr. Rash without cause or as a result of death or disability, we have agreed to pay him an amount equal to twice his annual base salary; provided that such severance payments cease upon acceptance of employment with an entity that owns and operates rural hospitals. Mr. Rash has agreed not to compete with our company until the earlier of: (i) termination of his employment for a period of two years; or (ii) the consummation of a sale of our company. In addition, Mr. Rash has agreed not to solicit our employees following the termination of his employment for a period of two years.

54


Table of Contents

     Mr. Rutledge resigned his position as President and Chief Operating Officer of our company effective February 1, 2004 due to health concerns. Following his resignation, Mr. Rutledge entered into an employment agreement with our company to serve in the position of Acquisition and Construction Projects Specialist. The agreement provides for customary restrictions on the use of confidential information about, his ability to compete with, and his ability to solicit employees of, our company and its subsidiaries during the term of the agreement. In exchange for these agreements, Mr. Rutledge is to receive a salary of $518,333 per year, as well as health insurance and other employee benefits. He is not eligible for bonus compensation. The term of the agreement is 28 months.

Severance Agreements

     Our company has entered into executive severance agreements with Messrs. Rash, Slipkovich, Anderson, Wall and Hannon. The agreements provide benefits to such executive officers upon:

  •   termination by our company without cause;
 
  •   termination by the executive officer with cause; and
 
  •   termination following a change in control.

     In the event that we terminate any of these executive officers without cause, or he terminates his employment with us for cause, he will receive an amount equal to 200% of his annual base compensation determined by reference to his base salary in effect at the time of termination. Should the executive officer’s employment be terminated within 24 months after a change in control, he will receive:

  •   an amount equal to 200% of his annual base compensation determined by reference to his base salary in effect at the time of change in control;
 
  •   an amount equal to 200% of the highest annual bonus that he would be eligible to receive during the fiscal year ending during which the change in control occurs; and
 
  •   continued insurance coverage and fringe benefits for 24 months following the change in control.

     Certain of our executive officers will receive benefits under the terms of their severance agreements upon completion of the merger with LifePoint Hospitals, Inc., as more fully described in the Joint Proxy Statement/Prospectus filed on February 18, 2005.

Retention Plan

          To foster the continued employment of corporate employees in connection with a possible change in control of our company, the Board adopted a retention plan on July 30, 2004 for the benefit of all corporate employees who are not parties to the executive severance agreements described above and none of whom are executive officers of our company. Under the retention plan, lump-sum cash retention bonuses will become payable to participants on the earlier to occur of (i) 90 days following the effective time of the proposed transaction with LifePoint and (ii) the termination of the participant’s employment following the effective time of the proposed transaction by us or our successor without cause, by the participant for good reason, or as a result of the participant’s death or disability. The base retention payment will be equal to each participant’s annual base salary as in effect immediately prior to the effective time of the proposed transaction. Approximately 15 participants will also receive an additional severance payment equal to six months’ base salary if their employment is terminated prior to the first anniversary of the effective time of the proposed transaction for one of the reasons specified above. In addition, if any participant’s employment is terminated for one of the reasons specified above prior to the first anniversary of the effective time of the proposed transaction, that participant will receive a severance payment in an amount equal to the participant’s cost of maintaining his or her present coverage under our welfare benefit plans for a period of twelve months. If all our employees covered by the retention plan receive all of the benefits in accordance with the terms of the retention plan as described above, the total amount payable would be approximately $5.9 million.

Compensation Committee Interlocks and Insider Participation

          No executive officer of our company served as a member of the compensation committee or as a director of any other entity whose executive officer serves as a director of our company.

55


Table of Contents

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Equity Compensation Plan Information

     The following table provides information as of December 31, 2004 with respect to compensation plans (including individual compensation arrangements) under which shares of our common stock are authorized for issuance.

                         
                    Number of securities  
                    remaining available for  
    Number of securities to             future issuance under  
    be issued upon exercise of     Weighted-average     equity compensation plans  
    outstanding options,     exercise price of outstanding     (excluding securities  
    warrants and rights     options, warrants and rights     reflected in column (a))  
Plan category   (a)     (b)     (c)  
Equity compensation plans approved by security holders (1)
    7,034,692     $ 15.01       1,162,680  
 
                       
Equity compensation plans not approved by security holders (2)
    0       N/A       0  
 
                 
 
                       
Total
    7,034,692     $ 15.01       1,162,680  


(1)   Represents stock options granted or issuable under our 1997 Long-Term Equity Incentive Plan.
 
(2)   We have no equity compensation plans not approved by our shareholders.

     Our company also sponsors an Employee Stock Purchase Plan. We do not grant or issue any shares of our common stock pursuant to such plan, but rather facilitate the purchase of shares of our common stock by employees in a cost-efficient manner.

Security Ownership Of Certain Beneficial Owners And Management

     The following table sets forth information with respect to ownership of our common stock as of March 1, 2005, by:

  •   each person known by us to be the beneficial owner of more than 5% of our company’s common stock;
 
  •   each of our directors;
 
  •   each of our executive officers named in the summary compensation table on page 52; and
 
  •   all of our directors and executive officers as a group.

     To our knowledge, unless otherwise indicated, each shareholder listed below has sole voting and investment power with respect to the shares beneficially owned. We are unaware of any person, other than those listed below, who beneficially owns more than 5% of the outstanding shares of our common stock. Under Securities and Exchange Commission rules, the number of shares shown as beneficially owned includes shares of common stock subject to options that currently are exercisable or will be exercisable within 60 days of March 1, 2005. Shares of common stock subject to options that are currently exercisable or will be exercisable within 60 days of March 1, 2005 are considered to be outstanding for the purpose of determining the percentage of the shares held by a holder, but not for the purpose of computing the percentage held by others. The table below assumes the completion of the proposed merger of LifePoint and our company. Upon the effective time of the proposed merger, all options issued under the 1997 Long-Term Equity Incentive Plan not previously vested will become fully vested and exercisable. The merger is expected to become effective on or about March 31, 2005.

56


Table of Contents

     All computations are based on 50,285,014 shares of common stock outstanding on March 1, 2005.

                 
Name of   Number of Shares     Percent of Common Stock  
Beneficial Owner, Executive Officer or Director   Beneficially Owned     Beneficially Owned  
Barclays Bank Plc (1)
               
45 Fremont St., 17th Floor
               
San Francisco, CA 94105
    3,743,654       7.5 %
Paulson & Co., Inc. (2)
               
590 Madison Avenue
               
New York, NY 10022
    2,832,000       5.6  
Martin S. Rash (3)(14)
    1,823,486       3.5  
John M. Rutledge (4) (14)
    794,014       1.6  
Daniel S. Slipkovich (5)(14)
    330,000       *  
Christopher T. Hannon (6)(14)
    289,714       *  
Joseph P. Nolan (7)(14)
    119,634       *  
James T. Anderson (8)(14)
    381,573       *  
Howard T. Wall, III (9)(14)
    369,110       *  
Winfield C. Dunn (10)(14)
    103,868       *  
Paul J. Feldstein (11)(14)
    90,470       *  
David R. Klock (12)(14)
    42,202       *  
Michael P. Haley (13)(14)
    37,000       *  
All executive officers and directors as a group
               
(15 persons)(15)
    4,905,555       9.0  


*   Less than 1%
 
(1)   The number of shares listed as beneficially owned by Barclays Bank Plc includes shares held by certain of its affiliates. Information is derived from a Schedule 13G filed by Barclays Bank Plc on February 14, 2005.
 
(2)   The number of shares listed as beneficially owned by Paulson & Co., Inc. includes shares held by certain of its affiliates. Information is derived from a Schedule 13G filed by Paulson & Co., Inc. on February 18, 2005.
 
(3)   Includes 639,578 shares owned directly by Mr. Rash and options to purchase 1,183,908 shares granted under the 1997 Long-Term Equity Incentive Plan.
 
(4)   Includes options to purchase 794,014 shares under the 1997 Long-Term Equity Incentive Plan.
 
(5)   Includes options to purchase 330,000 shares under the 1997 Long-Term Equity Incentive Plan.
 
(6)   Includes 25,276 shares owned directly by Mr. Hannon and options to purchase 264,438 shares under the 1997 Long-Term Equity Incentive Plan.
 
(7)   Includes options to purchase 119,634 shares under the 1997 Long-Term Equity Incentive Plan.
 
(8)   Includes 7,098 shares owned directly by Mr. Anderson and options to purchase 374,475 shares granted under the 1997 Long-Term Equity Incentive Plan.
 
(9)   Includes 9,216 shares owned directly by Mr. Wall and options to purchase 359,894 shares granted under the 1997 Long-Term Equity Incentive Plan.
 
(10)   Includes 5,000 shares owned directly by Mr. Dunn and options to purchase 98,868 shares under the 1997 Long-Term Equity Incentive Plan.
 
(11)   Includes 25,000 shares owned directly by Mr. Feldstein and options to purchase 65,470 shares under the 1997 Long-Term Equity Incentive Plan.
 
(12)   Includes options to purchase 42,202 shares granted under the 1997 Long-Term Equity Incentive Plan.
 
(13)   Includes 2,000 shares owned directly by Mr. Haley and options to purchase 35,000 shares granted under the 1997 Long-Term Equity Incentive Plan.
 
(14)   The address of each of Messrs. Rash, Rutledge, Slipkovich, Hannon, Anderson, Dunn, Wall, Nolan, Feldstein, Klock and Haley is 105 Westwood Place, Suite 400, Brentwood, TN 37027.
 
(15)   Includes options to purchase 4,186,708 shares granted under the 1997 Long-Term Equity Incentive Plan.

57


Table of Contents

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Certain Relationships And Related Transactions

Employment Agreement with John M. Rutledge

     Mr. Rutledge resigned his position as President and Chief Operating Officer of our company effective February 1, 2004 due to health concerns. Following his resignation, Mr. Rutledge entered into an employment agreement with our company to serve in the position of Acquisition and Construction Projects Specialist. The agreement provides for customary restrictions on the use of confidential information about, his ability to compete with, and his ability to solicit employees of, our company and its subsidiaries during the term of the agreement. In exchange for these agreements, Mr. Rutledge is to receive a salary of $518,333 per year, as well as health insurance and other employee benefits. He is not eligible for bonus compensation. The term of the agreement is 28 months.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

     The following table presents fees billed by Ernst & Young LLP for professional audit services and for other services rendered by Ernst & Young LLP for fiscal years 2004 and 2003:

                 
    2004     2003  
Audit Fees (1)
  $ 2,701,065     $ 857,000  
Audit-Related Fees (2)
  $ 176,118     $ 30,000  
Tax Fees (3)
  $ 203,453     $ 635,000  
All Other Fees (4)
  $ 32,828     $ 86,000  
 
           
Total
  $ 3,113,464     $ 1,608,000  
 
           


1.   Audit fees include fees associated with the annual audit, the reviews of our company’s quarterly reports on Form 10-Q, statutory audits, and assistance with and review of documents filed with the Securities and Exchange Commission.
 
2.   Audit-related services include fees for employee benefit plan audits.
 
3.   Tax fees include fees for preparation of federal and state tax returns, claims for refunds, tax payment-planning services, assistance with tax audits and appeals, and tax advice related to acquisitions, employee benefit plans, requests for rulings or technical advice from taxing authorities.
 
4.   All other fees include permitted advisory services.

     All audit-related services, tax services and other services were pre-approved by the Audit Committee, which concluded that the provision of such services is compatible with maintaining Ernst & Young’s independence. The Audit Committee’s Outside Auditor Independence Policy provides for pre-approval of audit, audit-related and tax services specifically described by the Committee on an annual basis and, in addition, individual engagements anticipated to exceed pre-established thresholds must be separately approved. The policy also requires specific approval by the Committee if total fees for audit-related and tax services would exceed total fees for audit services in any fiscal year. The policy authorizes the Committee to delegate to one or more of its members pre-approval authority with respect to permitted services.

58


Table of Contents

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)(1) and (a)(2) List of Financial Statements and Financial Statement Schedule

     The Consolidated Financial Statements of our company required to be included in Part II, Item 8 are indexed on Page F-1 and submitted as a separate section of this report.

     
Exhibit    
Number   Description of Exhibit
 
3.1
  Amended and Restated Certificate of Incorporation of Province Healthcare Company, as filed with the Delaware Secretary of State on June 16, 2000 (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended June 30, 2000, Commission File No. 0-23639)
 
   
3.2
  Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Province Healthcare Company, as filed with the Delaware Secretary of State on May 22, 2002 (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-3/A filed June 11, 2002, Registration No. 333-86578)
 
   
3.3
  Amended and Restated Bylaws of Province Healthcare Company (incorporated by reference to the exhibits filed with the Registrant’s Current Report on Form 8-K, dated December 12, 2002, Commission File No. 0-23639)
 
   
4.1
  Form of Common Stock Certificate (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-3/A filed June 11, 2002, Registration No. 333-86578)
 
   
4.2
  Indenture, dated as of November 20, 2000 between Province Healthcare Company and National City Bank, including the forms of Province Healthcare Company’s 41/2% Convertible Subordinated Notes due 2005 (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-3, dated January 24, 2001, Registration No. 333-54192)
 
   
4.3
  Registration Rights Agreement, dated as of November 20, 2000, among Province Healthcare Company and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse First Boston Corporation, UBS Warburg LLC, First Union Securities, Inc. and Robertson Stephens, Inc. as Initial Purchasers (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-3, dated January 24, 2001, Registration No. 333-54192)
 
   
4.4
  Indenture, dated as of October 10, 2001, between Province Healthcare Company and National City Bank, including the forms of Province Healthcare Company’s 4 1/4% Convertible Subordinated Notes due 2008 (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-3, filed December 20, 2001, Registration No. 333-75646)
 
   
4.5
  Registration Rights Agreement, dated as of October 10, 2001, among Province Healthcare Company and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, First Union Securities, Inc., UBS Warburg LLC and Banc of America Securities LLC as Initial Purchasers (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-3, filed December 20, 2001, Registration No. 333-75646)
 
   
4.6
  Rights Agreement, dated as of January 3, 2003, between Province Healthcare Company and Wachovia Bank, N.A. (incorporated by reference to the exhibits filed with the Registrant’s Current Report on Form 8-K, dated January 3, 2003, Commission File No. 0-23639)
 
   
4.7
  Subordinated Indenture, dated as of May 27, 2003, between Province Healthcare Company and U.S. Bank Trust National Association (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended June 30, 2003, Commission File No. 0-23639)

59


Table of Contents

     
Exhibit    
Number   Description of Exhibit
 
4.8
  First Supplemental Indenture to Subordinated Indenture, dated as of May 27, 2003, between Province Healthcare Company and U.S. Bank Trust National Association, as Trustee, with respect to the issuance of 7 1/2% Senior Subordinated Notes due 2013 (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended June 30, 2003, Commission File No. 0-23639)
 
   
10.1
  Stockholders Agreement, dated as of December 17, 1996, by and among Brim, Inc., GTCR Fund IV, L.P., Leeway & Co., First Union Corporation of Virginia, AmSouth Bancorporation, Martin S. Rash, Richard D. Gore, Principal Hospital Company and certain other stockholders (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1, filed August 27, 1997, Registration No. 333-34421)
 
   
10.2
  First Amendment to Stockholders Agreement, dated as of July 14, 1997, by and among Province Healthcare Company, GTCR Fund IV, L.P., Martin S. Rash, Richard D. Gore and certain other stockholders (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed November 13, 1997, Registration No. 333-34421)
 
   
10.3
  Second Amendment to Stockholders Agreement, dated as of September 30, 1997, between Province Healthcare Company, GTCR Fund IV, L.P., Martin S. Rash, Richard D. Gore and certain other stockholders (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed November 13, 1997, Registration No. 333-34421)
 
   
10.4
  Registration Agreement, dated as of December 17, 1996, by and among Brim, Inc., Principal Hospital Company, GTCR Fund IV, L.P., Leeway & Co., First Union Corporation of Virginia, AmSouth Bancorporation and certain other stockholders (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1, filed August 27, 1997, Registration No. 333-34421)
 
   
10.5
  Senior Management Agreement, dated as of December 17, 1996, between Brim, Inc., Martin S. Rash, GTCR Fund IV, L.P., Leeway & Co. and Principal Hospital Company (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1, filed August 27, 1997, Registration No. 333-34421)
 
   
10.6
  First Amendment to Senior Management Agreement, dated as of July 14, 1997, between Province Healthcare Company, Martin S. Rash and GTCR Fund IV, L.P. (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed November 13, 1997, Registration No. 333-34421)
 
   
10.7
  Second Amendment to Senior Management Agreement, dated as of October 15, 1997, between Province Healthcare Company, Martin S. Rash and GTCR Fund IV, L.P. (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed November 13, 1997, Registration No. 333-34421)
 
   
10.8
  Executive Severance Agreement by and between Province Healthcare Company and Martin S. Rash, dated October 18, 1999 (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended March 31, 2000, Commission File No. 0-23639)(B)
 
   
10.9
  Executive Severance Agreement by and between Province Healthcare Company and James Thomas Anderson, dated October 18, 1999 (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended March 31, 2000, Commission File No. 0-23639)(B)
 
   
10.10
  Executive Severance Agreement by and between Province Healthcare Company and Daniel S. Slipkovich, dated February 1, 2004 (incorporated by reference to the exhibits filed with the Registrant’s Annual Report on Form 10-K for the fiscal period ended December 31, 2003, Commission File No. 001-31320) (B)
 
   
10.11
  Executive Severance Agreement by and between Province Healthcare Company and Howard T. Wall, III, dated October 18, 1999 (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended March 31, 2000, Commission File No. 0-23639) (B)

60


Table of Contents

     
Exhibit    
Number   Description of Exhibit
 
10.12
  Executive Severance Agreement by and between Province Healthcare Company and Christopher T. Hannon, dated October 23, 2002 (incorporated by reference to the exhibits filed with the Registrant’s Annual Report filed on Form 10-K for the fiscal period ended December 31, 2002, Commission File No. 001-31320) (B)
 
   
10.13
  Province Healthcare Company Amended and Restated Employee Stock Purchase Plan (incorporated by reference to the exhibits filed with the Registrant’s Definitive Proxy Statement on Schedule 14A, filed on April 26, 2002, Commission File No. 0-23639)(B)
 
   
10.14
  Province Healthcare Company Amended and Restated 1997 Long-Term Equity Incentive Plan (incorporated by reference to the exhibits filed with the Registrant’s Definitive Proxy Statement on Schedule 14A, filed on April 26, 2002, Commission File No. 0-23639) (B)
 
   
10.15
  Lease Agreement, dated October 1, 1996, by and between County of Starke, State of Indiana, and Principal Knox Company (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1, filed August 27, 1997, Registration No. 333-34421)
 
   
10.16
  Lease Agreement, dated December 1, 1993, by and between Palo Verde Hospital Association and Brim Hospitals, Inc. (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed October 8, 1997, Registration No. 333-34421)
 
   
10.17
  Lease Agreement, dated May 15, 1986, as amended, by and between Fort Morgan Community Hospital Association and Brim Hospitals, Inc. (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed October 8, 1997, Registration No. 333-34421)
 
   
10.18
  Lease Agreement, dated April 24, 1996, as amended, by and between Parkview Regional Hospital, Inc. and Brim Hospitals, Inc. (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed October 8, 1997, Registration No. 333-34421)
 
   
10.19
  Lease Agreement and Annex, dated June 30, 1997, by and between The Board of Trustees of Needles Desert Communities Hospital and Principal-Needles, Inc. (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1, filed August 27, 1997, Registration No. 333-34421)
 
   
10.20
  Lease and Management Agreement and Annex, dated June 9, 1998, by and between St. Landry Parish Hospital Service District No. 1 and PHC-Eunice, Inc. (incorporated by reference to the exhibits filed with the Registrant’s Annual Report filed on Form 10-K for the fiscal period ended December 31, 2001, Commission File No. 0-23639)
 
   
10.21
  Lease Agreement, dated February 15, 2000, by and between The City of Ennis, Texas, PRHC-Ennis, L.P. and Province Healthcare Company (incorporated by reference to the exhibits filed with the Registrant’s Annual Report filed on Form 10-K for the fiscal period ended December 31, 2001, Commission File No. 0-23639)
 
   
10.23
  Lease Agreement and Annex, dated as of December 7, 2001, by and among Hospital Service District No. 2 of the Parish of St. Mary, State of Louisiana, PHC-Morgan City, L.P. and Province Healthcare Company. (incorporated by reference to the exhibits filed with the Registrant’s Annual Report filed on Form 10-K for the fiscal period ended December 31, 2001, Commission File No. 0-23639)
 
   
10.24
  Lease Agreement, dated December 17, 1996, between Brim, Inc. and Encore Senior Living, L.L.C. (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed October 8, 1997, Registration No. 333-34421)
 
   
10.25
  Corporate Purchasing Agreement, dated April 21, 1997, between Aligned Business Consortium Group and Principal Hospital Company (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1, filed August 27, 1997, Registration No. 333-34421)

61


Table of Contents

     
Exhibit    
Number   Description of Exhibit
 
10.26
  First Amendment to Securities Purchase Agreement, dated as of December 31, 1997, between Principal Hospital Company and Leeway & Co. (incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1/A filed November 13, 1997, Registration No. 333-34421)
 
   
10.27
  Amended and Restated Agreement of Limited Partnership, dated June 30, 1997, between PHC of Delaware, Palestine-Principal G.P., Inc., Palestine-Principal, Inc. and Mother Frances Hospital Regional Healthcare Center (incorporated by reference to the exhibits filed with the Registrant’s Annual Report on Form 10-K, for the fiscal period ended December 31, 2000, Commission File No. 0-23639)
 
   
10.28
  Amended and Restated Participation Agreement, dated as of November 13, 2001, among Province Healthcare Company, as Construction Agent and Lessee, various parties as Guarantors, Wells Fargo Bank Northwest, National Association, as the Owner Trustee under the PHC Real Estate Trust 1998-1, various banks and lending institutions as Holders, various banks and lending institutions as Lenders, Bank of America, N.A. as Syndicate Agent, UBS Warburg LLC, as Co-Documentation Agent, Merrill Lynch, as Co-Documentation Agent, First Union Securities, Inc., as Sole Book-Runner and Co-Lead Arranger, Bank of America, N.A., as Co-Lead Manager and First Union National Bank, as Agent (incorporated by reference to the exhibits filed with the Registrant’s Annual Report filed on Form 10-K for the fiscal period ended December 31, 2001, Commission File No. 0-23639)
 
   
10.29
  Amendment No. 1 to Certain Operative Agreements dated as of March 29, 2002, among Province Healthcare Company, as the Lessee and as the Construction Agent, the various parties thereto from time to time, as guarantors, Wells Fargo Bank Northwest, National Association (formerly known as First Security Bank, National Association), as the Owner Trustee, the various banks and other lending institutions which are parties thereto from time to time, as holders, the various banks and other lending institutions which are parties thereto from time to time, as lenders and First Union National Bank, as the agent for the lenders and respecting the Security Documents, as the agent for the Lenders and the Holders, to the extent of their interests (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q for the quarterly period ended March 31, 2002, Commission File No. 0-23639)
 
   
10.30
  Third Amended and Restated Senior Credit Agreement, dated as of November 13, 2001, among Province Healthcare Company, First Union National Bank, as Agent and Issuing Bank, and various parties thereto (incorporated by reference to the exhibits filed with the Registrant’s Annual Report filed on Form 10-K for the fiscal period ended December 31, 2001, Commission File No. 0-23639)
 
   
10.31
  Asset Purchase Agreement, dated April 29, 1998, between Province Healthcare Company, PHC-Lake Havasu, Inc. and Samaritan Health System (incorporated by reference to the exhibits filed with the Registrant’s Current Report on Form 8-K, dated May 14, 1998, Commission File No. 0-23639)
 
   
10.32
  Asset Sale Agreement, dated July 23, 1999, between Tenet Healthcare Corporation and Province Healthcare Company (incorporated by reference to the exhibits filed with the Registrant’s Current Report on Form 8-K, dated October 18, 1999, Commission File No. 0-23639)
 
   
10.33
  Amendment No. 1 to Asset Sale Agreement, dated September 29, 1999, between Tenet Healthcare Corporation and Province Healthcare Company (incorporated by reference to the exhibits filed with the Registrant’s Current Report on Form 8-K, dated October 18, 1999, Commission File No. 0-23639)
 
   
10.34
  Second Amendment to Credit Agreement and Consent, dated March 28, 2003, among Province Healthcare Company, Wachovia Bank, National Association, as Agent, and various parties thereto (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended March 31, 2003 Commission File No. 0-23639)

62


Table of Contents

     
Exhibit    
Number   Description of Exhibit
 
10.35
  Amendment No. 2 to Certain Operative Agreement, dated as of March 28, 2003, among Province Healthcare Company, as the Lessee and as the Construction Agent, the various parties thereto from time to time, as guarantors, Wells Fargo Bank Northwest National Association, as the Owner Trustee, the various banks and other lending institutions which are parties thereto from time to time, as holders, the various banks and lending institutions which are parties thereto from time to time, as lenders, and Wachovia Bank, National Association, as the agent for the Lenders and respecting the Security Documents, as the agent for the Lenders and the Holders (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended March 31, 2003 Commission File No. 0-23639)
 
   
10.36
  Third Amendment to Credit Agreement and Consent, dated May 27, 2003, among Province Healthcare Company, Wachovia Bank, National Association, as Agent, and various parties thereto (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report field on Form 10-Q, for the quarterly period ended June 30, 2003, Commission File No. 0-23639)
 
   
10.37
  Fourth Amendment to Credit Agreement and Consent, dated June 30, 2003, among Province Healthcare Company, Wachovia Bank, National Association, as Agent, and various parties thereto (incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report field on Form 10-Q, for the quarterly period ended June 30, 2003, Commission File No. 0-23639)
 
   
10.38
  Employment Agreement with John M. Rutledge, dated February 1, 2004 (incorporated by reference to the exhibits filed with the Registrant’s Annual Report on Form 10-K for the fiscal period ended December 31, 2003, Commission File No. 001-31320) (B)
 
   
10.39
  Fifth Amendment to Credit Agreement and Consent, dated April 30, 2004, among Province Healthcare Company, Wachovia Bank, National Association, as Agent, and various parties thereto (A)
 
   
10.40
  Agreement and Plan of Merger, dated as of August 15, 2004, by and among LifePoint Hospitals, Inc., Lakers Holding Corp., Lakers Acquisition Corp., Pacers Acquisition Corp. and Province Healthcare Company (incorporated by reference to the exhibits filed with the Registrant’s Current Report on Form 8-K filed on August 17, 2004, Commission File No. 001-31320)
 
   
10.41
  Amendment No. 1 to Agreement and Plan of Merger, dated as of January 25, 2005, by and among LifePoint Hospitals, Inc., Lakers Holding Corp., Lakers Acquisition Corp., Pacers Acquisition Corp. and Province Healthcare Company (incorporated by reference to the exhibits filed with the Registrant’s Joint Proxy Statement on Schedule 14A included in Amendment No. 3 to Form S-4 filed by Lakers Holding Corp. on February 18, 2005, Commission File No. 333-119929 deemed filed by Registrant pursuant to Rule 14a-6(j)).
 
   
10.42
  Amendment No. 2 to Agreement and Plan of Merger, dated as of March 15, 2005, by and among LifePoint Hospitals, Inc., Lakers Holding Corp., Lakers Acquisition Corp., Pacers Acquisition Corp. and Province Healthcare Company (incorporated by reference to the exhibits filed with the Registrant’s Current Report on Form 8-K, Commission File No. 001-31320).
 
   
21.1
  Subsidiaries of the Registrant (A)
 
   
23.1
  Consent of Ernst & Young LLP (A)
 
   
31.1
  Certification pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (A)
 
   
31.2
  Certification pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (A)
 
   
32.1
  Certifications pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (C)

63


Table of Contents


(A)   Filed herewith
 
(B)   Management Compensatory Plan or Arrangement
 
(C)   Furnished herewith

64


Table of Contents

SIGNATURES

     Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     
  Province Healthcare Company
 
   
Date: March 24, 2005
By: /s/ Steven R. Brumfield
 
   
  Steven R. Brumfield
Vice President and Controller

65


Table of Contents

POWER OF ATTORNEY

     The undersigned directors of Province Healthcare Company, a Delaware corporation, do hereby constitute and appoint Martin S. Rash their lawful attorney and agent with full power and authority to do any and all acts and things and to execute any and all instruments which said attorney and agent may determine to be necessary or advisable or required to enable said corporation to comply with the Securities Exchange Act of 1934, as amended, and any rules or regulations or requirements of the Securities and Exchange Commission in connection with this Annual Report on Form 10-K. Without limiting the generality of the foregoing power and authority, the powers granted include the power and authority to sign the names of the undersigned directors in the capacities indicated below to this Annual Report on Form 10-K or amendments or supplements thereto, and each of the undersigned hereby ratifies and confirms all that said attorney and agent shall do or cause to be done by virtue hereof.

     Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

         
/s/ Martin S. Rash
Martin S. Rash
  Chairman of the Board and Chief Executive Officer   March 22, 2005
/s/ Winfield C. Dunn
Winfield C. Dunn
  Director   March 22, 2005
/s/ Paul J. Feldstein
Paul J. Feldstein
  Director   March 22, 2005
/s/ Michael P. Haley
Michael P. Haley
  Director   March 22, 2005
/s/ David R. Klock
David R. Klock
  Director   March 22, 2005
/s/ Joseph P. Nolan
Joseph P. Nolan
  Director   March 22, 2005
/s/ Christopher T. Hannon
Christopher T. Hannon
  Senior Vice President and Chief Financial Officer   March 22, 2005

66


Table of Contents

PROVINCE HEALTHCARE COMPANY
FORM 10-K - ITEM 8 AND ITEM 15(a)(1)

INDEX TO FINANCIAL STATEMENTS

The following consolidated financial statements are filed as a part of this report under Item 8-Financial Statements and Supplementary Data:

         
    Page  
Annual Financial Statements
       
    F-1  
    F-2  
    F-3  
    F-4  
    F-5  
    F-6  
    F-7  
    F-8  

Financial statement schedules are not required under the related instructions or are inapplicable and therefore have been omitted.

67


Table of Contents

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

     The management of Province Healthcare Company (the “Company”) is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that:

     (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;

     (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

     (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

     Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

     Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2004. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on our assessment and those criteria, management believes that the Company maintained effective internal control over financial reporting as of December 31, 2004.

     On June 1, 2004, the Company acquired Memorial Medical Center in Las Cruces, New Mexico (“Memorial Medical Center”). The Company has excluded from its assessment of and conclusion on the effectiveness of internal control over financial reporting, Memorial Medical Center’s internal control over financial reporting. For the year ended December 31, 2004, Memorial Medical Center accounted for 10.5% of the Company’s revenues. As of December 31, 2004, Memorial Medical Center accounted for 8.2% of the Company’s total assets, excluding $79.5 million of goodwill that was recorded in connection with the acquisition of Memorial Medical Center.

     The Company’s independent registered public accounting firm has issued an attestation report on management’s assessment of the Company’s internal control over financial reporting. That report appears on page F-2 of this Report.

F-1


Table of Contents

REPORT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ON INTERNAL CONTROL OVER FINANCIAL REPORTING

The Board of Directors and Shareholders of Province Healthcare Company

We have audited management’s assessment, included in the accompanying Management’s Report on Internal Control Over Financial Reporting, that Province Healthcare Company (the “Company”) and subsidiaries maintained effective internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

As indicated in the accompanying Management’s Report on Internal Control over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls over financial reporting of Memorial Medical Center in Las Cruces, New Mexico, a material business acquired on June 1, 2004. Memorial Medical Center is included in the December 31, 2004 consolidated financial statements of the Company and accounted for 10.5% of the Company’s revenues for the year ended December 31, 2004. As of December 31, 2004, Memorial Medical Center accounted for 8.2% of the Company’s total assets, excluding $79.5 million of goodwill that was recorded in connection with the acquisition of Memorial Medical Center. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Memorial Medical Center.

In our opinion, management’s assessment that the Company maintained effective internal control over financial reporting as of December 31, 2004, is fairly stated, in all material respects, based on the COSO criteria. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2004, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Province Healthcare Company and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of income, changes in stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2004, and our report dated March 22, 2005 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Nashville, Tennessee
March 22, 2005

F-2


Table of Contents

REPORT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders of Province Healthcare Company

We have audited the accompanying consolidated balance sheets of Province Healthcare Company and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of income, changes in stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2004. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Province Healthcare Company and subsidiaries at December 31, 2004 and 2003, and the consolidated results of their operations and their cash flows for each of the three years in the period ended December 31, 2004, in conformity with U.S. generally accepted accounting principles.

As discussed in Note 1 to the consolidated financial statements, the Company changed, in 2002, its method of accounting for goodwill and other intangible assets.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of the Company’s internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated March 22, 2005 expressed an unqualified opinion thereon.

                                                              /s/ Ernst & Young LLP

Nashville, Tennessee
March 22, 2005

F-3


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
                 
    December 31,  
    2004     2003  
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 9,824     $ 46,117  
Accounts receivable, less allowance for doubtful accounts of $78,274 in 2004 and $66,835 in 2003
    137,052       110,335  
Inventories
    21,796       18,424  
Prepaid expenses and other
    14,068       14,614  
Assets of discontinued operations
    1,365       14,995  
 
           
Total current assets
    184,105       204,485  
 
               
Property and equipment, net
    578,587       459,843  
Goodwill
    388,709       309,191  
Other assets
    31,666       36,874  
 
           
 
  $ 1,183,067     $ 1,010,393  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
  $ 32,235     $ 16,083  
Accrued salaries and benefits
    32,653       27,852  
Accrued expenses
    25,933       14,241  
Current portion of long-term debt
    76,241       743  
Liabilities of discontinued operations
    346       5,156  
 
           
Total current liabilities
    167,408       64,075  
 
               
Long-term debt, less current portion
    428,383       447,956  
Other liabilities
    69,090       49,579  
Minority interests
    2,387       1,910  
Commitments and contingencies
           
 
               
Stockholders’ equity:
               
Preferred stock - $0.01 par value, 100,000 shares authorized, none issued and outstanding
           
Common stock - - $0.01 par value; 150,000,000 shares authorized, 50,030,550 shares and 48,841,157 shares issued and outstanding at December 31, 2004 and 2003, respectively
    500       488  
Additional paid-in-capital
    319,996       306,091  
Retained earnings
    195,685       141,186  
Accumulated other comprehensive loss
    (382 )     (892 )
 
           
Total stockholders’ equity
    515,799       446,873  
 
           
 
  $ 1,183,067     $ 1,010,393  
 
           

See accompanying notes.

F-4


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)
                         
    Year Ended December 31,  
    2004     2003     2002  
Revenues:
                       
Net patient revenue
  $ 872,275     $ 735,841     $ 649,954  
Other
    10,631       10,367       8,308  
 
                 
 
    882,906       746,208       658,262  
Expenses:
                       
Salaries, wages and benefits
    323,565       282,794       261,499  
Purchased services
    85,698       68,872       69,934  
Supplies
    114,186       95,579       84,408  
Provision for doubtful accounts
    95,015       72,583       53,201  
Other operating expenses
    96,934       88,137       69,447  
Rentals and leases
    11,250       9,007       8,284  
Transaction costs
    851              
Depreciation and amortization
    46,881       37,617       32,169  
Interest expense
    29,652       26,262       21,285  
Minority interests
    687       260       34  
Loss (gain) on sale of assets
    30       75       (77 )
Loss on early extinguishment of debt
          486        
 
                 
Total expenses
    804,749       681,672       600,184  
 
                 
Income from continuing operations before provision for income taxes
    78,157       64,536       58,078  
Income taxes
    28,101       22,816       23,240  
 
                 
Income from continuing operations
    50,056       41,720       34,838  
Discontinued operations, net of tax:
                       
(Loss) earnings from operations
    (2,220 )     (1,149 )     1,274  
Net gain (loss) on divestitures
    6,663       (8,952 )      
 
                 
 
    4,443       (10,101 )     1,274  
 
                 
Net income
  $ 54,499     $ 31,619     $ 36,112  
 
                 
Earnings (loss) per common share:
                       
Basic:
                       
Continuing operations
  $ 1.01     $ 0.85     $ 0.72  
Discontinued operations:
                       
(Loss) earnings from operations
    (0.04 )     (0.02 )     0.03  
Net gain (loss) on divestitures
    0.13       (0.18 )      
 
                 
Net income
  $ 1.10     $ 0.65     $ 0.75  
 
                 
Diluted:
                       
Continuing operations
  $ 0.96     $ 0.84     $ 0.70  
Discontinued operations:
                       
(Loss) earnings from operations
    (0.03 )     (0.02 )     0.03  
Net gain (loss) on divestitures
    0.11       (0.15 )      
 
                 
Net income
  $ 1.04     $ 0.67     $ 0.73  
 
                 

See accompanying notes.

F-5


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in thousands, except share amounts)
                                                 
                                    Accumulated        
                    Additional             Other        
    Common Stock     Paid-In     Retained     Comprehensive        
    Shares     Amount     Capital     Earnings     Loss     Total  
Balance at December 31, 2001
    47,488,984     $ 475     $ 288,948     $ 73,455     $ (873 )   $ 362,005  
Exercise of stock options and related income tax benefit
    1,031,998       10       13,952                   13,962  
Treasury stock
    1,545             45                   45  
Issuance of common stock from employee stock purchase plan
    59,022       1       1,032                   1,033  
Other
                125                   125  
Comprehensive income:
                                               
Net income
                      36,112             36,112  
Change in fair value of derivatives, net of tax of $53
                            (80 )     (80 )
 
                                             
Comprehensive income
                                  36,032  
 
                                   
Balance at December 31, 2002
    48,581,549       486       304,102       109,567       (953 )     413,202  
Exercise of stock options and related income tax benefit
    143,882       1       828                   829  
Issuance of common stock from employee stock purchase plan and other
    115,726       1       1,161                   1,162  
Comprehensive income:
                                               
Net income
                      31,619             31,619  
Change in fair value of derivatives, net of tax of $38
                            61       61  
 
                                             
Comprehensive income
                                  31,680  
 
                                   
Balance at December 31, 2003
    48,841,157       488       306,091       141,186       (892 )     446,873  
Exercise of stock options and related income tax benefit
    932,451       9       12,711                   12,720  
Issuance of common stock from employee stock purchase plan and other
    256,942       3       1,194                   1,197  
Comprehensive income:
                                               
Net income
                      54,499             54,499  
Change in fair value of derivatives, net of tax of $318
                            510       510  
 
                                             
Comprehensive income
                                  55,009  
 
                                             
 
                                   
Balance at December 31, 2004
    50,030,550     $ 500     $ 319,996     $ 195,685     $ (382 )   $ 515,799  
 
                                   

See accompanying notes.

F-6


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
                         
    Year Ended December 31,  
    2004     2003     2002  
Cash flows from operating activities:
                       
Income from continuing operations
  $ 50,056     $ 41,720     $ 34,838  
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
                       
Depreciation and amortization
    46,881       37,617       32,169  
Deferred income taxes
    29,373       14,215       8,776  
Provision for professional liability
    4,300       5,476       7,209  
Loss on early extinguishment of debt
          486        
Loss (gain) of sale of assets
    30       75       (77 )
Changes in operating assets and liabilities, net of effects from acquisitions and disposals:
                       
Accounts receivable
    (12,596 )     (1,172 )     6,511  
Inventories
    (887 )     712       (1,311 )
Prepaid expenses and other
    (2,726 )     (3,347 )     4,012  
Accounts payable and accrued expenses
    9,184       (4,107 )     (2,696 )
Accrued salaries and benefits
    (521 )     4,505       (315 )
Other
    3,162       8,165       1,022  
 
                 
Net cash provided by operating activities
    126,256       104,345       90,138  
Cash flows from investing activities:
                       
Purchase of property and equipment
    (90,557 )     (56,926 )     (45,469 )
Purchase of hospitals and healthcare entities
    (152,215 )           (171,157 )
Sale of hospitals and healthcare entities
    14,667              
 
                 
Net cash used in investing activities
    (228,105 )     (56,926 )     (216,626 )
Cash flows from financing activities:
                       
Proceeds from long-term debt
    110,372       194,199       134,321  
Repayments of debt
    (56,150 )     (213,049 )     (44,048 )
Issuance of common stock
    12,200       2,574       11,037  
 
                 
Net cash provided by (used in) financing activities
    66,422       (16,276 )     101,310  
 
                 
Net cash (used in) provided by continuing operations
    (35,427 )     31,143       (25,178 )
Net cash (used in) provided by discontinued operations
    (866 )     349       841  
 
                 
(Decrease) increase in cash and cash equivalents
    (36,293 )     31,492       (24,337 )
Cash and cash equivalents at beginning of period
    46,117       14,625       38,962  
 
                 
Cash and cash equivalents at end of period
  $ 9,824     $ 46,117     $ 14,625  
 
                 
Supplemental cash flow information:
                       
Cash paid for interest
  $ 28,706     $ 23,986     $ 19,958  
 
                 
Cash paid for income taxes, net
  $ 1,840     $ 10,322     $ 14,848  
 
                 
Acquisitions:
                       
Assets acquired
  $ 170,921     $     $ 181,268  
Liabilities assumed
    (18,706 )           (10,111 )
 
                 
Cash paid, net of cash acquired
  $ 152,215     $     $ 171,157  
 
                 

See accompanying notes.

F-7


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2004

1. ORGANIZATION AND ACCOUNTING POLICIES

ORGANIZATION

     Province Healthcare Company (the “Company”) was founded on February 2, 1996, and is engaged in the business of owning and leasing hospitals in non-urban communities throughout the United States. As of December 31, 2004, the Company owned or leased 21 general acute care hospitals in 13 states with an aggregate of 2,533 licensed beds. Effective April 30, 2004, the Company sold Glades General Hospital in Belle Glade, Florida and, effective June 30, 2004, sold Brim Healthcare, Inc., its hospital management subsidiary. The operations of Glades General Hospital and Brim Healthcare, Inc. are reported as discontinued operations, as further discussed in Note 3. The Company’s remaining hospitals and operations are reported as continuing operations.

BASIS OF CONSOLIDATION

     The accompanying consolidated financial statements include the accounts of the Company, its majority-owned subsidiaries and partnerships in which the Company or one of its subsidiaries is a general partner and has a majority voting interest. All significant intercompany accounts and transactions have been eliminated in consolidation.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

     The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to bad debts, contractual discounts, risk management reserves and intangible assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of its consolidated financial statements:

Allowance for Doubtful Accounts

     Substantially all of the Company’s accounts receivable are related to providing healthcare services to the Company’s hospitals’ patients. The Company’s ability to collect outstanding receivables from third-party payors and others is critical to its operating performance and cash flows. The primary collection risk lies with uninsured patient accounts or patient accounts for which a balance remains after primary insurance has paid. Insurance coverage is verified prior to treatment for all procedures scheduled in advance and walk-in patients. Insurance coverage is not verified in advance of procedures for emergency room patients. Deductibles and co-payments are generally determined prior to the patient’s discharge with emphasis on collection efforts before discharge. Once these amounts are determined, any remaining patient balance is identified and collection activity is initiated before the patient is discharged. The Company’s standard collection procedures are then followed until such time that management determines the account is uncollectible, at which point the account is written off. For hospitals that the Company has owned in excess of one year, the Company’s policy with respect to estimating its allowance for doubtful accounts is to reserve 50% of all self-pay accounts receivable aged between 121 and 150 days and 100% of all self-pay accounts that have aged greater than 150 days. For hospitals that the Company has owned less than one year, the Company estimates the allowance for doubtful accounts by applying a hospital-specific reserve percentage for each self-pay and non self-pay accounts receivable 30 day aging category, beginning with the 0-30 day aging category, with all self-pay and non-self pay accounts fully reserved at 150 days. Accordingly, substantially all of the Company’s bad debt expense is related to uninsured patient accounts and patient accounts for which a balance remains after primary insurance has paid. The Company continually monitors its accounts receivable balances and utilizes cash collections data and other analytical tools to support the basis for its estimates of the provision for doubtful accounts. In addition, the Company performs hindsight procedures on historical collection and write-off experience to determine the reasonableness of its policy for estimating the allowance for doubtful

F-8


Table of Contents

accounts. Significant changes in payor mix or business office operations, or deterioration in aging accounts receivable could result in a significant increase in this allowance.

     In general, the standard collection cycle at the Company’s hospitals is as follows:

  •   Upfront cash collection of deductibles, co-payments, and self-pay accounts.
 
  •   From the time the account is billed until the period 120 days after the billing, internal business office collections and early out program collections are performed.
 
  •   From the time the account is 121 days after billing until the period one year after billing, uncollected accounts are turned over to one of two primary collection agencies utilized by the Company.
 
  •   One year following the date of billing, any uncollected accounts are written off and the accounts are turned over to a secondary collection agency.

     Uncollected accounts are manually written off: (a) if the balance is less than $10.00, (b) when turned over to an outside secondary collection agency at 365 days, or (c) earlier than 365 days if all collection efforts indicate an account is uncollectible. Once accounts have been written off, they are not included in our gross accounts receivable or allowance for doubtful accounts.

     The Company owned or leased three hospitals in Texas, which accounted for 16.1% and 16.6% of net accounts receivable in 2004 and 2003, respectively. The Company owned or leased four hospitals in Louisiana, which accounted for 9.5% and 13.2% of net accounts receivable in 2004 and 2003, respectively. The Company owned or leased two hospitals, one of which was acquired in 2004, in New Mexico which accounted for 16.2% and 3.6% of net accounts receivable in 2004 and 2003, respectively.

     Same-store upfront cash collections for the year ended December 31, 2004 were approximately $13.5 million compared to $11.5 million and $8.1 million for the years ended December 31, 2003 and 2002, respectively.

Allowance for Contractual Discounts

     The Company derives a significant portion of its revenues from Medicare, Medicaid and other payors that receive discounts from its standard charges. The Medicare and Medicaid regulations and various managed care contracts under which these discounts must be calculated are often complex and subject to interpretation and adjustment. In addition, the services authorized and provided and resulting reimbursement are often subject to interpretation. These interpretations sometimes result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract negotiations occur frequently, necessitating the Company’s continual review and assessment of the estimation process. The Company’s hospitals’ computerized billing systems do not automatically calculate and record contractual allowances. Rather, the Company utilizes an internally developed contractual model to estimate the allowance for contractual discounts on a payor - specific basis, given its interpretation of the applicable regulations or contract terms. The Company’s contractual model for Medicare and Medicaid inpatient services utilizes the application of actual DRG data to individual patient accounts to calculate contractual allowances. For all inpatient and outpatient non-Medicare and non-Medicaid services, the Company’s contractual model utilizes six month historical paid claims data by payor for such services to calculate the contractual allowances. Differences between the contractual allowances estimated by the Company’s contractual model and actual paid claims are adjusted when the individual claims are paid. The Company’s contractual model is updated each quarter. In addition to the contractual allowances estimated and recorded by the Company’s contractual model, the Company also records an allowance equal to 100% of all Medicare, Medicaid, and other insurance payors accounts receivable that are aged greater than 365 days.

Risk Management Reserves

     The Company purchased a professional liability claims-made reporting policy effective January 1, 2004. This coverage is subject to a $5.0 million self-insured retention per occurrence for general and professional liability and provides coverage up to $50.0 million for claims incurred during the annual policy term. This retention amount increases our exposure for claims occurring prior to December 31, 2002 and reported on or after January 1, 2004, due to the increased retention amount as compared to prior years. In 2002, the Company had a claims-made reporting policy subject to a $750,000 deductible and a $2.0 million self-insured retention per occurrence, providing coverage up to $51.0 million for claims incurred during the annual policy term in 2002. In 2001, the Company maintained insurance for individual malpractice claims exceeding $50,000 per medical incident, subject to an annual maximum of

F-9


Table of Contents

$500,000 for claims occurring and reported in 2001. The Company purchased a tail policy that provides an unlimited claim reporting period for its professional liability for claims incurred in 2000 and prior years. The Company estimates its self-insured retention portion of the malpractice risks using an outside actuary which uses historical claims data, demographic factors, severity factors and other actuarial assumptions. The Company maintains a reserve to cover both reported claims and claims that have been incurred but not yet reported within its self-insured retention.

     Workers’ compensation claims are insured with a deductible with stop loss limits of $100,000 per accident and a $1.9 million and $2.2 million minimum cap on total losses for the 1999 and 2000 years, respectively, and $250,000 per accident and a $6.6 million and $3.0 million minimum cap on total losses for the 2002 and 2001 years, respectively. The Company increased the deductible loss amount to $500,000 per accident effective January 1, 2003. The minimum cap for total 2003 losses is $12.0 million. The minimum cap for total 2004 losses is $12.1 million. In 2002 and 2003, the Company’s arrangement with the insurance provider allowed it to prepay the expected amounts of annual workers’ compensation claims, which are based upon claims experience. The claims processor tracks payments for the policy year. At the end of the policy year, the claims processor compares the total amount prepaid by the Company to the actual amount paid by the claims processor. This comparison will ultimately result in a receivable from or a payable to the claims processor. The Company is fully insured in the commercial marketplace for workers’ compensation claims prior to January 1, 1999. The Company utilized loss run reports provided by the claims administrator to determine the appropriate range of loss reserves for the 1999 year and subsequent years. The Company’s accruals are calculated to cover the risk from both reported claims and claims that have been incurred but not yet reported.

Intangible Assets

     The Company adopted Statement of Financial Accounting Standards No. 141, “Business Combinations” (“SFAS No. 141”), effective July 1, 2001 and Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets” (“SFAS No. 142”), effective January 1, 2002. Under SFAS No. 142, goodwill and indefinite lived intangible assets from acquisitions prior to July 1, 2001 are no longer amortized effective January 1, 2002, but are subject to annual impairment tests. The Company performed its annual impairment tests as of October 1, 2004, 2003 and 2002 and did not incur any impairment charge. In accordance with the new rules, goodwill resulting from acquisitions after June 30, 2001 has not been amortized. Other intangible assets will continue to be amortized over their useful lives.

     Management of the Company evaluates all acquisitions independently to determine the appropriate amortization period for identified intangible assets. Each evaluation includes an analysis of factors such as historic and projected financial performance, evaluation of the estimated useful lives of buildings and fixed assets acquired, the indefinite lives of certificates of need and licenses acquired, the competition within local markets, and lease terms where applicable.

Revenue Recognition

     The Company recognizes revenues in the period in which services are performed. Accounts receivable, as reflected on the accompanying consolidated balance sheets, include amounts due from third-party payors, patients, and others. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. A summary of the payment arrangements with major third-party payors follows:

  •   Medicare—Inpatient acute hospital services rendered to Medicare program beneficiaries are paid at prospectively determined rates per diagnosis related group (“DRG”). These DRG rates vary according to a patient classification system that is based on clinical, diagnostic, and other factors. Outpatient services are generally reimbursed under the outpatient prospective payment system, which pays a fixed rate for a given bundle of outpatient services. These bundles are known as Ambulatory Payment Classifications or “APC’s”. Inpatient nonacute services, related to Medicare beneficiaries are paid based on a cost reimbursement methodology subject to various cost limits. The Company is reimbursed for cost-based services at a tentative rate, with final settlement determined after submission of annual cost reports by the Company and audits thereof by the Medicare fiscal intermediary. The Company’s classification of patients under the Medicare program and the appropriateness of their admission are subject to an independent review. The majority of the Company’s Medicare cost reports have been audited by the Medicare fiscal intermediary through December 31, 2001.
 
  •   Medicaid—The Medicaid programs in all states, other than California, in which the Company owns or leases hospitals are prospective payment systems which generally do not have retroactive cost report settlement procedures. Inpatient services rendered to the recipients under the Medi-Cal program (California’s Medicaid program) are reimbursed either under contracted rates or reimbursed for cost reimbursable items at a tentative rate with final settlement determined after submission of annual

F-10


Table of Contents

      cost reports by the Company and audits thereof by Medi-Cal. The Company leases two hospitals in California, and its Medi-Cal cost reports have been audited by the Medi-Cal fiscal intermediary through December 31, 2001.
 
  •   Other—The Company also has entered into payment agreements with certain commercial insurance carriers, health maintenance organizations and preferred provider organizations. The basis for payment to the Company under these agreements includes prospectively determined rates per discharge, discounts from established charges, and prospectively determined daily rates.

     In 2004, 2003, and 2002, the Company owned or leased three hospitals in Texas, which accounted for 15.0%, 16.6%, and 17.6% of net patient revenue, respectively. In 2004, 2003, and 2002 the Company owned or leased four hospitals in Louisiana, which accounted for 15.0%, 17.6% and 17.6% of net patient revenue, respectively. The Company owned or leased two hospitals in New Mexico, one of which was acquired in 2004, which accounted for 15.2% of net patient revenue in 2004.

     Final determination of amounts earned under the Medicare and Medicaid programs often occur in subsequent years because of audits by the programs, rights of appeal and the application of numerous technical provisions. Differences between original estimates and subsequent revisions (including final settlements) are included in the consolidated statements of income in the period in which the revisions are made, and resulted in an increase in net patient revenue of $9,876,000, of which $2,857,000 related to facilities that had not previously qualified for disproportionate share payments in prior years, and $5,482,000 in 2004 and 2003, respectively, and a decrease in net patient revenue of $908,000 in 2002.

     The Company provides care without charge to patients who are financially unable to pay for the healthcare services they receive. Because the Company does not pursue collection of amounts determined to qualify as charity care, they are not reported in net patient revenues.

Discontinued Operations

     In accordance with the provisions of Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” (“SFAS No. 144”), which the Company adopted effective January 1, 2002, the Company has presented the financial position, operating results and cash flows of Glades General Hospital and Brim Healthcare, Inc. as discontinued operations in the accompanying consolidated financial statements as of December 31, 2004 and 2003 and for each of the years in the three year period ending December 31, 2004. Operating results for each of the years in the three year period ending December 31, 2004 and the major classes of assets and liabilities for the years ended December 31, 2004 and 2003 for the Company’s discontinued operations are presented in Note 3.

Cash Equivalents

     The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company places its cash in financial institutions that are federally insured and limits the amount of credit exposure with any one financial institution.

Accounts Receivable

     The Company receives payment for services rendered from federal and state agencies (under the Medicare, Medicaid and TRICARE programs), managed care health plans, commercial insurance companies, employers and patients. During the years ended December 31, 2004, 2003, and 2002, approximately 47.8%, 48.8%, and 56.7%, respectively, of the Company’s net patient revenue from continuing operations related to patients participating in the Medicare and Medicaid programs. Management recognizes that revenues and receivables from government agencies are significant to its operations, but it does not believe that there are significant credit risks associated with these government agencies. Management does not believe that there are any other significant concentrations of revenues from any particular payor that would subject it to any significant credit risks in the collection of its accounts receivable.

Inventories

     Inventories are stated at the lower of cost, determined by the first-in, first-out method, or market.

F-11


Table of Contents

Property and Equipment

     Property and equipment are stated at cost, less accumulated depreciation and amortization. Routine maintenance and repairs are charged to expense as incurred. Expenditures that increase capacities or extend useful lives are capitalized. Depreciation expense, including amortization of assets capitalized under capital leases, is computed using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized on a straight-line basis over the lesser of the terms of the respective leases or their estimated useful lives. Buildings and improvements are depreciated over estimated useful lives ranging generally from 20 to 40 years. Estimated useful lives of equipment vary generally from 3 to 20 years.

     Prior to January 1, 2002, the Company recognized impairments of long-lived assets in accordance with SFAS No. 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of”. In accordance with SFAS No. 144, when events, circumstances or operating results indicate that the carrying values of certain long-lived assets and related identifiable intangible assets (excluding goodwill) that are expected to be held and used might be impaired, the Company considers the recoverability of assets to be held and used by comparing the carrying amount of the assets to the present value of future net cash flows expected to be generated by the assets. If assets are identified as impaired, the impairment is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets as determined by independent appraisals or estimates of discounted future cash flows.

Other Assets

     Other assets consist primarily of costs associated with the issuance of debt which are amortized on a straight-line basis, which approximates the interest method, over the life of the related debt, and costs to recruit physicians to the Company’s markets, which are deferred and amortized over the term of the respective physician recruitment agreement, which is generally three years. Amortization of deferred loan costs is included in interest expense. Deferred loan costs totaled $11,739,000 (net of accumulated amortization of $15,569,000) and $15,305,000 (net of accumulated amortization of $11,940,000) at December 31, 2004 and 2003, respectively. Amortization of physician recruiting costs is included in other operating expenses. Net physician recruiting costs included in the accompanying consolidated balance sheets at December 31, 2004 and 2003 totaled $16,395,000 and $17,107,000, respectively.

Income Taxes

     The Company accounts for income taxes under the asset and liability method. This method requires the recognition of deferred tax assets and liabilities for the expected future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company assesses the likelihood that deferred tax assets will be recovered from future taxable income to determine whether a valuation allowance should be established.

Other Noncurrent Liabilities

     Other noncurrent liabilities consist primarily of insurance liabilities, supplemental deferred compensation liability, and deferred income taxes.

Minority Interests

     The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned entities controlled by the Company. Accordingly, the Company has recorded minority interests in the earnings and equity of such consolidated entities.

Stock Based Compensation

     The Company, from time to time, grants stock options for a fixed number of common shares to employees and directors at a fixed exercise price. The Company accounts for employee stock option grants using the intrinsic value method in accordance with Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“Opinion 25”), and related interpretations, and accordingly, recognizes no compensation expense for the stock option grants when the exercise price of the options equals, or is greater than, the market price of the underlying stock on the date of grant.

F-12


Table of Contents

     The following proforma information is being presented in accordance with Statement of Financial Accounting Standards No. 148, “Accounting for Stock-Based Compensation - Transition and Disclosure”, which was adopted by the Company effective January 1, 2003. Had compensation cost for the Company’s stock-based compensation plans been determined based on the fair value at the grant date for awards under these plans consistent with the methodology prescribed under SFAS No. 123, “Accounting for Stock-Based Compensation” (“SFAS No. 123”), net income and earnings per share would have been reduced to the pro forma amounts indicated in the following table (in thousands, except per share data):

                         
    2004     2003     2002  
Net income - as reported
  $ 54,499     $ 31,619     $ 36,112  
Less pro forma effect of stock option grants
    (4,749 )     (4,744 )     (10,922 )
 
                 
Pro forma net income
  $ 49,750     $ 26,875     $ 25,190  
 
                 
Earnings per share - as reported
                       
Basic
  $ 1.10     $ 0.65     $ 0.75  
Diluted
  $ 1.04     $ 0.67     $ 0.73  
Earnings per share - pro forma
                       
Basic
  $ 1.00     $ 0.55     $ 0.52  
Diluted
  $ 0.96     $ 0.55     $ 0.51  

     Pro forma information regarding net income and earnings per share is required by SFAS No. 123, “Accounting for Stock Based Compensation”, and has been determined as if the Company had accounted for its employee stock options under the fair value method of that Statement. The fair value for these options was estimated at the date of grant using a Black-Scholes option pricing model with the following weighted-average assumptions for 2004, 2003 and 2002, respectively: risk-free interest rate of 2.80%, 2.47% and 4.11%; dividend yield of 0%; volatility factor of the expected market price of the Company’s common stock of .560, .634 and .594; and a weighted-average expected life of the option of 4.0, 4.0 years and 3.9 years. The estimated weighted average fair values of shares granted during 2004, 2003 and 2002, using the Black-Scholes option pricing model, were $7.30, $4.04 and $9.46, respectively.

     The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including the expected stock price volatility. Because changes in the subjective input assumptions can materially affect the fair value estimate, in management’s opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its employee stock options.

     For purposes of pro forma disclosures, the estimated fair value of the options is amortized to expense over the options’ vesting period.

     In accordance with Statement of Financial Accounting Standards No. 128, “Earnings Per Share” (“SFAS No. 128”), the calculation of diluted earnings per share for the year ended December 31, 2003 using the “if converted” method includes the impact of the Company’s convertible notes. Since the Company reports discontinued operations, income from continuing operations has been utilized in determining whether the convertible notes were dilutive or antidilutive to earnings per share. The convertible notes were dilutive to earnings per share on income from continuing operations and were antidilutive to net income for the year ended December 31, 2003. The convertible notes were antidilutive to earnings per share on pro forma income from continuing operations and pro forma net income for the year ended December 31, 2002.

Interest Rate Swap Agreements

     The Company enters into interest rate swap agreements as a means of managing its interest rate exposure. The differential to be paid or received is recognized over the life of the agreement as an adjustment to interest expense.

     Effective January 2001, the Company adopted Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities”, as amended (“SFAS No. 133”). SFAS No. 133 requires that all derivatives, whether designated in hedging relationships or not, be recognized on the balance sheet at fair value and requires the recognition of the resulting gains or losses as adjustments to earnings or other comprehensive income. In accordance with the provisions of SFAS No. 133, the Company designated its outstanding interest rate swap agreement as a fair value hedge and determined that this hedge qualifies for treatment under the short-cut method of measuring effectiveness. Under the provisions of SFAS No. 133, this hedge is determined to be

F-13


Table of Contents

perfectly effective and there is no requirement to periodically evaluate effectiveness. This derivative and the related hedged debt amount has been recognized in the consolidated financial statements at its respective fair value.

Recently Issued Accounting Pronouncements

     In December 2003, the Financial Accounting Standards Board (“FASB”) issued Revised Interpretation No. 46, “Consolidation of Variable Interest Entities” (“FIN 46R”), which requires the consolidation of variable interest entities. FIN 46R, as revised, was applicable to financial statements of companies that had interests in special purpose entities, as defined, during 2003. Effective as of the first quarter of 2004, FIN 46R was applicable to financial statements of companies that have interests in all other types of entities. Adoption of FIN 46R had no effect on the Company’s financial position, results of operations or cash flows.

     In December 2004, the FASB issued Statement of Financial Accounting Standards No. 123R, “Share-Based Payments” (“SFAS No. 123R”), a revision of Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation”, which addresses financial accounting and reporting for costs associated with stock-based compensation. SFAS No. 123R addresses all forms of share-based payment awards, including shares issued under employee stock purchase plans and stock options. SFAS No. 123R will require the Company to recognize compensation expense beginning July 1, 2005, in an amount equal to the fair value of share-based payments related to unvested share-based payment awards over the applicable vesting period. As permitted by SFAS No. 123, the Company currently accounts for share-based payments to employees using Opinion 25’s intrinsic value method and, as such, generally recognizes no compensation cost for employee stock options. Accordingly, the adoption of SFAS No. 123R’s fair value method will have a significant impact on the Company’s results of operations, although it will have no impact on the Company’s overall financial position. The impact of the adoption of SFAS No. 123R cannot be predicted at this time because it will depend on levels of share-based payments granted in the future. However, had the Company adopted SFAS No. 123R in prior periods, the impact of that standard would have approximated the impact of SFAS No. 123 as described in the disclosure of pro forma net income and earnings per share in Note 1 to the Company’s consolidated financial statements.

2. PENDING ACQUISITION BY LIFEPOINT HOSPITALS, INC.

     The Company announced on August 16, 2004 that it had entered into a definitive merger agreement with LifePoint Hospitals, Inc. (“LifePoint”) in which LifePoint will acquire the Company for approximately $1.7 billion in cash, stock and the assumption of the Company’s debt. The transaction is expected to close in the first half of 2005.

     Pursuant to the definitive agreement, if the proposed transaction is consummated, the businesses of LifePoint and the Company will be combined under a newly formed company, which will be renamed LifePoint Hospitals, Inc. (“New LifePoint”). Each stockholder of the Company will receive a per share consideration comprised of $11.375 in cash and a number of shares of New LifePoint common stock equal to an exchange ratio of between .3447 and .2917 per common share of the Company, which will represent a value of $11.375 if the volume weighted average of the daily sales prices for share of LifePoint common stock for the 20 consecutive trading day period ending at the close of business on the third trading day prior to closing (the “LifePoint average share price”) is between $33.00 and $39.00. If the LifePoint average share price is $33.00 or less, the exchange ratio will be 0.3447, and if the LifePoint average share price is $39.00 or more, the exchange ratio will be 0.2917.

     The agreement provides for alternative structures. While it is anticipated that shares received by the Company’s stockholders will be received in a tax-free exchange, the parties have agreed to a taxable alternative structure at the same price if necessary to complete the acquisition.

     Each of the Boards of Directors of LifePoint and the Company have unanimously approved the proposed transaction. Completion of the transaction is subject to approval by the LifePoint stockholders and the Company’s stockholders, receipt of necessary financing by LifePoint and certain other conditions.

3. DISCONTINUED OPERATIONS

     On April 30, 2004 the Company sold substantially all of the assets and assigned certain liabilities of Glades General Hospital (“Glades”) in Belle Glade, Florida, to a wholly-owned subsidiary of the Health Care District of Palm Beach County for approximately $1.5 million, resulting in an immaterial gain on divestiture. Effective June 30, 2004, the Company sold the stock of Brim Healthcare, Inc. (“Brim”) to Brim Holding Company, Inc., an independent investor-owned Delaware corporation, for approximately $13.2 million, resulting in a pre-tax gain on divestiture of $11.3 million ($7.0 million gain net of tax). The operations of Glades and Brim are

F-14


Table of Contents

reported as discontinued operations and the operating results for the years ended December 31, 2004, 2003 and 2002 are presented in the following table (in thousands):

                         
    YEAR ENDED DECEMBER 31,  
    2004     2003     2002  
Revenues
  $ 17,150     $ 45,480     $ 46,085  
Operating expenses
    20,096       45,052       41,242  
Depreciation and amortization
    49       1,699       2,062  
Interest expense
    143       478       672  
(Gain) loss on divestitures
    (10,774 )     11        
Impairment charge
          13,773        
 
                 
Total expenses
    9,514       61,013       43,976  
 
                 
Income (loss) before provision for income taxes
    7,636       (15,533 )     2,109  
Income taxes (benefit)
    3,193       (5,432 )     835  
 
                 
Earnings (loss) from discontinued operations
  $ 4,443     $ (10,101 )   $ 1,274  
 
                 

     In connection with the decision to sell Glades, the Company wrote off goodwill associated with the hospital, wrote off the net book value of physician recruiting costs and wrote down the other assets of Glades to their estimated net realizable value, less cost to sell. These charges are included in the impairment charge recorded in 2003.

     The major classes of assets and liabilities of discontinued operations in the consolidated balance sheets as of December 31, 2004 and 2003 are as follows (in thousands):

                 
    Year Ended December 31,  
    2004     2003  
Cash
  $ 438     $ 17  
Accounts receivable, net
    922       6,931  
Inventories
          529  
Prepaid expenses and other current assets
    5       392  
Property and equipment, net
          3,157  
Goodwill
          80  
Other assets
          33  
Deferred income taxes
          3,856  
 
           
Total assets of discontinued operations
    1,365       14,995  
 
           
Accounts payable
          812  
Accrued salaries and benefits
    84       1,603  
Accrued expenses
    217       513  
Long-term debt
          982  
Income taxes payable
          1,246  
Deferred income taxes
    45        
 
           
Total liabilities of discontinued operations
    346       5,156  
 
           
Net assets of discontinued operations
  $ 1,019     $ 9,839  
 
           

     The Company will continue to pursue collection of the remaining net accounts receivable under its standard collection policies.

4. ACQUISITIONS

2004 Acquisition

     In June 2004, the Company acquired Memorial Medical Center in Las Cruces, New Mexico, through a long-term capital lease agreement, for approximately $152.2 million, including working capital and direct and incremental costs of the acquisition. To finance this acquisition, the Company borrowed $110.0 million under its senior bank credit facility and used approximately $42.2 million of available cash. This is the Company’s second New Mexico hospital and is one of two hospitals in the community, serving a population in excess of 150,000.

F-15


Table of Contents

2002 Acquisitions

     In May 2002, the Company acquired Memorial Hospital of Martinsville and Henry County in Martinsville, Virginia, for approximately $129.2 million, including working capital. To finance this acquisition, the Company borrowed $86.0 million under its revolving credit facility and used approximately $43.2 million of available cash. This is the Company’s first Virginia hospital and is the only hospital in the county, serving a population in excess of 100,000.

     In June 2002, the Company acquired Los Alamos Medical Center in Los Alamos, New Mexico, for approximately $39.0 million, including working capital. To finance this acquisition, the Company borrowed $37.0 million under its revolving credit facility and used $2.0 million from available cash. This was the Company’s first New Mexico hospital and is the only hospital in the community, serving a population of approximately 50,000.

     The hospitals acquired by the Company in 2004 and 2002 are the primary providers of healthcare services in their markets and, as previously underperforming hospitals, present the Company with the opportunity, under its management, to increase profitability and garner local market share. The Company’s strategy with respect to these markets is to improve hospital operations, expand healthcare services to increase market share by reducing patient out-migration, and recruit and retain quality physicians to increase the quality of healthcare and the breadth of healthcare services.

     The foregoing acquisitions were accounted for using the purchase method of accounting. The operating results of the hospitals acquired in 2004 and 2002 have been included in the accompanying consolidated statements of income from the respective dates of acquisition.

     The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the hospital acquisition completed in 2004 (in thousands):

         
Accounts receivable, net
  $ 14,121  
Inventories
    2,485  
Prepaid expenses and other
    257  
 
     
Total current assets acquired
    16,863  
 
       
Property and equipment
    74,537  
Goodwill
    79,518  
Other
    3  
 
     
Total assets acquired
    170,921  
 
       
Total liabilities assumed
    (18,706 )
 
     
Net assets acquired
  $ 152,215  
 
     

     The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the hospital acquisitions completed in 2002 (in thousands):

         
Accounts receivable, net
  $ 12,913  
Inventories
    2,177  
Prepaid expenses and other
    119  
 
     
Total current assets acquired
    15,209  
 
       
Property and equipment
    63,457  
Goodwill
    101,815  
Other
    787  
 
     
Total assets acquired
    181,268  
 
       
Total liabilities assumed
    (10,111 )
 
     
Net assets acquired
  $ 171,157  
 
     

F-16


Table of Contents

Pro Forma Acquisition Information

     The following pro forma information reflects the operations of the hospitals acquired in 2004 and 2002, as if the respective transactions had occurred as of the first day of the fiscal year immediately preceding the year of the acquisitions (in thousands, except per share data):

                         
    2004     2003     2002  
Net revenue
  $ 945,542     $ 883,335     $ 701,850  
Net income
  $ 52,630     $ 24,674     $ 38,112  
Earnings per share:
                       
Basic
  $ 1.06     $ 0.51     $ 0.79  
Diluted
  $ 1.01     $ 0.55     $ 0.77  

     The pro forma results of operations do not purport to represent what the Company’s results would have been had such transactions, in fact, occurred at the beginning of the periods presented or to project the Company’s results of operations in any future period.

5. PROPERTY AND EQUIPMENT

     Property and equipment consists of the following (in thousands):

                 
    DECEMBER 31,  
    2004     2003  
Land
  $ 40,263     $ 23,344  
Land improvements
    6,602       5,292  
Leasehold improvements
    20,036       19,554  
Buildings and improvements
    408,878       335,788  
Equipment
    243,632       191,900  
 
           
 
    719,411       575,878  
Less accumulated depreciation and amortization
    (163,344 )     (121,835 )
 
           
 
    556,067       454,043  
Construction-in-progress (estimated cost to complete at December 31, 2004 - $82,037)
    22,520       5,800  
 
           
 
  $ 578,587     $ 459,843  
 
           

     Depreciation expense totaled approximately $46,320,000, $37,120,000 and $32,059,000 in 2004, 2003 and 2002, respectively. Assets under capital leases were $4,614,000 and $6,206,000, net of accumulated amortization of $7,927,000 and $5,631,000 at December 31, 2004 and 2003, respectively. Interest is capitalized in connection with construction projects at the Company’s facilities. The capitalized interest is recorded as part of the asset to which it relates and is depreciated over the asset’s estimated useful life. In 2004 and 2003, $1,357,000 and $712,000 of interest cost, respectively, was capitalized.

6. LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS

     Long-term debt consists of the following (in thousands):

                 
    December 31,  
    2004     2003  
Credit facility
  $ 55,000     $  
Senior subordinated notes
    198,337       196,634  
Convertible subordinated notes
    248,470       248,470  
 
           
 
    501,807       445,104  
Obligations under capital leases (see Note 10)
    2,817       3,595  
 
           
 
    504,624       448,699  
Less current portion
    (76,241 )     (743 )
 
           
 
  $ 428,383     $ 447,956  
 
           

F-17


Table of Contents

CREDIT FACILITY

     The Company maintains a bank senior credit facility (“Credit Facility”) of $250,000,000. At December 31, 2004, the Company had outstanding letters of credit of $8,277,000, reducing the amount available under the Credit Facility to $186,723,000.

     On June 1, 2004, in connection with the acquisition of Memorial Medical Center in Las Cruces, New Mexico, the Company borrowed $110.0 million under its senior revolving bank credit facility to finance the acquisition. The Company subsequently repaid $55.4 million (including $0.4 million borrowed under the revolver in the third quarter of 2004) of the revolver borrowing with the proceeds from the sale of Brim Healthcare, Inc. and from cash flows from operations.

     The loans under the Credit Facility bear interest, at the Company’s option, at the adjusted base rate or at the adjusted LIBOR rate. The interest rate ranged from 3.875% to 5.125% during 2004. The Company pays a commitment fee, which varies from one-half to three-eighths of one percent of the unused portion, depending on the Company’s compliance with certain financial ratios. The Company may prepay any principal amount outstanding under the Credit Facility at any time before the maturity date of November 13, 2006.

     The Credit Facility contains limitations on the Company’s ability to incur additional indebtedness (including contingent obligations), sell material assets, retire, redeem or otherwise reacquire its capital stock, acquire the capital stock or assets of another business, and pay dividends. The Credit Facility also requires the Company to maintain a specified net worth and meet or exceed certain coverage, leverage, and indebtedness ratios. Indebtedness under the Credit Facility is secured by substantially all assets of the Company.

     In April 2004, the Company amended its senior bank credit facility to, among other items, (i) obtain consent for a limited repurchase of a portion of the Company’s 4 1/2% Convertible Subordinated Notes due 2005 and/or the 4 1/4% Convertible Subordinated Notes due 2008, (ii) adjust the timing of the step down of leverage covenants, and (iii) approve the acquisition of Memorial Medical Center as a Permitted Acquisition.

7 1/2% SENIOR SUBORDINATED NOTES

     In May 2003, the Company completed its public offering of $200,000,000 aggregate principal amount of 7 1/2% Senior Subordinated Notes due June 1, 2013 (the “7 1/2% Senior Subordinated Notes”). Net proceeds of the offering totaling $194,212,000 were used to repay $114,300,000 in existing borrowings under the Credit Facility and to repurchase $74,030,000 of the Company’s 4 1/2% Convertible Subordinated Notes. The 7 1/2% Senior Subordinated Notes bear interest from May 27, 2003 at the rate of 7 1/2% per year, payable semi-annually on June 1 and December 1, beginning on December 1, 2003. The Company may redeem all or a portion of the 7 1/2% Senior Subordinated Notes on or after June 1, 2008, at the then current redemption prices, plus accrued and unpaid interest. In addition, at any time prior to June 1, 2006, the Company may redeem up to 35% of the aggregate principal amount of the 7 1/2% Senior Subordinated Notes within 60 days of one or more common stock offerings with the net proceeds of such offerings at a redemption price of 107.5% of the principal amount, plus accrued and unpaid interest. Note holders may require the Company to repurchase all of the holder’s notes at 101% of their principal amount plus accrued and unpaid interest in some circumstances involving a change of control. The 7 1/2% Senior Subordinated Notes are unsecured and subordinated to the Company’s existing and future senior indebtedness. The 7 1/2% Senior Subordinated Notes rank equal in right of payment to the Company’s 4 1/2% Convertible Subordinated Notes due 2005 and its 4 1/4% Convertible Subordinated Notes due 2008. The 7 1/2% Senior Subordinated Notes effectively rank junior to the Company’s subsidiary liabilities. The indenture contains limitations on the Company’s ability to incur additional indebtedness, sell material assets, retire, redeem or otherwise reacquire its capital stock, acquire the capital stock or assets of another business, and pay dividends.

4 1/4% CONVERTIBLE SUBORDINATED NOTES

     In October 2001, the Company sold $172,500,000 of Convertible Subordinated Notes due October 10, 2008 (the “4 1/4% Notes”). Net proceeds of approximately $166,400,000 were used to reduce the outstanding balance on the revolving line of credit and for acquisitions. The 4 1/4% Notes bear interest from October 10, 2001 at the rate of 4 1/4% per year, payable semi-annually on April 10 and October 10, beginning on April 10, 2002. The 4 1/4% Notes are convertible at the option of the holder at any time on or prior to maturity into shares of the Company’s common stock at a conversion price of $27.70 per share. The conversion price is subject to adjustment. The Company may redeem all or a portion of the 4 1/4% Notes on or after October 10, 2004, at the then current redemption prices, plus accrued and unpaid interest. Note holders may require the Company to repurchase all of the holder’s notes at 100% of their principal amount plus accrued and unpaid interest in some circumstances involving a change of control. The 4 1/4% Notes are

F-18


Table of Contents

unsecured and subordinated to the Company’s existing and future senior indebtedness. The 4 1/4% Notes are ranked equal in right of payment to the Company’s 4 1/2% Notes due in 2005 and its 7 1/2% Senior Subordinated Notes due 2013. The 4 1/4% Notes effectively rank junior to the Company’s subsidiary liabilities. The indenture does not contain any financial covenants. A total of 6,226,767 shares of common stock have been reserved for issuance upon conversion of the 4 1/4% Notes.

4 1/2% CONVERTIBLE SUBORDINATED NOTES

     In November and December 2000, the Company sold $150,000,000 aggregate principal amount of 4 1/2% Convertible Subordinated Notes due November 20, 2005 (the “4 1/2% Notes”). The 4 1/2% Notes bear interest from November 20, 2000 at the rate of 4 1/2% per year, payable semi-annually on May 20 and November 20, beginning on May 20, 2001. The 4 1/2% Notes are convertible at the option of the holder at any time on or prior to maturity into shares of the Company’s common stock at a conversion price of $26.45 per share. The conversion price is subject to adjustment. The Company may redeem all or a portion of the 4 1/2% Notes on or after November 20, 2003, at the then current redemption prices, plus accrued and unpaid interest. Note holders may require the Company to repurchase all of the holder’s notes at 100% of their principal amount plus accrued and unpaid interest in some circumstances involving a change of control.

     In 2003, the Company repurchased $74,030,000 of the 4 1/2% Notes from the proceeds from the sale of the 7 1/2% Senior Subordinated Notes as discussed above. The Company recorded a $486,000 pretax loss associated with the early extinguishment of debt related to the repurchase of the 4 1/2% Notes.

     The 4 1/2% Notes are unsecured obligations and rank junior in right of payment to all of the Company’s existing and future senior indebtedness. The 4 1/2% Notes rank equal in right of payment to the Company’s 4 1/4% Convertible Subordinated Notes due 2008 and its 7 1/2% Senior Subordinated Notes due 2013. The 4 1/2% Notes effectively rank junior to the Company’s subsidiary liabilities. The indenture does not contain any financial covenants. A total of 2,872,760 shares of common stock have been reserved for issuance upon conversion of the remaining 4 1/2% Notes.

INTEREST RATE SWAP AGREEMENTS

     Interest rate swap agreements are used to manage the Company’s interest rate exposure. In 1998, the Company entered into an interest rate swap agreement, which effectively converted for a five-year period $45,000,000 of floating-rate borrowings to fixed-rate borrowings. In January 2001, the Company terminated $16,500,000 of the $45,000,000 swap agreement, leaving a notional amount of $28,500,000 converted to fixed-rate borrowings. The Company secured a 5.625% fixed interest rate on the swap agreement, which was subsequently amended to a 4.45% fixed interest rate during 2002. In May 2003, the Company terminated the remainder of the previously existing swap agreement.

     In July 2003, the Company entered into an interest rate swap agreement which effectively converted for a ten-year period $100,000,000 of the $200,000,000 fixed rate borrowings under the 7 1/2% Senior Subordinated Notes to floating-rate borrowings. The Company secured a LIBOR plus 2.79% floating interest rate over the term of the interest rate swap agreement. The Senior Subordinated Notes are recorded net of the $1,663,000 fair value adjustment of the interest rate swap. The interest rate swap agreement is a fair value hedge. The outstanding agreement exposes the Company to credit losses in the event of non-performance by the counterparty to the financial instrument. The Company anticipates that the counterparty will fully satisfy its obligations under the contract.

AGGREGATE MATURITIES

     Aggregate maturities of long-term debt at December 31, 2004, excluding capital leases (see Note 10), are as follows (in thousands):

         
2005
  $ 75,970  
2006
    55,000  
2007
     
2008
    172,500  
2009
     
Thereafter
    198,337  
 
     
 
  $ 501,807  
 
     

F-19


Table of Contents

7. STOCKHOLDERS’ EQUITY

COMMON STOCK

     On April 30, 2002, the Company effected a three-for-two stock split, in the form of a 50% stock dividend, to stockholders of record on April 20, 2002. The stock split resulted in the issuance of 15.9 million shares of common stock and a transfer between additional paid-in capital and common stock of $159,000.

     All historical references to common share, earnings per share amounts and conversion rights under debt instruments included in the consolidated financial statements and notes thereto have been restated to reflect the three-for-two split.

PREFERRED SHARE PURCHASE RIGHTS

     To establish a new shareholders’ rights plan, on December 30, 2002, the Board of Directors declared a dividend distribution of one Preferred Share Purchase Right (“Right”) on each outstanding share of the Company’s common stock. The dividend distribution was payable to shareholders of record on January 10, 2003. Under certain circumstances, each Right will entitle shareholders to buy one ten-thousandth of a share of newly created Series A Junior Participating Preferred Stock of the Company at an exercise price of $75.00. The Rights are redeemable at $.01 per Right at any time before a person has acquired 15% or more of the Company’s outstanding common stock. The Preferred Share Purchase Right Plan will expire on December 31, 2012.

     The Rights have certain anti-takeover effects. The rights will cause substantial dilution to a person or group that attempts to acquire the Company on terms not determined by the Board of Directors to be in the best interest of all shareholders. The Rights should not interfere with any merger or other business combination approved by the Board of Directors.

STOCK OPTIONS

     In March 1997, the Company’s Board of Directors and shareholders approved the 1997 Long-Term Equity Incentive Plan (the “Plan”). The Company has reserved 12,620,286 shares for issuance under the Plan. Under the Plan, options to purchase shares may be granted to officers, employees, and directors. The options have a maximum term of ten years and generally vest in five equal annual installments. Options are generally granted at not less than market price on the date of grant.

     The following is a summary of option transactions during 2004, 2003 and 2002:

                 
    Number of     Option  
    Options     Price Range  
Balance at December 31, 2001
    5,219,878     $ 2.03 - $23.00  
Options granted
    2,492,327       10.80 - 23.50  
Options exercised
    (1,031,997 )     2.03 - 23.50  
Options forfeited
    (1,009,375 )     2.03 - 23.50  
 
             
 
               
Balance at December 31, 2002
    5,670,833       2.03 - 23.50  
Options granted
    1,454,150       7.71 - 13.52  
Options exercised
    (143,882 )     2.03 - 11.50  
Options forfeited
    (214,212 )     6.72 - 23.50  
 
             
 
               
Balance at December 31, 2003
    6,766,889       2.03 - 23.50  
Options granted
    1,660,000       14.16 - 17.62  
Options exercised
    (927,951 )     2.03 - 21.08  
Options forfeited
    (464,246 )     7.17 - 23.50  
 
             
 
               
Balance at December 31, 2004
    7,034,692     $ 2.03 - $23.50  
 
             

F-20


Table of Contents

The following table summarizes information concerning outstanding and exercisable options at December 31, 2004:

                                     
    OPTIONS OUTSTANDING     OPTIONS EXERCISABLE  
            WEIGHTED                    
            AVERAGE                    
            REMAINING   WEIGHTED             WEIGHTED  
            CONTRACTUAL   AVERAGE             AVERAGE  
    NUMBER     LIFE   EXERCISE     NUMBER     EXERCISE  
       RANGE OF EXERCISE PRICES   OUTSTANDING     (YEARS)   PRICE     EXERCISABLE     PRICE  
$2.03 - $7.17
    282,769     4.3   $ 6.81       282,769     $ 6.81  
7.71 - 7.71
    1,028,856     8.2     7.71       127,696       7.71  
8.95 - 11.50
    947,185     5.9     10.76       653,685       10.65  
11.56 - 15.75
    887,650     9.2     15.30       21,950       12.65  
15.83 - 16.40
    1,037,775     7.9     16.09       307,539       16.35  
16.67 - 16.71
    797,376     6.5     16.69       797,376       16.69  
17.62 - 18.20
    808,206     8.1     18.02       226,541       18.20  
18.67 - 21.08
    533,673     6.9     20.00       392,736       20.25  
23.00 - 23.00
    24,808     6.6     23.00       20,164       23.00  
23.50 - 23.50
    686,394     7.4     23.50       667,050       23.50  
 
                               
$2.03 - $23.50
    7,034,692     7.4     15.01       3,497,506       16.21  
 
                               

     At December 31, 2003 and 2002, respectively, 3,356,852 and 2,636,954 options were exercisable. At December 31, 2004, the Company had options representing 1,162,680 shares available for future grant.

EMPLOYEE STOCK PURCHASE PLAN

     In May 1998 the Company’s Board adopted, and in June 1998 the stockholders approved, the Province Healthcare Company Employee Stock Purchase Plan (the “ESPP”). Under the ESPP, employees may purchase shares of common stock at 85% of market price on the first day of the year or 85% of the market price on the last day of the year, whichever is lower. The shares are purchased each year with funds withheld from employees through payroll deductions from January 1 through December 31. A total of 1,125,000 shares of Common Stock have been reserved for issuance under the ESPP. Participation in the ESPP commenced June 1, 1998. Shares issued under the ESPP totaled 256,942, 126,874 and 59,022 in 2004, 2003 and 2002, respectively.

8. INCOME TAXES

     The provision for income taxes from continuing operations consists of the following amounts (in thousands):

                         
    2004     2003     2002  
Current:
                       
Federal
  $ 3,679     $ 7,840     $ 13,045  
State
    (243 )     761       1,419  
 
                 
 
    3,436       8,601       14,464  
Deferred:
                       
Federal
    21,870       13,312       7,939  
State
    2,795       903       837  
 
                 
 
    24,665       14,215       8,776  
 
                 
 
  $ 28,101     $ 22,816     $ 23,240  
 
                 

     The differences between the Company’s effective income tax rate and the statutory federal income tax rate are as follows (in thousands):

                                                 
    2004     2003     2002  
Statutory federal rate
  $ 27,355       35.0 %   $ 22,588       35.0 %   $ 20,327       35.0 %
State income taxes, net of federal income tax benefit
    1,659       2.1       1,081       1.7       1,467       2.5  
Permanent differences
    387       0.5       271       0.4       232       0.4  
Other
    (1,300 )     (1.6 )     (1,124 )     (1.7 )     1,214       2.1  
 
                                   
 
  $ 28,101       36.0 %   $ 22,816       35.4 %   $ 23,240       40.0 %
 
                                   

F-21


Table of Contents

     The components of the Company’s deferred tax assets and (liabilities) for continuing operations are as follows (in thousands):

                 
    DECEMBER 31,  
    2004     2003  
Depreciation and amortization
  $ (53,797 )   $ (33,659 )
Accounts receivable
    (10,068 )     (4,215 )
Accruals and reserves
    1,201       1,947  
Insurance reserves
    6,470       4,789  
Third party settlements
    2,965       2,224  
Operating leases
    (2,520 )     (2,201 )
Capital lease interest
    702       683  
Other
    214       582  
 
           
Net deferred tax liability
  $ (54,833 )   $ (29,850 )
 
           

     In the accompanying consolidated balance sheets, net current deferred tax liabilities of $8,118,000 and $2,015,000 are included in accrued expenses at December 31, 2004 and 2003, respectively. Net noncurrent deferred tax liabilities of $46,715,000 and $27,835,000 are included in other liabilities at December 31, 2004 and 2003, respectively.

     The Company recorded a deferred tax liability of $318,000 related to interest rate swap agreements during 2004. The expense of the deferred taxes is recorded in comprehensive income.

     The Company has been examined by federal and various state tax authorities. The completed examinations did not have a negative impact on the financial condition or results of operations of the Company. In 2004, the Company recorded a reduction in its provision for income taxes of approximately $800,000 due to final resolution of examinations on certain issues by taxing authorities of audits that had been ongoing for over one year.

9. EARNINGS PER SHARE

     The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

                         
    2004     2003     2002  
Earnings per common share:
                       
Income from continuing operations
  $ 50,056     $ 41,720     $ 34,838  
Add convertible notes interest, net of tax
    7,781       8,325        
 
                 
Income from continuing operations
    57,837       50,045       34,838  
Discontinued operations
    4,443       (10,101 )     1,274  
 
                 
Net income
  $ 62,280     $ 39,944     $ 36,112  
 
                 
Weighted average shares:
                       
Weighted average shares - basic
    49,543       48,692       48,146  
Dilution for employee stock options
    1,395       613       1,307  
Dilution for convertible notes
    9,100       10,243        
 
                 
Weighted-average shares - diluted
    60,038       59,548       49,453  
 
                 
Basic earnings per common share:
                       
Income from continuing operations
  $ 1.01     $ 0.85     $ 0.72  
Discontinued operations
    0.09       (0.20 )     0.03  
 
                 
Net income
  $ 1.10     $ 0.65     $ 0.75  
 
                 
Diluted earnings per common share:
                       
Income from continuing operations
  $ 0.96     $ 0.84     $ 0.70  
Discontinued operations
    0.08       (0.17 )     0.03  
 
                 
Net income
  $ 1.04     $ 0.67     $ 0.73  
 
                 

     In accordance with SFAS No. 128, the calculation of diluted earnings per share for the year ended December 31, 2004 using the “if converted” method includes the impact of the Company’s convertible notes. Since the Company reports discontinued operations, income from continuing operations has been utilized in determining whether the convertible notes were dilutive or antidilutive to earnings per share. The convertible notes were dilutive to earnings per share on income from continuing operations and net income for the year ended December 31, 2004. The convertible notes were dilutive to earnings per share on income from continuing operations and were anti-dilutive to net income for the year ended December 31, 2003. The effect of the convertible notes to purchase 5,672,160

F-22


Table of Contents

shares of common stock, and related interest expense, were not included in the computation of diluted earnings per share in 2002 because their effect would have been anti-dilutive.

10. LEASES

     The Company leases various buildings, office space and equipment. The leases expire at various times and have various renewal options. These leases are classified as either capital leases or operating leases based on the terms of the respective agreements. Future minimum payments at December 31, 2004, by year and in the aggregate, under capital leases and noncancellable operating leases with initial terms of one year or more consist of the following (in thousands):

                 
    CAPITAL     OPERATING  
    LEASES     LEASES  
2005
  $ 479     $ 7,609  
2006
    469       6,803  
2007
    471       5,324  
2008
    478       4,634  
2009
    414       3,059  
Thereafter
    2,311       15,538  
 
           
Total minimum lease payments
    4,622     $ 42,967  
 
             
Amount representing interest (at rates ranging from 3.94% to 9.74%)
    (1,805 )        
 
             
Present value of net minimum lease payments (including $271 classified as current)
  $ 2,817          
 
             

11. COMMITMENTS AND CONTINGENCIES

LITIGATION SETTLEMENT

     In January 2005, the Company executed a confidential settlement agreement (the “Settlement Agreement”) to resolve litigation and other disputes arising in 2002. Under the terms of the Settlement Agreement, the Company paid $0.5 million in January 2005 for conditions satisfied under the terms of the Settlement Agreement. This amount has been expensed and accrued in the December 31, 2004 financial statements. The Company also funded approximately $2.5 million in an escrow account payable over a two year period upon the satisfaction of certain future events, including non-competition.

COMMITMENTS

     In 2004, the Company began construction of a new 60-bed acute care hospital in Ft. Mohave, Arizona. This new hospital is currently estimated to cost approximately $31,000,000, of which approximately $7,790,000 has been incurred at December 31, 2004. Construction of the Ft. Mohave facility is anticipated to be completed in the third quarter of 2005. In 2004, the Company also began construction of a 52-bed replacement facility for its existing 72-bed facility in Eunice, Louisiana. The replacement facility is estimated to cost approximately $25,600,000, of which approximately $1,095,000 has been incurred at December 31, 2004. Construction of the Eunice replacement facility is anticipated to be completed in the second quarter of 2006.

GENERAL LIABILITY CLAIMS

     The Company is subject to claims and suits arising in the ordinary course of business, including claims for damages for personal injuries, employment-related claims, breach of management contracts and for wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions, plaintiffs may seek punitive or other damages against the Company, which are generally not covered by insurance. In management’s opinion, the Company is currently not a party to any proceeding that would have a material adverse effect on the Company’s results of operations or financial condition.

ACQUISITIONS

     The Company has acquired hospitals with prior operating histories. The hospitals that the Company acquires may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations. Although the Company obtains

F-23


Table of Contents

contractual indemnification from sellers covering these matters, such indemnification may be insufficient to cover material claims or liabilities for past activities of acquired hospitals.

PHYSICIAN COMMITMENTS

     In order to recruit and retain physicians to the communities it serves, the Company has committed to provide certain financial assistance in the form of recruiting agreements with various physicians. In consideration for a physician relocating to one of its communities and agreeing to engage in private practice for a specified period of time, the Company may loan certain amounts of money to a physician, generally not to exceed a period of one year, to assist in establishing his or her practice. The actual amount of such commitments to be subsequently advanced to physicians often depends on the financial results of the physicians’ practice during the guarantee period. Amounts advanced under the recruiting agreements are generally forgiven pro rata over a period of three years contingent upon the physician continuing to practice in the respective community. Estimated future commitment payments for physicians under recruiting agreements in effect at December 31, 2004 are approximately $22,895,000.

12. RETIREMENT PLANS

     The Company sponsors defined contribution employee benefit plans which cover substantially all employees. Employees may contribute a percentage of eligible compensation subject to Internal Revenue Service limits. The plans call for the Company to make matching contributions, based on either a percentage of employee contributions or a discretionary amount as determined by the Company. Contributions by the Company to the plans totaled $3,281,000, $3,198,000 and $2,854,000 for the years ended December 31, 2004, 2003 and 2002, respectively.

     The Company sponsors a nonqualified supplemental deferred compensation plan for selected management employees. As determined by the Board of Directors, the plan provides a benefit of 1% to 3% of the employee’s compensation. The participant’s amount is fully vested, except in those instances where the participant’s employment terminates for any reason other than retirement, death or disability, in which case the participant forfeits a portion of the employer’s contribution depending on length of service. Plan expenses totaled $122,000, $148,000 and $226,000 for the years ended December 31, 2004, 2003 and 2002, respectively.

13. FAIR VALUES OF FINANCIAL INSTRUMENTS

     Cash and Cash Equivalents-The carrying amount reported in the consolidated balance sheets for cash and cash equivalents approximates fair value.

     Accounts Receivable and Accounts Payable-The carrying amount reported in the consolidated balance sheets for accounts receivable and accounts payable approximates fair value.

     Long-Term Obligations-The carrying value of the Company’s 4 1/2% Notes, 4 1/4% Notes, and 7 1/2% Senior Subordinated Notes was $75,970,000, $172,500,000 and $200,000,000, respectively, at December 31, 2004. The fair value of the Company’s 4 1/2% Notes, 4 1/4% Notes, and 7 1/2% Notes was $76,540,000, $174,656,000 and $209,962,000, respectively, at December 31, 2004, based on the quoted market prices at December 31, 2004.

     Interest Rate Swap Agreement-The fair value of the Company’s interest rate swap agreement is $1,663,000 at December 31, 2004, based on quoted market prices for similar debt issues.

14. ALLOWANCES FOR DOUBTFUL ACCOUNTS

     A summary of activity in the Company’s allowance for doubtful accounts is as follows (in thousands):

                                         
                            Accounts        
    Balance at     Provision for     Allowances     Written Off     Balance at  
    Beginning of     Doubtful     Acquired in     Net of     End of  
    Period     Accounts     Acquisitions     Recoveries     Period  
Year ended December 31, 2002
  $ 44,476     $ 53,201     $ 10,729     $ (43,694 )   $ 64,712  
Year ended December 31, 2003
  $ 64,712     $ 72,583     $     $ (70,460 )   $ 66,835  
Year ended December 31, 2004
  $ 66,835     $ 95,015     $ 19,547     $ (103,123 )   $ 78,274  

F-24


Table of Contents

15. QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

     Quarterly financial information for the years ended December 31, 2004 and 2003 is summarized below (in thousands, except per share data):

                                 
    Quarter  
    First     Second     Third     Fourth  
2004
                               
Net revenues
  $ 200,577     $ 208,534     $ 235,315     $ 238,480  
Income from continuing operations
  $ 12,207     $ 11,830     $ 11,891     $ 14,128  
Discontinued operations
    (646 )     6,369       (362 )     (918 )
 
                       
Net income
  $ 11,561     $ 18,199     $ 11,529     $ 13,210  
 
                       
Basic earnings (loss) per share:
                               
Income from continuing operations
  $ 0.25     $ 0.24     $ 0.24     $ 0.28  
Discontinued operations
    (0.01 )     0.13       (0.01 )     (0.02 )
 
                       
Net income
  $ 0.24     $ 0.37     $ 0.23     $ 0.26  
 
                       
Diluted earnings (loss) per share:
                               
Income from continuing operations
  $ 0.24     $ 0.23     $ 0.23     $ 0.27  
Discontinued operations
    (0.01 )     0.11       (0.01 )     (0.02 )
 
                       
Net income
  $ 0.23     $ 0.34     $ 0.22     $ 0.25  
 
                       
2003
                               
Net revenues
  $ 182,443     $ 183,935     $ 184,789     $ 195,041  
Income from continuing operations
  $ 9,892     $ 9,919     $ 10,201     $ 11,708  
Discontinued operations
    (41 )     (258 )     (394 )     (9,408 )
 
                       
Net income
  $ 9,851     $ 9,661     $ 9,807     $ 2,300  
 
                       
Basic earnings (loss) per share:
                               
Income from continuing operations
  $ 0.20     $ 0.20     $ 0.21     $ 0.24  
Discontinued operations
                (0.01 )     (0.19 )
 
                       
Net income
  $ 0.20     $ 0.20     $ 0.20     $ 0.05  
 
                       
Diluted earnings (loss) per share:
                               
Income from continuing operations
  $ 0.20     $ 0.20     $ 0.21     $ 0.23  
Discontinued operations
                (0.01 )     (0.16 )
 
                       
Net income
  $ 0.20     $ 0.20     $ 0.20     $ 0.07  
 
                       

     The amounts presented in the preceding table for the first quarter of 2004 and 2003 reflect the restatement of Brim Healthcare, Inc. as a discontinued operation. The Form 10-Q for the quarterly period ended March 31, 2004, as filed, reflected Brim Healthcare, Inc. in continuing operations. The restatement of Brim Healthcare, Inc. as a discontinued operation resulted in a decrease of $4,299,000 in net revenues, an increase in income from continuing operations of $63,000 and an increase in the loss from discontinued operations of $63,000 for the quarter ended March 31, 2004. The restatement of Brim Healthcare, Inc. as a discontinued operation resulted in a decrease of $4,021,000 in net revenues, a decrease in income from continuing operations of $147,000 and a decrease in the loss from discontinued operations of $147,000 for the quarter ended March 31, 2003. The restatement of Brim Healthcare, Inc. as a discontinued operation did not have any effect on net income for the quarters ended March 31, 2004 and 2003.

16. SUBSEQUENT EVENT

        On March 18, 2005, in connection with the pending acquisition by LifePoint, the Company commenced a cash tender offer and consent solicitation for any and all of its 7 1/2% Senior Subordinated Notes. In addition, Lakers Holding Corp., a subsidiary of LifePoint, commenced a cash tender offer on that date for any and all of the Company’s 4 1/4% Notes. The tender offer consideration for each $1,000 principal amount of 7 1/2% Senior Subordinated Notes validly tendered and accepted for purchase will be based on a fixed spread of 50 basis points over the yield on the price, as of April 12, 2005, of the 2.625% U.S. Treasury Note due May 15, 2008, plus accrued interest minus a consent payment equal to $20 per $1,000 principal amount tendered and accepted for purchase. The tender offer consideration for each $1,000 principal amount of 4 1/4% Notes validly tendered and accepted for purchase will be $1,060, plus accrued interest. The tender offer on the 7 1/2% Senior Subordinated Notes is scheduled to expire on April 15, 2005 and the tender offer on the 4 1/4% Notes is scheduled to expire on April 14, 2005, unless extended or terminated earlier.

F-25